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Abstract
Australian elapid venoms are composed of multiple protein toxins. There is a paucity
of data for the structure of these toxins. Mass spectrometry provides avenues for
investigating the proteins found within Australian snake venoms. In this thesis, native
mass spectrometry was used to analyse the whole venoms of Acanthophis antarcticus
(common death adder), Notechis scutatus (mainland tiger snake), Oxyuranus
microlepidotus (inland taipan) and Oxyuranus scutellatus scutellatus (coastal taipan).
Whole venoms were fractionated using size exclusion chromatography prior to mass
spectrometry analysis. The protein fractions in the venoms could be separated into
four mass categories (red > 100 kDa; yellow 100 to 40 kDa; green, 40 to 6 kDa; blue,
< 6 kDa). Variations in the number and masses of venom proteoforms were reported
between this thesis and previous investigations. This was attributed to differences in
venom protein expression between individual snakes, and from different geographical
locations.
The next objective of this thesis was to screen the Australian elapid venoms for
trimeric phospholipase A2 (PLA2). For this analysis, snake species from the genera
Acanthophis, Notechis, Oxyuranus and Tropidechis were investigated. Size exclusion
chromatography for each of the venoms yielded peaks with elution volumes expected
for trimeric phospholipase A2. These size exclusion fractions were then analysed for
phospholipase A2 activity using a colorimetric assay. All size exclusion fractions
suspected to contain trimeric phospholipase A2 were found to have PLA2 activity.
SDS-PAGE and sequence analysis of these fractions indicated that they contained
PLA2, as well as other venom proteins (such as factor Xa-like proteins). Subsequent
native mass spectrometry of these size exclusion fractions confirmed that all of the
vii

venoms contained heterotrimers, which had genera-specific characteristics.
Investigations into the glycosylation of these toxins indicated that the trimeric PLA2
from the Notechis genera had two glycosylated subunits, and one of the trimer
isoforms from the venom of Tropidechis carinatus (rough-scaled snake) was not
glycosylated. All other trimers had a single glycosylated subunit. Mass differences
between trimer isoforms were primarily due to differences in glycosylation. Ion
mobility mass spectrometry analysis of the trimeric phospholipase A2 indicated that
they all have similar three-dimensional architectures based on collisional cross
sections.
A continuous mass spectrometry assay was developed to measure the enzymatic
activity of phospholipase A2 against phosphatidylcholine liposomes. The experimental
setup allowed for the measurement of the activity of paradoxin (PDx), a trimeric
phospholipase A2 from the venom of the inland taipan, at a toxicologically relevant
concentration. Further experimentation revealed that the kinetic parameters obtained
for paradoxin were similar to those obtained for a viper toxin using a pH stat method.
These values for PDx were Vmax, 14.9 nMs-1, Km 97.1 µM and kcat 2.5 s-1. The activity
of paradoxin was also measured in the presence of different divalent metals. In
agreement with the literature, these experiments showed that paradoxin required
calcium to be active, and that the greatest activity for paradoxin was observed when
both calcium and magnesium were present.
The instrument conditions for the analysis of intact oligomeric complexes using the
Agilent 6560 ion mobility Q-TOF, a drift tube ion mobility mass spectrometer, were
determined. These settings were used to measure the collisional cross sections of some
standard native proteins over a mass range ~8-330 kDa, the results of which were
viii

mostly comparable to previous investigations. The Agilent 6560 ion mobility Q-TOF
was then used to determine the collisional cross sections of paradoxin and its subunits.
This was done to determine the effectiveness of paradoxin and other venom proteins
as calibrants for collisional cross section estimates using travelling wave ion mobility
mass spectrometry. When paradoxin and its subunits were used as calibrants, the
collisional cross section calculations obtained for most protein ions over a mass range
of ~12-70 kDa were within three percent of the literature values determined previously
using drift tube ion mobility mass spectrometry (DTIM-MS). Travelling wave ion
mobility mass spectrometry (TWIM-MS) investigations revealed that paradoxin is
highly resistant to conformational changes induced by organic solvents or collisional
energy. These structural properties made it ideal for use as a calibrant for measuring
the collisional cross section of other proteins using TWIM-MS.
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Chapter 1 : General Introduction
Organisms capable of producing cytotoxins are found throughout nature. Some
eukaryotic organisms have developed specialized glands capable of producing toxins, as
well as tools (such as hollowed fangs or stingers) for delivering them into their target.
Solutions containing toxins produced and delivered in this fashion are referred to as
venoms.
Snakes from the families Viperidae and Elapidae are endowed with the ability to produce
venom, which contain many protein constituents that exhibit toxic activities. Some of
these proteins have been investigated for use as therapeutic or diagnostic agents. Many
of the protein components found in Australian elapid venoms, such as the trimeric
phospholipase A2 (PLA2) have yet to be fully characterized. This thesis describes the
characterization of some of these enzymes and presents the development of some mass
spectrometry (MS)-based methods which utilize PLA2 in the method.

1.1.

Snake venoms

In many Australian habitats, snakes play the crucial role of the mesopredator; they feed
on small mammals but are eaten by larger carnivores. The inherent competitiveness
within these systems is a biological arms race between the prey, predators and competing
species. The weapon of choice for snakes belonging to the family Elapidae is highly toxic
venom.1, 2 Australia’s venomous land snakes belong to this family. Their venoms contain
multiple proteins and peptides, which can induce a variety of physiological effects, such
as coagulopathy, neurotoxicity and myotoxicity.3-11 The relatively high potency of these
venoms in mouse models compared to those of other snakes from around the world has
1

led to native elapid species becoming an iconic feature of Australia’s dangerous wildlife.
Evolutionary studies have given some insight as to how these deadly cocktails have
developed.
1.1.1.

Evolution of snake venoms

Snake venoms contain toxins which evolved from non-toxic proteins, and act
synergistically together to induce cytotoxic effects.6, 12-14 It has been hypothesized that
the toxic components have not evolved in a linear fashion, but have switched back and
forth from being toxic to non-toxic over time.10 When a venom protein gains cytotoxic
activity, it may lose its previous non-toxic function. Specific examples of this are
discussed in Chapter 3. The selection pressures on a specific snake family affects the rate
at which this switching occurs.15
In the context of reptile evolution, Elapidae is a relatively young family, with a high rate
of speciation (Figure 1.1). This is reflected in the diversity of proteins found within their
venoms, as well as the pharmacological effects they exhibit. Examination of RNA
transcripts by Fry and colleagues2 suggests that elapid venoms are currently subject to
positive evolutionary selection; they are undergoing rapid diversification, generating
novel toxins. Further work by the same group suggests that positive selection is leading
to the development of a broader tool kit of toxic proteins.15 This study also suggested that
once a ‘sufficient’ number of toxins has developed, the venoms will be subject to negative
selection pressures, resulting in the phasing out of redundant venom components. The
multi-subunit PLA2 could be an example of an evolutionarily recent adaptation due to
positive selection, as these potent toxin complexes have only been found in a few
Australian elapid species. These multi-subunit toxins are the key focus of this thesis.
2

Figure 1.1: Abridged evolutionary
tree of the family Elapidae.
Snake species of interest in this
research for Acanthophis (red),
Notechis (purple), Oxyuranus (blue)
and
Tropidechis
(green)
are
highlighted. Taken from Figueroa et
al. (2016).16
Multi-subunit PLA2 have been found in some brown snake (Pseudonaja, hexameric),
death adder (Acanthophis, trimeric) and taipan (Oxyuranus, trimeric) venoms.17-23 These
snake genera are closely related (Figure 1.1), suggesting that PLA2 oligomerisation is a
recent evolutionary event. However, transcriptomics work has indicated that multisubunit PLA2 are more wide-spread, and thus are found in more distantly related genera,
such as Tropidechis.2, 24 If true, the rapid rate of evolution of elapid toxin could mean that
oligomeric PLA2 assemblages other than what has been reported (trimers and hexamers)
may exist in the Australian elapid venoms.17-23 The fact that hexameric PLA2, up to this
3

point, have only been reported in the venom of Pseudonaja textilis supports this line of
thought. One technique that could be harnessed for detecting the presence of these
oligomers and characterizing their structure is electrospray ionization mass spectrometry
(ESI-MS, see section 1.3.1 on page 17 for details).
The evolutionary pressures described above also likely affect the post-translational
modifications on elapid toxins. For example, mass differences between the glycosylated
subunits of trimeric PLA2 from taipan and death adder venoms suggests that there are
inter-genera and -species differences in the glycosylation for the elapids.17, 18, 25 An indepth analysis would allow researchers to see the range of modifications for these toxins.
This information could then be used to determine whether the different modifications
correlate with differences in pharmacological effects between toxins. This correlation
may support evolutionary data used to estimate the rate of change for the posttranslational modifications and provide insight into why they occurred. The paucity of
data available for post-translational modifications on these toxins, as well as their native
structures is due to the range of techniques previously available to investigate the
composition of these venoms, which do not directly reveal the molecular details of
glycosylation (discussed in section 1.2.4 on page 15).
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1.1.2.

Composition of Australian snake venoms and activities of the protein
constituents

Table 1.1 shows common proteins found in the venoms of snake species from the genera
Acanthophis, Notechis and Oxyuranus. They include PLA2, long and short chain
neurotoxins (three finger toxins), Kunitz type protease inhibitors, L-amino acid oxidases
and factor Xa-like proteins (FXa).

Factor Va-like

5ʹ-nucleotidase

SVMP

Acetlycholinesterase

L-amino acid oxidase

Factor Xa-like

C-type lectin

Nerve growth factor

PLA2 inhibitor

PLA2

Vespryn

KPI

LCN

Snake species

SCN

Table 1.1: Composition of elapid snake venoms detected by Birrell et al. (2007).4

A. antarcticus
✔ ✔
✔
✔
✔ ✔ ✔
N. scutatus
✔ ✔
✔
✔ ✔ ✔
N. a. niger
✔ ✔
✔
✔ ✔ ✔ ✔ ✔
N. a. serventyi
✔ ✔
✔
✔
✔ ✔
✔
O. microlepidotus ✔ ✔
✔ ✔ ✔
✔
✔ ✔
O. s. scutellatus
✔
✔
✔
✔
✔ ✔
T. carinatus
✔ ✔ ✔ ✔
✔
✔ ✔ ✔
Proteins were identified using mass spectrometry to sequence peptide fragments obtained
from the trypsin digestion of protein blots excised from 2D SDS-PAGE. Abbreviations:
short chain neurotoxins, SCN; long chain neurotoxins, LCN; Kuntiz-type serine protease
inhibitor; KPI; phospholipase A2, PLA2; snake venom metalloprotease, SVMP. Table was
adapted from Birrell et al. (2007).4
Factor Va-like proteins (FVa) are also a feature of taipan venom.2, 4 These proteins are
likely a recent product of positive evolutionary selection, as they only appear in the
venoms of Oxyuranus (taipan) and Pseudonaja (brown snake).2,

4, 48, 50

Another

observation that can be made from the data published by Birrell et al. (2007),4 is that there
5

appears to be a weak correlation between the absence of FXa and the presence of snake
venom metalloprotease. This could suggest some degree of negative selection within
elapid venoms. However, without proteomics and genomics data from multiple snakes, it
is impossible to firmly make this assertion. This highlights the need for more detailed
investigations of these toxins in order to precisely determine their compositions, which
will inform which components of these venoms are undergoing positive or negative
evolutionary selection.

1.2.

Phospholipase A2

Phospholipases are the largest group of lipid-modifying enzymes, and are wide-spread in
nature, and have many physiological roles.26 These enzymes can be separated into five
classes based on which ester bond of the phospholipid they hydrolyse (Figure 1.2).
Secreted PLA2 are a major component of Elapidae venoms.4, 27 They have masses in the
range of 12.5 and 15 kDa, based on amino acid sequence,27,

28

and can also be

glycosylated, leading to a total mass of around 17-20 kDa.17, 25 These proteins also contain
six to eight inter-subunit disulfide bonds, which help maintain their tertiary structure.17,
27-29

Evolutionary evidence indicates that snake venom PLA2 are modified versions of an

ancestral digestive enzyme.14, 30
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Figure 1.2: Hydrolysis sites of phospholipase.
Hydrolysis sites for the classes of phospholipases are indicated on structure of a generic
phospholipid, where R represents the head group. PLA1 cleave at the sn-1 position and
PLA2 cleave at the sn-2 position of fatty acid chains on a phospholipid. PLB cleave both
the sn-1 and sn-2 fatty acid chains. PLC hydrolyses the phosphodiester bond distal to the
head group. PLD removes the polar head group.27, 31
1.2.1.

Physiological effects of cytotoxic PLA2 found in Australian snake venom

The role of PLA2 is to help incapacitate and kill prey via the cytotoxic activities of
myotoxicity, neurotoxicity and/or antiplatelet activity,28, 32 as well as assist in breakdown
of food.9, 33, 34 Generally, these toxins only induce one type of cytotoxicity, however, some
toxins such as crotoxin from the venom of nose-horned viper (Europe and Middle East)
and notexin from the mainland tiger snake (Australia), have multiple toxicities.32 There
are many features of these modes of toxicity, such as the cellular targets of the multisubunit variants of these toxins, which are unknown. The proposed mechanisms for how
PLA2 induce neurotoxicity and myotoxicity are very similar (Figure 1.3).
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Figure 1.3: PLA2 mechanisms for myotoxicity and neurotoxicity.
The proposed mechanisms that PLA2 use to induce myotoxicity (A) or neurotoxicity (B)
are as follows: 1. Myotoxic PLA2 bind to muscle cells via lipid protein domains or cell
surface receptors, which is noted with an R in A, while neurotoxic PLA2 target neuronal,
pre-synaptic cell surface receptors which are noted with an R in B. 2. Surface-bound PLA2
hydrolyses membrane phospholipids leading to the formation of pores. 3. Change in
osmotic pressure within the cell causes Ca2+ influx, some PLA2 and other venom
constituents enter the cell, affecting many cellular processes and organelles. Figure was
taken from Montecucco et al. (2008).32
Most neurotoxic PLA2 work pre-synaptically (β-neurotoxins),35-37 and it is thought they
bind to cell surface receptors,38-40 while myotoxic PLA2 are reported to target lipid
membrane domains and cell surface proteins.41 Once PLA2 binds to a cell, it hydrolyses
the phospholipids that constitute the plasma membrane, leading to the formation of pores
and an influx of Ca2+ and venom proteins into the cell.32 Ringoni et al. (2008)
demonstrated that, in nerve cultures, lyso-lipids (produced as a result of membrane lipid
hydrolysis by PLA2) also disrupted neuronal cell membranes.42 The proteases and PLA2
which enter the cell hydrolyse and damage intracellular membrane systems.32 For
example, snake venom neurotoxins with presynaptic neurotoxic activity enter cells and
damage mitochondria.43 Damage caused by PLA2 can be reversible or irreversible,
depending on the mode of action.32, 44 An example of this is the irreversible damage
caused by myotoxins that induce necrosis of muscle cells45 or reversible damage caused
by neurotoxins that leads to the hydrolysis of synaptic vesicles.32
8

These considerations highlight the challenges in determining the mechanism(s) of action
for toxic elapid PLA2. Firstly, the multitude of effects that these toxins can have on a
target cell can make it difficult to decipher and assign the magnitude for each effect. For
example, what are the relative effects of cell membrane disruption due to enzymatic
activity and/or lyso-lipid insertion? Do the lyso-lipids produced by hydrolysing the
mitochondrial membrane affect other organelles? And if so, to what extent? Previous
work has provided insight to the cytotoxic mechanisms of elapid PLA2,42, 43, 46, 47 however,
there are still more details about these mechanisms that need to be fully elucidated. The
second challenge is in determining and comparing the PLA2 under toxicologicallyrelevant conditions. Rigoni et al. (2008) reported that the enzymatic activity determined
from a colorimetric assay did correlate to the ability of a toxin to damage mitochondria.43
However, Paoli et al. (2009) found no obvious correlation in enzyme activities of the
elapid PLA2 between nerve cells and the colorimetric assay, and found that the nerve cell
PLA2 activity was significantly lower than that measured in the in vitro colorimetric
assay.47
One of the major reasons for this difference is likely that the colorimetric assay uses a
single type of modified lipid (PC, where the sn-2 ester oxygen has been replaced by a
sulfur atom), and measurements were made in the presence of detergent. This means that
although the assay is useful for determining if PLA2 activity is present in a sample, it does
not necessarily comment on activity against physiologically-relevant lipids within a lipid
bilayer. Finally, the structural motifs responsible for the cytotoxic activity of elapid PLA2,
as well as their cellular targets have yet to be fully elucidated. The current state of
knowledge in this regard is presented below.
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1.2.2.

Structural motifs involved in cytotoxic activity

Studies aimed at determining snake venom PLA2 structural motifs involved in cytotoxic
activity have primarily focused on snakes from the family Viperidae. These toxins are of
a similar structure to those found in Australian snake venoms (Figure 1.4). The most in
depth research has been conducted on ammodytoxin, a neurotoxic Viperidae PLA2
monomer. The amino acids which are primarily responsible for neurotoxic activity of this
toxin are (motif 1) located on and near the three α-helices above the calcium loop, (motif
2) the β-wing and its adjacent α-helix (Figure 1.4).48-53

Figure 1.4: Structural motifs involved in cytotoxic activity of snake venom PLA2.
A Crystal structure of ammodytoxin from the long-nosed viper (A. ammodytes, PDB:
3G8H)54. Amino acids which effect cytotoxic activity (via point mutations, shown as
sticks) are located in two distinct regions of this toxin. B Crystal structure of notexin from
the mainland tiger snake (N. scutatus, PDB: 1AE7)55. The analogous structural regions
for motifs 1 and 2 of ammodytoxin are labelled on this structure.

A substantial change in cytotoxic activity occurred when the amino acids 105-109
(YIYRN) were changed to KKYML (motif 1, Figure 1.5A). These changes led to a more
than 200-fold decrease in toxicity but increased enzymatic activity. This structural motif
is likely involved in the binding of ammodytoxin to a specific cell receptor, such as
cytochrome c oxidase, its proposed cellular target for binding to the mitochondrial
10

membrane.56 There has been one study investigating the same region on notexin, a
monomeric PLA2 from the venom of Notechis scutatus. Chemical modification of a Trp
residue which corresponds to W116 on the crystal structure of notexin (Figure 1.5B55)
reduced its toxicity by approximately 10-fold without changing the enzymatic activity.57
This amino acid is located in the same structural region as R108 in motif 1 on
ammodytoxin (comparison of Figure 1.5A and B). A closer inspection of amino acids in
the region of motif 1 for notexin (Figure 1.5B) reveals a cluster of aromatic and positive
residues (R17, H21 and W116). These amino acids are not present in this region for nontoxic PLA2.58-60 These data suggest this region may be responsible for the neurotoxic
activities of PLA2 from elapids. Comparison of motif 2 of ammodytoxin to the
structurally analogous regions of notexin shows that the latter also contains a number of
aromatic and positive amino acids in this region (Figure 1.5C and D). Evolutionarily, this
may suggest that the use of these structural regions for inducing cytotoxic effects may
have evolved before vipers and elapids split into distinct groups.
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Figure 1.5: Comparison of ammodytoxin toxic motifs to notexin.
A Amino acids shown to affect toxicity (point mutations) in motif 1 from ammodytoxins.
B The analogous structural region in notexin, with aromatic and positive amino acids
shown as sticks. The single amino acid thought to be involved in the cytotoxic activity of
this toxin (W116) is labelled. C Amino acids shown to affect toxicity (point mutations)
in motif 2 from ammodytoxin. D The analogous structural region in notexin, with
aromatic and positive amino acids shown as sticks.
The effect of individual residues on the activity of PLA2 highlights the importance of
having accurate structural and sequence data for these proteins, as regions and individual
residues from PLA2 described above can be identified as having a role in toxicity,
enzymatic activity or the binding of Ca2+. The data presented in these studies support the
hypothesis proposed by Casewell et al. (2012), that PLA2 evolution may have been
dynamic, rather than direct,14, 30 as the amino acids relating to toxicity may be, at least in
12

some cases, separate from enzymatic activity.10 Understanding the mechanism these
toxins use to induce their cytotoxic effects could be important for medical research. Some
of these toxins have been shown to have anticancer activity.61 It is possible that the
specific activities PLA2 can be modified, meaning it may be possible to change the target
and/or reduce the toxicity of a PLA2 for use as anticancer agents or for other therapeutic
effects.
1.2.3.

Oligomerisation and cytotoxic activity

Investigations into the whole venoms of many snake species revealed that PLA2 enzymes
can have a variety of quaternary structures.23,
enzymatically active subunit,17,

21, 63

62

Multimeric PLA2 have only one

however, assembly with the inactive subunits

enhances the overall toxicity of the complex.63 The effects of the inactive subunits on
toxicity have been demonstrated using a number of PLA2.17, 19, 21 The potency of a toxin
is related to the total binding affinity of its subunits.63 However, it has previously been
demonstrated with taipoxin (TPx, the trimeric PLA2 from the venom of the coastal taipan)
that not all subunits are necessary to elicit a specific toxicity.64 Specifically, it was shown
that only the γ subunit of that toxin only had a role in enhancing the myotoxic activity.
Also, by comparing relative masses to the amino acid sequence, the γ subunit has a
substantial glycan attached. Figure 1.6 shows the theoretical three-dimensional structure
of the γ subunit of TPx, generated from structural predictions based on its amino acid
sequence. Based on the work of Harris and Maltin (1982)64 described above, it is likely
that the glycan has a role in the myotoxic activity of this toxin. However, its actual effect
on toxicity is unknown.
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Figure 1.6: Predicted location of the glycan on the γ subunit of TPx, based on the work
presented in Fohlman et al. (1977).65
The three-dimensional model for the γ subunit of TPx was generated using (PS)2-v2
protein structure prediction server66, 67 (http://ps2.life.nctu.edu.tw/index.php) from the
available sequence data.65 The model was reconstructed using the crystal structure (PDB:
1GP768) of an acidic PLA2 from the venom of king cobra (Ophiophagus hannah) as a
template. The amino acid proposed to be the site of glycation (N97), based on the peptide
sequence data of Fohlman et al. (1977)65 is shown in orange.
A study by Faure et al. (1993) indicated that there is a relationship between the stability
of the dimeric toxin, cotroxin from the south American rattle snake (Crotalus durissus
terrificus) and the lethality of this toxin.69 There are also multiple facets to consider when
assessing the potency of PLA2; an example of this is the ability of PLA2 to target
mitochondria.43 The potency against mitochondria is proportional to the enzymatic
activity of the toxins tested.43 However, owing to the lack of data for the cellular targets
and kinetics of PLA2, it is difficult to identify all the factors which affect toxicity.70
Without this information, it is impossible to examine the effects of oligomerisation on
activity against the organelles of snake PLA2 cellular targets.
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The majority of studies conducted on multimeric PLA2 from native snake species have
inferred their quaternary structure based on their subunit masses and their size exclusion
chromatography profiles.17,

20, 21, 65

These methods do not accurately predict the

stoichiometry of a protein complex, particularly when a subunit is of a relatively low
molecular mass. The three-dimensional conformation of these toxins has yet to be fully
elucidated. Furthermore, there is a paucity of data available for the peptide sequence and
the type and extent of glycosylation of the oligomeric PLA2. This information could be
obtained using modern mass spectrometry (MS) techniques. MS has previously been used
to determine the subunit stoichiometry of the multi-subunit PLA2 from the brown snake
and taipan venoms.23, 25
1.2.4.

Techniques used to investigate multi-subunit PLA2

The investigations into the evolution and composition of Australian snake venoms have
utilized a variety of techniques.2, 4, 14, 15, 71-76 For example, size exclusion chromatography
(SEC) has been used to estimate the mass of the multi-subunit PLA2.17-21 Sequence data
obtained via Edman degradation65,
spectrometry (LC-MS/MS)4,
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77, 78

and liquid chromatography tandem mass

were used to determine the stoichiometry of toxin

complexes. Using gel filtration and subunit masses alone led to Pearson et al. (1993)19
mischaracterising the multi-subunit PLA2 textilotoxin as a pentamer; the correct subunit
stoichiometry (hexamer) was later determined using native nanoESI-MS.23 This is due to
the higher resolving power of ESI-MS techniques for protein masses compared to gel
filtration.
A similar situation occurred with the trimeric PLA2 from the inland and coastal taipans,
where large differences in glycosylation and subunit diversity between the trimeric toxins
15

from these venoms were missed.25 Comparisons of whole PLA2 monomer sequences
obtained from transcriptomes also suggest that the multi-subunit PLA2 exist in more
venoms than those currently known.2
Determining the prevalence of these toxins existing in elapid venoms, as well as their
subunit diversity is of great importance. Toxin isoforms can exhibit disparate activities63,
64, 69

and they make up about 10% (w/w) of the protein in the deadliest venoms, and have

comparatively lower LD50 than many of the other components.19, 20, 22, 25 Without this
information, the causes for the differences in potency between elapids could be difficult
to determine. Overall, the current data highlight the need for further structural analysis of
these toxins. One technique that can be used for the analysis of native structures is MS.

1.3.

Mass spectrometry

Mass spectrometry is primarily used to measure the mass of ionized, gaseous molecules
based on their mass-to-charge ratio (m/z) and has played an important role over the last
century79-81 in proteomics, glycomics, drug discovery, clinical testing and geology. Over
the last three decades, it has become a powerful tool for investigating and characterising
the mass and sequence of proteins, as well as the subunit stoichiometry of protein
complexes.82-85 The ability to analyse these characteristics has been primarily due to the
development of MS ionization conditions which maintain the integrity of biomolecules.86,
87

The development of these techniques has allowed the analysis of protein complexes

with masses well into the mega Dalton range.88
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1.3.1.

Electrospray ionization

There are a variety of ionization techniques available for MS experiments. The earliest
methods of ionization led to fragmentation of biomolecules, thus preventing the analysis
of intact proteins. This limitation was overcome with the development of electrospray
ionization (ESI). In this technique, a solution is passed through a capillary to which an
electrical current is applied. This creates a Taylor cone, causing the formation and
emission of charged droplets containing analytes (Figure 1.7). In the ionization source
under a counter-current stream of inert gas, such as nitrogen, the droplets begin to
evaporate, reducing their diameter. Once the droplets are sufficiently small, the reduction
in the distance between like charges causes the droplet to distort, and then burst once the
force of Coulombic repulsion within the droplet exceeds its surface tension (Rayleigh’s
limit). The process of desolvation and Coulombic fission continues until the solvent is
evaporated leaving charged analytes (such as proteins). For proteins, the charged amino
acids exposed on the protein’s outer surface, are ionized, and under some conditions,
noncovalent interactions are preserved.89, 90 One proposed mechanism of ionization is
called the “charge residue model” and it applies for large globular analytes.91 Other
mechanisms have been proposed for low molecular weight analytes (e.g. ion evaporation
model) and disordered polymers (chain ejection model), and are described elsewhere.9194

Depending on the conditions, the exposed basic (positive ion mode) or acidic (negative

ion mode) residues on the surface of the proteins are ionized.80
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Figure 1.7: Nanoelectrospray ionization process for native proteins analysis.
Developed from Gaskell et al. (1997).95
This technique has been further developed by the introduction of nanoelectrospray
ionization mass spectrometry (nanoESI-MS). This version of ESI has advantages when it
comes to analysing the native-like structure of low abundance proteins. For example, this
technique only requires a small amount of sample (~2 µL) compared to ESI experiments.
The reduced flow rate and capillary size also allow for the formation of smaller droplets,
which are more readily evaporated.96, 97 The easier solvent evaporation is thought by some
to help maintain the protein’s quaternary structural integrity, thus improving the detection
of noncovalent protein complexes.82, 94
1.3.2.

Transmission of large biomolecules

To analyse the native structure of a large protein, its ions need to be slowed down as it
passes through the different ion guides of the mass spectrometer onto the detector, while
remaining intact. One of the key ways of doing this is by increasing the gas pressure
during ion transmission. The effect of pressure on the detection of large analytes was first
noted by Douglas and French.98 In that study, they found that an increase in pressure
could lead to higher ion counts for analytes. Investigations in the early 2000s using
18

Micromass LC-T ESI-MS TOF and Mariner orthogonal-acceleration TOF instruments
showed that increasing gas pressure improved the detection of non-covalent protein
complexes.99, 100 Further investigation showed that ions of large protein complexes had
high kinetic energy, with multiple trajectories and required to be slowed down and
focused for efficient ion transmission.101 This is known as collisional focusing –
dissipating analyte kinetic energy by interaction with a neutral gas within an ion guide.94
This is most commonly done with a radio frequency (RF) ion guide and results in more
efficient ‘trapping’ of ions. A detailed overview of the development and analysis of noncovalent complexes by mass spectrometry is presented in a review by Robinson and coworkers.94
The ionization method described in section 1.3.1 has allowed for the analysis of intact
protein complexes. The earliest studies used this technique to analyse heme-bound
myoglobin.90 As the advantages of this technique became more apparent, it was tested on
larger complexes. It was used to show that 4-oxalocrotonate tautomerase is a ~41 kDa
hexameric protein.102 Three years later, the native-like structure of GroEL, a 801 kDa
tetradecamer was detected using ESI-MS.103 Viruses with molecular weights of around
18 MDa have been detected by MS.88 This technique can also be used to analyse proteinprotein and protein-ligand interactions. For example, the subunit exchange of DNAbinding protein from Escherichia coli was monitored using nanoESI-MS.104 This study
showed that subunits with a truncated C-terminal allowed for faster subunit exchange.
NanoESI-MS has also been used to monitor the subunit interactions and effects of posttranslational modification of αB-crystallin, superoxide dismutase 1 and heat shock
protein 27.105-109 These techniques can be coupled with collision-induced dissociation
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(CID) and ion mobility mass spectrometry (IM-MS) to analyse protein native quaternary
architecture, stoichiometry, inter-subunit interactions and topography.23, 110
1.3.3.

Collison-induced dissociation and assignment of subunit stoichiometries

In CID experiments, the collisional cell is used to dissociate non-covalent protein
complexes into their subunits.110 This technique works by increasing the voltage of the
trap collision cell, which leads to ionized proteins colliding with the neutral buffer gas
with higher kinetic energies.83 These collisions can dislodge constituent subunits and at
higher energies, break covalent bonds. Some non-covalent interactions are more
susceptible to CID, for example the absence of solvent in the gas phase (MS experiment)
has been proposed to strengthen electrostatic interactions compared to solution phase
techniques, while weakening or not affecting hydrophobic ones.111 The dissociated
constituents can then be compared to the native-like complex to determine its
stoichiometry. The assignment of dissociation products can be difficult to do without
being able to specify which ion is dissociated. This is overcome by using tandem mass
spectrometry (MS/MS). During MS/MS experiments, a quadrupole which is positioned
before the collisional cell in a Q-TOF mass spectrometer, is used to select ions of a
specific m/z ratio, which are then subjected to collisional energy.83, 112, 113 Structural data
for these complexes can be inferred from the resulting product ions as described below.110,
114, 115

During MS/MS experiments, additional charges cannot be gained by the analyte, as CID
occurs after ionization. Charged amino acids involved in ionic interactions binding
subunits together are protected from protonation. This leads to a symmetrical distribution
of charge states for dissociation products, where the sum of the charges for each
20

corresponding product is equal to that observed for the precursor ion. Hence, the
dissociation of subunits from homogeneous multimeric proteins follows the sequential
pathway23:
y

y

nq →[n-1]q-x +mx1 →[n-2]q-(x+y) +mx1 +m2 →[n-3]q-(x+y+z) +mx1 +m2 +mz3
Where n is the number of subunits in the oligomer, q is the number of charges on the
oligomer, and x/y/z are the numbers of charges carried by a monomer (mn) after
dissociation from the precursor ion. The stoichiometry of the oligomer can then be
assigned by comparing its mass to the dissociated species. The experimental procedure
for achieving this is shown in Figure 1.8. The first step is to acquire a mass spectrum for
the complex of interest. This spectrum may also contain peaks from dissociated subunits
of the complex being analysed which can be used for comparison (monomers in solution).
Typically, the most abundant charge state of the protein complex of interest is subjected
to MS/MS. These ions are referred to as the precursor ions and are subjected to increasing
collisional energy to dissociate the complex into product ions (subunit constituents). The
charged amino acids protected by oligomer formation are not susceptible to ionization on
the subunits that were dissociated prior to ionization. Thus by comparing average charge
state for the monomers free in solution, to those dissociated via MS/MS, it is possible to
estimate the number of ionic interactions protected from ionization by the oligomeric
complex.48 This can be done by calculating and comparing the average charge state (𝑧𝑧)
of the analytes using following equation116:

𝑧𝑧 =

∑ 𝑧𝑧𝑖𝑖 × 𝐼𝐼𝑖𝑖
∑ 𝑧𝑧𝑖𝑖
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Where z is the charge state, I is its corresponding relative intensity and i is the range of
charges. However, care needs to be taken when interpreting these results: if the product
ions unfold during the dissociation process, charges from the oligomer can migrate to the
product ion. An in-depth overview of charge migration during CID experiments can be
found in Popa et al. (2016).117

Figure 1.8: Schematic for determining inter-subunit electrostatic interactions in
oligomeric proteins by MS/MS.
Theoretical spectrum of a heterodimeric protein complex indicated by associated pink
and lavender monomers is analysed by ESI-MS (spectrum, top left), revealing ions from
the dimer (9+, 10+) and ions for individual monomers (5+, 6+,7+). The 10+ ion of the dimer
is selected for MS/MS, dissociating the complex and giving rise to 4+, 5+ and 6+ ions of
the pink monomer and 4+, 5+ and 6+ ions of the lavender monomer. Figure taken from
Harrison and Aquilina (2016).25
1.3.4.

Ion mobility and three-dimensional structure

Over the last 15 years, ion mobility mass spectrometry (IM-MS) has been increasingly
used to analyse protein complexes.118 This technique measures the time it takes for an
analyte carried by an electric field to traverse a gas-filled tube (drift time). The charge,
drift time and mass of an analyte can be used to calculate its collisional cross section
22

(CCS).118, 119 These CCS measurements can be used as a guide to determine the threedimensional structure of proteins, since more compact (folded) structures will have
shorter drift times.119-122 IM-MS has been used to investigate protein folding123, 124 as well
as characterize the quaternary structure of multiple proteins,120,

125, 126

including

membrane proteins.127-130 The two most common types of IM used in protein research are
drift tube ion mobility mass spectrometry (DTIM-MS) and travelling wave ion mobility
mass spectrometry (TWIM-MS). These techniques are briefly described below, and
further discussion is presented in Chapter 6.
The most commonly applied form of ion mobility is DTIM-MS. This technique utilizes a
uniform electric field to push charged species through the drift tube against a counter flow
of buffer gas (Figure 1.9A). Since the ion velocity is directly proportional to the strength
of the electric field, its CCS can be directly calculated via the Mason-Schamp equation118:

1

3𝑧𝑧𝑧𝑧 2𝜋𝜋 2 1
𝛺𝛺 =
�
�
16𝑁𝑁 𝜇𝜇𝑘𝑘𝐵𝐵 𝑇𝑇 𝑘𝑘0
Where Ω is CCS, z is the charge on the analyte, e is the elementary charge, N is the number
density of the drift gas, µ is the reduced mass of the ion-neutral drift gas pair, kB is the
Boltzmann constant, T is gas temperature and k0 is the reduced mobility at standard
temperature and pressure.
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Figure 1.9: Schematic of ion mobility cells for DTIM-MS and TWIM-MS.
A DTIM-MS: Analyte ions (red, blue and green) are carried through the drift tube by a
constant electric field. Ions collide with the drift gas (pale blue) as they travel through the
drift tube. The larger the ion, the more encounters with the buffer gas, increasing the drift
time. B TWIM-MS: An electric wave is created by applying opposing DC voltages to
paired and adjacent rings. This pushes analyte ions (red, blue and green) through the ion
mobility cell. As the ions collide with the drift gas (pale blue), they are pushed back over
the waves. The larger the ion, the more it encounters the drift gas, pushing the ions back
over the wave, increasing the drift time.
TWIM-MS is commonly used for IM analysis of native-like protein structures. These
instruments contain a stacked-ring ion guide in which the paired rings have a direct
voltage (DC) applied, creating a barrier for the ions. The DC voltage is stepped along the
ion guide, which generates an electric field that moves charged species through a gas24

filled tube (Figure 1.9B).118 To measure CCS on a TWIM-MS system the drift time of an
analyte has to be compared to those of multiple charged species of known CCS and
similar average charge.119,
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This is necessary because TWIM-MS does not use a

continuous electric field (unlike DTIM-MS).

1.4.

Aims and scope

This work utilizes the mass spectrometry techniques described above to shed light on the
native structure of proteins found in Australian snake venoms. The prevalence and
structural characteristics of trimeric PLA2 were investigated. This was achieved using a
combination of MS-based techniques: ESI-MS, nanoESI-MS, CID, DTIM-MS and
TWIM-MS. In addition, the high stability of PLA2 and its subunits were exploited to
examine their usefulness as calibrants for CCS measurements in TWIM-MS experiments.
This thesis can be divided into two sections: (1) the screening of the whole venom
components and the structural characterisation of the trimeric PLA2 and (2) the
application of these proteins as reference ions in ion mobility experiments and in the
development of continuous ESI-MS based enzymatic assays.
The methods used to obtain the data presented in this work are given in Chapter 2. Chapter
3 describes the snake venom proteins identified by nanoESI-MS from size exclusion
chromatography of the whole venoms. The compositions of these venoms were compared
and related to the evolution and toxicological effects of these venoms. Chapter 4 shows
more detailed venom screening to look for the prevalence of trimeric PLA2 within these
venoms. MS/MS and CID were used to assign the subunit stoichiometries of these toxins.
MS spectra of denatured proteins were used to probe the subunit diversity and
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glycosylation. The quaternary structures of these proteins were also compared using
TWIM-MS.
Chapter 5 shows the development of a continuous ESI-MS enzymatic assay for the PLA2.
This assay is then used to assess the behaviour of PDx in the presence of liposomes under
different solution conditions. Chapter 6 highlights the conditions required to utilize the
DTIM-MS capabilities of the Agilent 6560 ion mobility Q-TOF for the CCS analysis of
native biomolecules. This mass spectrometer was then used to determine the CCS of PDx
and its subunits. The stabilities of PDx and its constituents in solution and the gas phase
were then investigated using circular dichroism (CD) and TWIM-MS. These very stable
proteins were then used as calibrants for CCS estimations using TWIM-MS, with the
results being compared to those obtained using DTIM-MS.
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Chapter 2 : General materials and methods
All solutions were prepared using Milli-Q water (Millipore, Bedford, USA). The whole
snake venoms were acquired from Venom Supplies Pty Ltd (Tundara, South Australia,
Australia). The venom samples purchased were pooled milks from several captive
individuals. Ammonium acetate (AmOAc), acetonitrile, isopropanol, formic acid,
methanol (MeOH) and hydrochloric acid were purchased from Ajax Finechem (Sydney,
New South Wales, Australia). The Cayman secreted phospholipase A2 assay kits were
purchased from Sapphire Science (Redfern, New South Wales, Australia). Lipids,
liposome extruder and liposome membrane filters were purchased from Avanti
(Alabaster, Alabama, USA). All other reagents were bought from Sigma-Aldrich (St
Louis, Missouri, USA), unless otherwise specified.

2.1.
2.1.1.

Sample preparation
Size exclusion chromatography of whole venom

Whole venom components were fractionated by using size exclusion chromatography.
The AmOAc solution (200 mM) was filtered through a 0.2 µm pore nylon filter before
use for chromatography. Approximately 10 mg of lyophilized venom from each snake
species was dissolved in 200 µL of 200 mM AmOAc. This solution was loaded onto a
Superdex-200 10/30 size exclusion column (GE Healthcare, Uppsala, Sweden), which
was pre-equilibrated with 200 mM AmOAc. Separation was carried out at room
temperature using an NGC chromatography system (Bio-Rad, California, USA), which
measured the absorbance at 280 and 216 nm. Size exclusion fractions (0.5 mL) containing
the whole venom components were collected and stored at -20°C until required.
27

2.1.2.

Preparation of protein samples

Unless otherwise stated, snake venom proteins were taken directly from the size exclusion
chromatography fractions without any further purification. Glutamate dehydrogenase
(GDH) was exchanged into 200 mM AmOAc by size exclusion chromatography (SEC)
using the method described in section 2.1.1. All other lyophilized non-venom proteins
were dissolved in 200 mM AmOAc to obtain solutions containing 5-10 µM of protein.
Fresh haemoglobin solution was prepared by mixing 1 µL of whole blood with 291 µL
of milli-Q water. The isotonic shock caused by the change in salt concentration lysed the
erythrocyte membranes. This solution was then made up to 300 µL by adding 8 µL of
7.5 M of AmOAc (giving 200 mM AmOAc). Based on typical blood levels, the final
haemoglobin concentration was between 7-10 µM in 200 mM AmOAc.
For the ion mobility MS, circular dichroism (CD) spectroscopy and enzyme kinetics
experiments, the concentrations of all proteins, except haemoglobin were determined by
UV absorbance. These measurements were taken at 280 nm on a ThermoFisher
NanoDropTM 2000c spectrophotometer (Waltham, Massachusetts, USA). The proteins’
molar absorption coefficients were calculated from their respective amino acid sequences
(https://web.expasy.org/protparam/). The absorption coefficient of taipoxin (TPx) was
used to estimate the concentration for all the trimeric PLA2, as the complete sequences
for these proteins were not available.
The masses and absorption coefficients for the proteins used in these experiments were:
ubiquitin (8,650 Da, 1,490 M-1cm-1), cytochrome c (12,360 Da, 11,585 M-1cm-1),
myoglobin

(17,560

Da,

13,980

M-1cm-1),

carbonic

anhydrase

(29,100

Da,

50,420 M-1cm-1) human serum albumin (HSA) (66,472 kDa, 34,445 M-1cm-1), glutamate
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dehydrogenase (GDH) (336,510 kDa, 291,570 M-1cm-1) and TPx (~46,000 kDa,
64,520 M-1cm-1). When required, proteins were concentrated using VIVASPIN 500 5 kDa
molecular weight cut-off concentrators (Littleton, Massachusetts, USA) on a Sigma 114K centrifuge (Sigma, Osterode am Harz, Germany).
2.1.3.

Deglycoslation of trimeric PLA2

To determine the masses of the deglycosylated subunits, 140 µL of the size exclusion
fractions containing trimeric PLA2 (protein concentration between 10-20 µM) was mixed
with 40 µL of peptide-N-glycosidase (PNGase) F solution (10 units/mL) and 20 µL of
reaction buffer (500 mM sodium phosphate, 200 mM Tris-HCl, pH 7.5). This solution
was left to react for 60 hours at 37°C. After treatment with PNGase, samples were placed
in 3500 Da molecular weight cut-off dialysis membranes (Spectra/Por, California, USA)
and dialyzed three times against 2 L of 200 mM AmOAc at 4 °C before MS analysis.

2.2.
2.2.1.

Mass spectrometry on the Waters Synapt (G1) HDMSTM
Nanoelectrospray ionization mass spectrometry

For all mass spectra acquired using nanoESI-MS on the Synapt (G1) HDMSTM (Waters,
Wilmslow, Manchester, UK) samples were introduced into the vacuum region of this
instrument by electrospraying 2 µL of solution from a gold-coated borosilicate
nanoelectrospray ionisation (nanoESI) capillary. These nanoESI needles were prepared
by pulling borosilicate glass capillaries (1.00 mm outer diameter, 0.78 mm inner
diameter; Harvard Apparatus, Holliston, Massachusetts, USA) with a Flaming/Brown p97 micropipette puller (Sutter Instruments, Novato, California, USA). A conductive gold
29

coating was applied to the needles using an Emitech K500x sputter coater (Quorum
Technologies, Lewes, East Sussex, UK). Mass spectra were obtained in positive mode.
The mass spectrometer had been modified for high mass range MS/MS.131
The conditions for the acquisitions were as follows (unless otherwise stated): capillary
voltage, 1.5 kV; sample cone, 140 V; extraction cone, 6.0 V; trap collision, 6 V; transfer
collision, 4 V; collision cell gas pressure, 1.57x10-2 mbar; backing gas, 4.0 mbar; trap
bias, 4.0 V. Experiments were carried out for at least 30 acquisitions, at one acquisition
per second. Prior to protein analysis, the instrument was calibrated against CsI solution
(10 mg/mL in 200 mM AmOAc) acquired on the same day. Data were acquired and
analysed using MassLynx version 4.1 software (Waters, Wilmslow, Manchester, UK).
Raw spectra were smoothed using the Savitsky-Golay method, where 24 channels were
smoothed twice. For the mass calculations, smoothed spectra were centred with a
minimum peak width at half height of 12, with a centroid top of 80%. Centred peaks were
manually picked using the ‘manual find components’ feature of MassLynx. The
calculated mass given is the average mass calculated for each charge state of a series. The
mass error between peaks was reported as 1 ± SD. All experiments were performed in
triplicate unless stated otherwise.
2.2.2.

Collisional cross section (CCS) calculations using travelling wave ion
mobility mass spectrometry

Samples were introduced into the mass spectrometer for acquisition of IM spectra using
nanoESI-MS on the Synapt (G1) HDMSTM (Waters, Manchester, UK) as described in
section 2.2.1. The protein concentrations used in these experiments were between 5-10
µM. The following instrument settings were used unless otherwise stated: capillary
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voltage, 1.5 kV; sample cone, 20 V; extraction cone, 2.0 V; trap collision, 6.0 V; transfer
collision, 4.0 V; transfer wave height 8.0 V; transfer wave height input, 251 m/s; IM wave
height, 10.0, 11.0 and 11.5 V; IM wave velocity, 380 m/s; collision cell gas pressure,
3.00×10−2 mbar; IM gas pressure, 5.0x10-1 mbar; backing gas, 4.02 mbar; trap bias, 22.5
V. Spectra were acquired and processed using MassLynx software v4.1 and Driftscope
v2.7 (Waters, Manchester, UK) as described in section 2.2.1.
The spectra acquired to determine the effects of organic solvent treatment, trap and cone
voltage gradients on the drift time of paradoxin (PDx) and its constituents, were converted
into heat maps using CIUsuite.132 All experiments were performed at least three times.
For the TWIM-MS CCS estimations, calibration curves were generated as previously
described by Robinson and colleagues.119 In brief, the mass-dependent flight time for all
ions was calculated using the following equation:

𝑡𝑡 ′𝐷𝐷 = 𝑡𝑡 𝐷𝐷 − �

𝐶𝐶�𝑚𝑚/𝑧𝑧
�
1000

Where tʹD is the corrected drift time, tD the measured experimental drift time, C is the
EDC constant (1.57 on our instrument) and m/z is the mass-to-charge ratio. The calibrant
ion CCS were corrected for charge state and reduced mass using the following equation:

𝛺𝛺′ =

𝛺𝛺

1

1 2
𝑧𝑧 × � �
𝜇𝜇

Where Ω’ is the corrected calibrant CCS, Ω is the measured CCS of the calibrant, z is the
charge and µ is the reduced mass. The tʹD of the calibrant ions was plotted against their
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respective ln(Ωʹ) under conditions where good mobility separation was obtained; liner
regression with a R2 ≥ 0.98, which is necessary for accurate CCS estimation.119, 133 The
relationship between tʹD and Ωʹ was expressed by the following equation:
𝑙𝑙𝑙𝑙(Ω′) = 𝑋𝑋 × ln(𝑡𝑡 ′ 𝐷𝐷 ) + 𝑙𝑙𝑙𝑙(𝐴𝐴)

Where ln(Ω’) is the natural log of the corrected calibrant CCS, X is the exponential
transformation factor, ln(tʹD) is the natural log of the corrected drift time and ln(A) is the
fit determined constant. This information was then used to calculate the corrected drift
time (tʹʹD) for reduced mass and charge for all ions using the following equation:

𝑡𝑡"𝐷𝐷 = 𝑡𝑡′𝐷𝐷

𝑋𝑋

1

1 2
× 𝑧𝑧 × � �
𝜇𝜇

Where tʹʹD is the second drift time correction, tʹD is the initial corrected drift time, X is the
exponential transformation factor, z is the ion charge and µ is the reduced mass.
Calibration curves were obtained by plotting the calibrant tʹʹD against their CCS (Ω). The
linear regression fit between tʹʹD and Ω was expressed by the following equation:
𝛺𝛺 = 𝑥𝑥𝑡𝑡"𝐷𝐷 + 𝑏𝑏

Where Ω is the CCS, x is the slope of the calibrant line, tʹʹD is the second drift time
correction, and b is the y-intercept. The CCS values of the unknown analytes were
calculated from the obtained calibration curve by inserting their tʹʹD into the above
equation. Arrival time distributions (ATD) for protein ions were converted into CCS (Å2)
using these calibration curves.
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2.2.3.
An

Enzyme assay methods
ESI-MS

enzymatic

assay

was

developed

to

measure

the

rate

of

lysophosphatidylcholine (lysoPC, product) formation from a phosphatidylcholine (PC)
liposomes (substrate) over a PC concentration range of 20 to 240 µM by snake venom
PLA2. The PLA2 were mixed with the liposomes just prior to being loaded into a syringe
for introduction into the mass spectrometer. The rate of lysoPC formation was determined
by converting lysoPC ion counts into a concentration using a standard curve. The effects
of temperature as well as different salt mixtures was also tested. Details are described
below.
Lipid standards were prepared from lyophilized PC and lysoPC by weighing appropriate
amounts of lipid into 1.75 mL glass vials, and then mixing with 1 mL of 10 mM AmOAc
in 90% MeOH (v/v). Aliquots of these solutions were diluted to make lipid stock solution
containing 20 µM PC. Each of these stock solutions was used to make a dilution series,
with final PC and lysoPC concentrations of 0.1, 0.5, 1.0, 1.5 and 2.0 µM. These dilution
series were used to generate standard curves to determine the PC concentration of the
liposome mixtures prepared using the instrument settings described below.
In the experiments where liposomes were used as a PLA2 substrate, lyophilized PC was
weighed into a glass vial, and then mixed with 1 mL of 100 mM AmOAc. Depending on
the experiment, BaCl2, CaCl2 or SrCl2 were added in different combinations and
concentrations (0.1, 0.5 and 1.0 mM) to the reaction solution (see Chapter 5, section
5.2.3.). This solution was mixed thoroughly and loaded onto an Avanti lipid extruder
fitted with a 100 nm filter (Alabaster, Alabama, USA), to make liposomes of this size.
The lipid solution was passed through the filter at least 21 times to generate liposomes of
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a consistent diameter. To determine the PC concentration of the liposome mixture by
ESI-MS, a 10 µL aliquot of this solution was diluted with 90 µL of MeOH, and analysed
using ESI-MS under the conditions described below. Further dilutions were made in 10
mM AmOAc/90% MeOH (v/v) to obtain a PC concentration within the range desired for
analysis. PC concentrations for the liposome mixture were calculated by comparing ion
counts (determined in the ESI mass spectra, see below) to the PC standard curve.
The rate of lysoPC formation by PLA2 hydrolysis was determined using a standard curved
for lysoPC at five concentrations (2.5, 5.0, 7.5, 10.0 and 12.5 µM) in the presence of 60
µM PC in 1 mM CaCl2 and 100 mM AmOAc. The linear regression for the change in
lysoPC ion counts with concentration was used to determine the rate of lysoPC formation
in the continuous assay.
All mass spectra were acquired using an ESI source on the Waters Synapt (G1) HDMSTM
Samples were injected into the source using a 500 µL glass syringe (3.26 mm syringe
inner diameter, Trajan Scientific Australia, Ringwood, Victoria, Australia) at a rate of 15
µL/min loaded onto a 55-2222 standard infusion syringe pump (Harvard Apparatus,
Holliston, Massachusetts, USA). The syringe temperature was maintained using a
Syringe Heater Kit (New Era Pump Systems, Inc., Farmingdale, New York, USA), fitted
with a flat spiral heat pad. Mass spectrometry conditions for the acquisition of mass
spectra were as follows: capillary voltage, 2.5 kV; sample cone, 50 V; extraction cone,
4 V; source temperature, 120 °C; cone flow rate, 50 L/hr; desolvation temperature,
300 °C; desolvation gas flow rate, 100 L/Hr; trap collision, 6 V; transfer collision, 4 V;
collision cell gas pressure, 4.76×10−3 mbar; backing gas, 2.5×100 mbar. The enzyme
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activity in the continuous assay was determined by converting the lysoPC (m/z 522.4) ion
counts into a concentration.

2.3.
2.3.1.

Settings for the Agilent 6560 ion mobility Q-TOF
Nanoelectrospray ionization mass spectrometry

This instrument was used to obtain the CCS for comparative analysis with those obtained
using TWIM-MS, presented in Chapter 6. Samples were introduced into the vacuum
region of this instrument by electrospraying 2 µL of solution from a platinum-coated
borosilicate nanoESI capillary. These nanoESI needles were prepared in the same way as
described in section 2.2.1, but instead of a gold coating, a gold-palladium mixture was
used. The protein concentrations used in these experiments were 5-10 µM. The optimized
conditions for the acquisition of MS spectra for native-like proteins on the Agilent 6560
ion mobility Q-TOF are shown in Table 2.1.
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Table 2.1: Optimized parameters used for the Agilent 6560 ion mobility Q-TOF.
Category
Name
Value
Unit
Entrance voltage
1200-1700
Volts
Exit voltage
250
Volts
IM Drift Tube
Pressure
3.95
Torr
Temperature
31
°C
Gas used
N2
N/A
High pressure Funnel Delta
100
Volts
High pressure Funnel RF
100
Volts
IM Front Funnel
Trap Funnel Delta
180
Volts
Trap Funnel Exit
50
Volts
Trap Funnel RF
100
Volts
IM Hex Entrance
41
Volts
IM Hex Delta
8
Volts
IM Hex RF
600
Volts
IM Rear Funnel
Rear Funnel Entrance
200
Volts
Rear Funnel Exit
35
Volts
Rear Funnel RF
130
Volts
Trap Fill Time
10000
µs
Trap Release Time
2000
µs
Trap Entrance
91
Volts
Trap Entrance Grid Delta
10.2
Volts
Trap Entrance Grid Low
99
Volts
IM Trap
Trap Exit
90
Volts
Trap Exit Grid 1 Delta
4
Volts
Trap Exit Grid 1 Low
87.8
Volts
Trap Exit Grid 2 Delta
8.2
Volts
Trap Exit Grid 2 Low
86.6
Volts
Fragmentor
50
Volts
Oct1 RF VPP
800
Volts
°C
Source
Gas Temp
Off
Flow rate
1.5
L/min
Capillary Voltage
1500
Volts
The Agilent 6560 (University of Adelaide) was fitted with a custom nanoflow device
(Figure 2.1) which was adapted from the standard nanospray source by fitting of a gas
line connected to a N2 gas supply. This modification enabled the application of a low
pressure gas flow to help initiate and maintain nanoflow of aqueous samples. Spectra
were acquired for thirty seconds at 1.08 acquisitions per second at each entrance voltage
for the CCS calculations (see section 2.3.2). Each of these experiments was repeated six
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times. The spectra acquisition and CCS calculations were performed using Mass Hunter
(Agilent, Santa Clara, California, USA) and were deconvoluted using UniDec.134

Figure 2.1: Agilent 6560 ion mobility Q-TOF needle holder with a custom nanoflow
device attached.
2.3.2.

Calculating protein CCS using drift tube ion mobility

CCS measurements by DTIM-MS (Agilent 6560) were obtained using a multi-field
approach. This method utilizes drift time measurements at multiple entrance voltages to
calculate the minimum amount of time a given ion spends outside the drift cell.135 The
IM entrance voltages used in these experiments were 1200, 1300, 1400, 1500, 1600 and
1700 V, with a drift cell pressure of 3.95 Torr (N2). The CCS of an analyte can be directly
calculated from DTIM-MS data via the Mason-Schamp equation118:
1

3𝑧𝑧𝑧𝑧 2𝜋𝜋 2 1
𝛺𝛺 =
�
�
16𝑁𝑁 𝜇𝜇𝑘𝑘𝐵𝐵 𝑇𝑇 𝑘𝑘0

Where Ω is the CCS, z is the analyte’s charge, e is the elementary charge, N is the number
density of the drift gas, µ is the reduced mass of the ion-neutral drift gas pair, kB is the
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Boltzmann constant, T is the gas temperature and k0 is the reduced mobility at standard
temperature and pressure. CCS calculations were performed using in-built tools in the
Agilent IM-MS Browser (B.07.01) software (Agilent, Santa Clara, California, USA).
Protein ATD were converted to CCS using the method proposed in Marchand (2017):135
𝐶𝐶𝐶𝐶𝐶𝐶 = 𝑎𝑎 ×

𝑧𝑧
× 𝑡𝑡𝐴𝐴
√𝜇𝜇

Where CCS is the collisional cross section, tA is the arrival time, a is the transformation
factor between tA and CCS, z is the charge and µ is the reduced mass.

2.4.

Peptide sequencing

The SEC fractions containing trimeric PLA2 were loaded onto a 15% SDS-PAGE gel,
bands were excised then digested by trypsin, as previously described.136
The LC-MS/MS data were acquired by Dr Matthew Padula, University of Technology,
Sydney using an Acquity M-class nanoLC system (Waters, USA) which was fitted to a
Q Exactive Plus mass spectrometer (Thermo Scientific). In these experiments, 5 µL of
the sample was loaded onto a nanoEase Symmetry C18 trapping column (180 mm x 20
mm) at a flow rate of 15 µL/min for 3 minutes prior to being washed onto a PicoFrit
column (75 µm ID x 300 mm; New Objective, Woburn, MA) packed with Magic C18AQ
resin (3 mm, Michrom Bioresources, Auburn, CA). Peptides were eluted from the column
at 0.3 µL/min with the following program using 98% acetonitrile, 0.2 % formic acid (v/v):
5-30% for 15 mins; 30-80% for 3 mins; 80% for 2 mins; 80-5% for 3 mins. Peptides were
ionized at a capillary voltage of 2400 V.
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A data dependant MS/MS analysis was performed, with survey scans of 350-1500 Da,
which were performed at 70000 resolution for peptides with charge states ≥ 2+ with an
AGC target of 3x106 and maximum injection time of 50 ms. The top 12 peptides from
this analysis were selected fragmented in the HCD cell using an isolation window of 1.4
m/z, an AGC target of 1x105 and maximum injection time of 100 ms. Fragments were
then scanned in the Orbitrap analyser at 17500 resolution, with product ion fragment
masses measured over a mass range of 120-2000 Da. The precursor peptide mass was
then excluded for 30 seconds.
The MS/MS data files were searched using Peaks Studio 8.5137-139 against the LudwigNR
database (composed of the UniProtKB, plasmoDB, and Ensembl databases vQ215;
19 375 804 sequences with 6 797 271 065 residues) and a database of common
contaminants with the following parameter settings: fixed modifications, none; variable
modifications, propionamide, oxidized methionine, deamidated asparagine; number of
allowed missed cleavages,

three; peptide mass tolerance: 10 ppm; MS/MS mass

tolerance: 0.05 Da. Search results were then filtered to include peptides with a –log10P
score that was determined by the False Discovery Rate (FDR) of <1 %, the score being
that where decoy database search matches were <1 % of the total matches.

2.5.

Circular dichroism spectroscopy

CD spectroscopy measurements were made using a Jasco J-810 spectropolarimeter
(Jasco, Eastson, Maryland, USA). Spectra were recorded using a 0.1 cm quartz cell and
the following parameters: λ, 250-190 nm; recording speed, 100 nm/min; response, 4 sec;
spectral band width, 1 nm; number of accumulated scans, 6; temperature, 20°C. Samples
were prepared as described in section 2.1.2, and left to equilibrate for at least 20 min at
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20°C in their respective solutions before analysis. The PLA2 concentration in these
solutions was ~5 µM.

2.6.

Colorimetric PLA2 activity assays

The Cayman secreted PLA2 colorimetric assay (Cayman Chemical, Ann Arbor,
Michigan, USA) has previously been used to investigate the enzymatic activity of trimeric
PLA217, 18, 140. In brief, enzymatic activity is measured against diheptanol thio-PC (Figure
2.2) at a concentration of 1.5 mM. The reaction buffer consists of 0.44 mM of 5,5ʹdithiobis-(2-nitrobenzoic acid) (DTNB) in 0.4 mM Tris-HCl buffer, 10 mM CaCl2, 100
mM KCl and 0.3 mM Triton X-100 at a pH of 7.5. These reactions were carried out at
24.5oC. The rate of reaction was determined by the change in absorbance at 414 nm over
time on a Spectramax 384 microplate reader (Molecular Devices, San Jose, California,
USA). The change in absorbance was converted to enzymatic activity using the following
equation (path length 1 cm):

𝑃𝑃𝑃𝑃𝑃𝑃2 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 =

∆𝐴𝐴414
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣
×
× 𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
𝜀𝜀𝑇𝑇𝑇𝑇𝑇𝑇
𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎

Where the PLA2 activity is given in µmol min-1 mL-1, ∆A414 is the change in absorbance
per minute, 𝜀𝜀DTNB is the extinction coefficient used for 2-nitro-5-thiobenzoic acid (TNB).

The reaction volume was 0.225 mL and the amount of sample added was 0.01 mL. This
assay uses an extinction coefficient of 10.66 mM-1cm-1 for TNB. This measurement was
carried out in triplicate for all proteins tested.
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Figure 2.2: Structure of diheptanol thio-PC from the colorimetric assay.
Structure taken from the Cayman secreted PLA2 colorimetric assay instruction manual.
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Chapter 3 : Whole venom analysis
3.1.

Introduction

The venoms of Australian elapids exhibit a range of cytotoxic effects and contain some
of the most potent snake cytotoxins. Despite their lethality, the whole venoms from
Acanthophis antarcticus (common death adder), Notechis scutatus (mainland tiger
snake), Oxyuranus microlepidotus (inland taipan) and Oxyuranus scutellatus scutellatus
(coastal taipan) have yet to be investigated in detail. Characterizing the whole venom
constituents from these snakes could be very beneficial, as they may provide new sources
of therapeutics and anti-venoms. Therefore, the goal of these experiments was to assess
the range of whole venom components from the Australian snakes mentioned above.
3.1.1. Composition of elapid venoms
Investigations into the composition of Australian snake venoms from the genera of
interest in this work (Acanthophis, Notechis and Oxyuranus) have indicated that three
finger toxins, Kunitz-type serine protease inhibitors, prothrombin activators, L-amino
acid oxidases and PLA2 are some of the most commonly found proteins in these venoms
(described below).4,

15

C-type lectins, disintegrins and 5ʹ-nucleosidases may also be

present.141-144
Venom composition varies not only according to genus and species, but may also vary
between individual snakes from different geographical locations.34,

145

The specific

activities of similar enzymes can vary between snake species.11 Significant variations in
venom composition between individual snakes living in the same habitat have been
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reported for the Viperidae family. Amazonas et al. (2018) showed that Bothrops atrox
(common lance-head) contains over 20 mRNA sequence variants for a given toxin family
(70-98% sequence homology), with significant variations in mRNA transcription and
translation into mature protein between individuals from the same geographical
location.146 This study also showed that snake venoms contain certain ‘core’ toxins, which
were present in the venoms of all the snakes tested.
The phenomenon with mRNA described above has also been noted for elapids by Liu et
al. (2019); the long chain neurotoxin α-bungarotoxin from the venoms of the banded krait
(Bungarus fasciatus) has multiple mRNA polymorphisms.147 This study also showed that
there is only one α-bungarotoxin gene, and that sequence variation (typically a single
amino acid switch) for that toxin arises from mRNA splicing. Similar single amino acid
point mutations have also been reported for Notechis11ʹ2 (called Notechis11ʹ2L, which
has a M8L mutation), a PLA2 found in the venom of the Australian mainland tiger snake
(N. scutatus).148, 149 A natural mutation consisting of a single amino acid substitution
(K16R) for notexin, a monomeric PLA2 found in the venom of N. scutatus, has also been
reported.150 The core toxins present in the venoms being investigated in this study are
likely PLA2 and three finger toxins, given their prevalence in elapid venoms.4, 15
Venom variability highlights the need to accurately determine the compositions of snake
venoms and characterise their components; since single amino acid switches in a variable
toxic motif can have a large effect on toxin potency. Where available, this information
has been of great importance to researchers, as some of the venom components have
therapeutic effects, such as analgesic, anticancer and bactericidal properties.61, 151-153 The
variance in therapeutic potency between the different toxin isoforms can help researchers
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narrow down the structural motifs responsible for these activities. Some common venom
components (excluding the PLA2, which were reviewed in Chapter 1) are described
below.
3.1.2. High mass venom proteins
Examples of higher mass venom proteins found in elapid venom are the prothrombin
activators, factor Xa-like (FXa) and factor Va-like (FVa) proteins. FXa and FVa toxins
are structurally and functionally similar to activated factor X and factor V clotting factors
found in blood.154 They induce their cytotoxic effects by disrupting homeostasis by
converting prothrombin into thrombin, and hence induce clotting.155 The threedimensional structures of these proteins, as well as how complexes are formed are shown
in Figure 3.1. The structural regions of the FVa are also highlighted in this figure. FXa
toxins found in snake venoms can be split into two classes: group D requires mammalian
factor V for maximum activity and group C which requires a venom FVa protein to be
present for full activity.155,

156

FXa toxins have masses of around 47 kDa, and are

commonly found in many Australian snake venoms, but FVa toxins are only found in the
genera Oxyuranus and Pseudonaja.2,

4, 156, 157

The relatedness of these snake genera

suggests that the recruitment of FVa proteins to their venoms is a recent evolutionary
event.2, 15, 73, 75 These enzymes have been recently adapted for clinical use as a blood
clotting agent to assist in blood collection for the isolation of plasma.158
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Figure 3.1: Three-dimensional structures of FXa and FVa proteins from Pseudonaja
textilis.
A FVa proteins have five structural regions; A1 (yellow), A2 (cyan), A3 (orange), C1
(green) and C2 (blue). B FXa from the venom of Pseudonaja textilis (red). C Venom
prothrombinase-like complex. D Magnified view of FXa bound to the flexible, C-terminal
peptide chain of the A2 structural region of FVa venom protein (shown as spheres).
Crystal structures were taken from Lechtenberg et al. (2013, pdb: 4BXS).154
Another class of large protein that is found in snake venoms is the L-amino oxidases
(M.W. of ~130 kDa). Crystallography of recombinant L-amino acid oxidase shows that
these proteins form homodimers (Figure 3.2); this is also supported by gel filtration
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studies on the native toxins.159-162 Previous investigations have shown that these toxins
undergo post-translational modification in the form of N-linked glycosylation, however,
their precise glycan composition is unknown.159, 163-165 These enzymes are highly active
against many L-amino acids, the oxidation of which leads to the formation of hydrogen
peroxide and a corresponding keto acid of the target amino acid.160, 166 Their enzymatic
activity endows them with the ability to induce a variety of toxic effects, such as
haemorrhaging, haemolysis, oedema and apoptosis.142,

159, 167, 168

In the context of

toxicology, the effects of these proteins on platelet aggregation are not well understood.
They have been shown to act as inhibitors of aggregation induced by ADP and U46619
(thromboxane receptor agonist), but can also induce this effect via the production of
hydrogen peroxide.159, 167 These proteins are of interest to researchers because of their
potential antitumor, antiparasitic and antibacterial properties.151, 152, 169, 170

Figure 3.2: Three-dimensional structure of L-amino oxidase.
Crystal structure of the L-amino oxidase from the venom of Bothrops jararacussu
(pdb: 4E0V) obtained by Ullah et al. (2012).160
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3.1.3. Low mass proteins and peptides
Three finger toxins are a well-researched component of Australian elapid venoms. They
are around 60 amino acids in length, with a tertiary structure which forms three loops
(fingers) stabilized by four or five disulfide bonds (Figure 3.3). These are one of the most
abundant protein families found in snake venoms.171 Three finger toxins can be broken
into three groups: short chain, long chain and non-conventional; the latter is unique to
Australian elapids.71, 172 They can adopt a variety of subunit stoichiometries, such as
monomers, homodimers and heterodimers (Figure 3.3).40 These toxins are post-synaptic
neurotoxins which bind to nicotinic acetylcholine receptors. The key cytotoxic functional
motif for short and long chain three finger toxins is between amino acid residues 49 to
55.71 The functional motif for non-conventional three finger toxins has yet to be
elucidated. A study by Jackson et al. (2013) has shown that these toxins have diverse
peptide sequences, with variation occurring in the cytotoxic motif.2 This variation would
likely explain the differences in activities between toxins. Three finger toxins have been
of great interest to researchers due to their analgesic properties and their ability to act as
stable scaffolds for novel binding motifs.40, 153, 172
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Figure 3.3: Three-dimensional structure of three finger toxins.
A variety of three-dimensional configurations can be adopted by three finger toxins. The
three loops of these toxins are labelled I, II and III. Taken from Kessler et al. (2017).172
Kunitz-type serine protease inhibitors, like three finger toxins, are approximately 60
amino acids in length but are stabilized by three disulfide bonds (Figure 3.4). In
Australian snake venom, some of these proteins are endowed with the ability to act as
neurotoxins, which block K+ and Ca2+ channels.173, 174 When these toxins gain neurotoxic
activity, they do not act as protease inhibitors.173, 174 This change is a vivid example of
toxin switching described in section 1.1.10 These proteins are also of interest to
researchers for their potential as therapeutics. The Kunitz-type serine protease inhibitor
PIVL from the venom of Macrovipera lebetina (Levant viper, which is native to North
Africa, Middle East and West Asia) has been shown to have antitumour and
antiangiogenic properties.175, 176 These proteins have been proposed as good scaffolds for
protein engineering and drug development.177, 178
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Figure 3.4: Structure of Kunitz-type serine protease inhibitor.
Crystal structure is of textilinin-1 (pdb; 1CTX) from Pseudonaja textilis from Millers et
al. (2009).179
3.1.4. Scope of Chapter
There were two main goals for this Chapter, which were: firstly to fractionate the whole
venoms of A. antarcticus, N. scutatus, O. microlepidotus and O. s. scutellatus via size
exclusion chromatography, and secondly, to analyze each of the size exclusions fractions
using nanoESI-MS and tentatively identify the proteins families found within each of
these venoms based on mass.
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3.2.

Results and Discussion

The work described below gives the first, in depth characterization of many of the
oligomeric components from the venoms of A. antarcticus, N. scutatus, O. microlepidotus
and O. s. scutellatus. High mass proteins were found in the venoms of O. s. scutellatus
and O. microlepidotus. Furthermore, the extent of protein diversity for the monomeric
toxins within these venoms was investigated, and the reported masses are compared to
the literature. Substantial differences in toxin isoform composition were also detected
between the work presented in this thesis and previous proteomic/transcriptomic studies,2,
4, 180

highlighting that care needs to be taken when interpreting data for venom

compositions.
3.2.1. Whole venom fractionation by size exclusion chromatography
Fractionation of these venoms by size exclusion chromatography yielded multiple peaks
(Figure 3.5). In order to facilitate comparisons between the venoms, peak regions were
assigned a colour code, based on the masses of protein components reported in other
venom investigations.2, 34, 140, 145, 180 This is discussed in greater detail below.
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Figure 3.5: Whole venom size exclusion profiles (Superdex 200 10/300 column).
Chromatographic profiles for the venoms of A. antarcticus, N. scutatus,
O. microlepidotus and O. s. scutellatus. See section 2.1.1 for full chromatographic
conditions.
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Peaks which eluted prior to 15 mL were denoted as the red fractions, which likely
contained toxins of masses greater than 100 kDa, such as the FVa proteins and L-amino
acid oxidases.159, 161, 162, 165, 167 Peaks corresponding to the yellow fractions are those
expected to contain venom proteins of masses between 40 to 100 kDa. Examples of
expected proteins in these fractions are the trimeric PLA2 and FXa protein.17, 18, 140, 155-157
Since these fractions would contain trimeric PLA2, the focus of this thesis, their detailed
analyses are described in Chapter 4. Green fraction peaks contain proteins of masses less
than 40 kDa. This would include the C-type lectins, monomeric PLA2 and short/long
chain neurotoxins.4 The blue fraction elution time (the Superdex 200 10/300 column void
volume) would likely contain very small peptide chains and metabolites. It should be
noted that this work primarily focuses on the protein components of snake venom, thus,
metabolites and small peptide chains within the venom (blue fraction) were not analysed
further.
Size exclusion chromatograms provided some insight about the relative abundance of
proteins (using UV absorbance) within these venoms. The absorbance at 280 nm in each
of the chromatograms, indicates that the most abundant proteins within these venoms can
be found in the green fraction (mass ≤ 40 kDa). As mentioned above, these fractions
would likely contain C-type lectins, monomeric PLA2 and short/long chain neurotoxins.4
Previous work by Tasoulis and Isbister (2017), indicated that the venom proteomes of N.
scutatus and O. s. scutellatus were primarily composed of PLA2 (by weight).181 Since the
same trend from the green fractions (contains a major peak with the highest relative
absorbance) was observed in all of the size exclusion chromatograms, this would suggest
that the monomeric PLA2 are also the most abundant proteins within these venoms. This
observation was examined further in section 3.2.3 on page 57.
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3.2.2. Proteins of mass greater than 100 kDa (‘red’ fraction)
For the MS analysis, only size exclusion fractions corresponding to peaks of a relative
abundance greater than 5% in their respective chromatograms were analysed. MS data
acquired in this work were compared with previous transcriptomics2, 180 and proteomics4
investigations.
All size exclusion chromatograms shown in Figure 3.5 contained peaks which correspond
to higher mass proteins (≥100 kDa). However, in the context of this investigation, the
proteins of mass ≥100 kDa from the venom of N. scutatus were not a major venom
fraction (less than 5% peak relative peak height), hence they were not analysed. The
taipan venom (Oxyuranus spp.) had the earliest eluting major peak (~12.5 mL), which
was investigated using nanoESI-MS mass spectrometry, as described in section 2.2.1.
Spectra of the size exclusion fractions corresponding to these peaks gave rise to multiple
peaks between the region m/z 5500-9000 (Figure 3.6). The major ion series found in both
venoms correspond to proteins with masses 177481 ± 1 Da and 177064 ± 7 Da for
O. microlepidotus and O. s. scutellatus, respectively. This is in the mass range expected
for FVa proteins, based on previous sequence data and glycomics work.4, 180
These data indicate that FVa is overexpressed in the taipan venoms compared to FXa
because FXa forms a complex with FVa2, 4 (the ~230 kDa protein discussed below) and
no free FXa was found in these venoms (expected in yellow fraction, see Chapter 4 for
details). This could have implications when testing the cytotoxicity of these toxins when
purified from whole venom, as FVa is incapable of inducing cytotoxic effects without
being bound to FXa.2, 4 For example, if one assumes that all of protein found within this
fraction corresponds to FXa-FVa complexes, any measurements taken (LD50, enzyme
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activity etc.) would be incorrect. Based on this work, it is recommended that future studies
testing the pro-coagulant activity of these toxins should use multiple chromatography
steps to isolate free FVa from FVa-FXa complexes.

Figure 3.6: NanoESI mass spectra of the red fraction for Oxyuranus spp. size exclusion
chromatograms (Figure 3.5).
Peaks likely corresponding to FVa are coloured red, while those likely corresponding to
a small peptide (P) bound to either FVa or the prothrombinase complex during
chromatography are shown in blue. The charge states are noted above their respective
peak.
The MS peaks detected for O. microlepidotus venom show a multimodal distribution,
which is indicative of multiple, overlapping charge state series (Figure 3.6). The minor
peak series within the O. microlepidotus was located in the m/z region 7500-8500, which
corresponded to protein of masses of approximately 230 kDa. The same pattern (although
to a lesser extent), was observed in the spectrum of O. s. scutellatus. Exact mass was
difficult to calculate for these ions, due to the overlapping peaks within each of the
spectra. Sequences of proteins in this mass range have not been reported in previous snake
venom investigations using peptide sequencing or transcriptomics.2, 4, 180 This suggests
that the ~230 kDa peaks were probably a multi-subunit protein or multiprotein complex.
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Two prominent peaks in the range m/z 1250-1750 were detected in the O. microlepidotus
spectrum (Figure 3.6). These peaks corresponded to an analyte with a mass of 6540.5 Da.
This mass corresponds to a small peptide, such as a Kunitz-type serine protease inhibitor
or three finger toxin. The presence of this peptide in the high mass peaks suggests that
the 6.5 kDa protein was present in a complex with a high mass venom protein, such as
the prothrombinase complex (FVa-FXa), but dissociated from the complex during mass
spectrometry analysis. If true, it is suggestive that this peptide is a 6.5 kDa Kunitz-type
serine protease inhibitor, as they have been shown to interact with, and inhibit, the activity
of FXa.182 The total mass of the peptide (6.5 kDa), FVa (177 kDa) and FXa (~47 kDa)
would be ~230.5 kDa, which would explain the presence of the ~230 kDa peak, and why
prothrombinase complex was not detected in the spectrum. The nature of the 230 kDa
species should be investigated in future work, by isolating the individual components
using a combination of chromatography and SDS-PAGE techniques for sequence analysis
and functional studies.
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Figure 3.7: NanoESI mass spectra of ‘red fractions’ from the size exclusion
chromatography (Figure 3.5) thought to contain L-amino acid oxidases.
Peaks corresponding to L-amino acid oxidase (LAAO) are coloured blue, those
corresponding to FVa are red. The charge states are noted above their respective peak.
NanoESI-MS peaks between m/z 5500-6500 were observed which eluted around 14 mL
(Figure 3.7). These were present in the venoms of A. antarcticus and O. microlepidotus,
and have calculated masses of 121808 Da and 124383 Da, respectively. These were also
detected in the venom of O. s. scutellatus, but were too low in abundance for further
analysis (see Figure 3.6). These protein masses did not correspond to any known mass
from previous proteomics and transcriptomics work, but are in the expected mass range
for glycosylated L-amino acid oxidases,159-162 to which their identity has been tentatively
assigned. The proposed L-amino acid oxidase from the venom of O. microlepidotus
(labelled LAAO in Figure 3.7) was approximately 2 kDa larger than that proposed in the
venom of A. antarcticus and had a higher average charge. Considering the relatively
minor mass differences between elapid L-amino acid oxidases peptide sequences, it is
likely that mass differences arise from variations in glycosylation. Comparable mass
variations due to glycosylation differences have been observed for other elapid toxins.4,
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17, 18, 25, 180

The higher average charge for the O. microlepidotus L-amino acid oxidase

compared to the A. antarcticus suggests that the former has a greater number of positively
charged amino acids on its surface. The additional positive charge on the surface of this
protein may affect cytotoxic activity of this toxin, and thus, warrants further investigation
in future studies.
L-amino acid oxidases were not found in proteomics studies of O. microlepidotus and O.
scutellatus venom.4 However, many of the protein spots from 2D-SDS-PAGE of the
taipan venoms were not analysed in that study. Some of the unanalysed spots on the taipan
gels were in similar positions to L-amino acid oxidases from other venoms. Based on this
information, it is possible that the L-amino acid oxidases were missed. St. Pierre et al.
(2005) detected L-amino acid oxidases in the venom of O. s. scutellatus but not O.
microlepidotus by transcriptomics.180 The differences between these investigations could
be due to the variations in venom between individual snakes. In the current work, these
fractions were not analysed for sequencing, so their identities are yet to be confirmed.
This highlights the need to perform whole venom investigations for multiple snakes of
the same species, from different geographical regions. However, this was outside the
scope of this study, thus it is recommended as future work.
3.2.3. Proteins of mass ≤ 40 kDa (‘green’ fraction)
The size exclusion fractions containing most of the venom protein located within the
green region of the chromatograms shown in Figure 3.5 were expected to contain
monomeric PLA2, based on previous investigations.181 Smaller peptide toxins, such as
three finger toxins were also expected to be found.2, 4 Mass spectra acquired from these
fractions contained multiple peaks between the m/z 1400-3000, which corresponded to
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proteins of masses 6-30 kDa (Figure 3.8). These proteins were broadly characterized into
likely protein families, based on mass. These categories were short chain neurotoxins (67 kDa), long chain neurotoxins (~8 kDa), PLA2 (12-15 kDa) and other low mass venom
proteins (>15 kDa).2, 4 The most numerous and abundant peaks detected in these spectra
had calculated masses in the range expected for monomeric PLA2. This supports the
hypothesis at the end of section 3.1.1: monomeric PLA2 are the most abundant proteins
within the venoms being tested. The masses detected in this study were then compared to
published

full

length

proteins

sequences

found

in

the

UniProt

database

(https://www.uniprot.org/) for the respective venoms.
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Figure 3.8: NanoESI mass spectra of the venom components from the ‘green fractions’
of the size exclusion chromatography (Figure 3.5).
Spectra are divided into three subsections, based on which protein family they likely
correspond to by mass. The blue subsection (m/z 1100-1700) are likely peptide toxins,
red subsection (m/z 1650-2900) are likely monomeric PLA2 and the green subsection
(m/z 2700-3200) likely correspond to cysteine-rich venom proteins (CRISP) and C-type
lectins (CLEC).
Variations in venom composition were expected between studies. This was because the
individual snakes investigated between studies were from different regions.2,

4, 180

Substantial intra-species differences in venom composition due to habitat and natural
variation in elapid toxins have been reported.34, 145, 148, 149 Observed mass differences
corresponding to natural variations in peptide sequence (single amino acid mutations) are
described below.
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Table 3.1: Masses of proteins from the size exclusion chromatography (Figure 3.5) that
likely correspond to short chain neurotoxins and Kunitz-type serine protease inhibitors
(Figure 3.8, blue subsection).
Literature
Experimental
Literature
Protein
Venom
masses
masses (Da)
proteins
family
(Da)
183
6679.2 ± 0.2
Aa-c
3FTx
6871.9*
6705.1 ± 0.4
6736.2 ± 0.1
A. antarcticus
6900.6 ± 0.3
7114.8 ± 0.6
6703.1 ± 0.1
Tigerin-1184
KPI
6681.6+
184
6761.9 ± 0.1
Tigerin-2
KPI
6619.4+
Tigerin-3184
KPI
6797.6+
N. scutatus
184
Tigerin-4
KPI
6735.8+
Short
3FTx
6639.5+
neurotoxin 1185
6715.6 ± 0.1
3FTx-Oxy3186
3FTx
6709.6+
6726.0 ± 0.1
3FTx-Oxy4186
3FTx
6787.6+
186
6736.7 ± 0.2
3FTx-Oxy5
3FTx
6277.3+
6815.7 ± 0.1
3FTx-Oxy6186
3FTx
6861.7+
Microlepidin-1184
KPI
6552.3+
O. microlepidotus
184
Microlepidin-2
KPI
6576.3+
Microlepidin-3184
KPI
6542.2+
184
Microlepidin-4
KPI
6473.1+
Microlepidin-5184
KPI
6301.9+
Short
6936.4 ± 0.1
3FTx
6725.6+
neurotoxin 1185
Short
7222.9 ± 0.1
3FTx
6781.7*
neurotoxin 2187
Short
3FTx
6331.3+
neurotoxin 3185
O. s. scutellatus
Taicotoxin184
KPI
6998.1+
184
Scutellin-1
KPI
6559.3+
Scutellin-2184
KPI
6586.3+
Scutellin-3184
KPI
6541.2+
184
Scutellin-4
KPI
6603.5+
Scutellin-5184
KPI
6363.9+
Techniques used in the literature to obtain their sequence mass: Proteomics, *;
transcriptomics/genomics +. 3FTx corresponds to three finger toxins and KPI corresponds
to Kunitz-type serine protease inhibitors.
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The masses of the 6-7 kDa proteins detected in this work are shown in Table 3.1. These
proteins likely correspond to short chain neurotoxins such as Kunitz-type serine protease
inhibitors or three finger toxins.2, 4 The lack of detailed venomics data for A. antarcticus
means that were was only one protein available for comparison. None of the
nanoESI-MS masses precisely matched the published theoretical sequence masses for the
6-7 kDa venom proteins. No post-translational modifications have been reported for the
small chain neurotoxins. Therefore, mass differences would likely be due to differences
in amino acid sequence.
Proteins of masses around 8-9 kDa would likely correspond to long chain neurotoxins.2,
4

Multiple proteins were detected in these venoms which could correspond to these toxins

(Table 3.2). The first thing to note is that there were no proteins of masses that could
correspond to long-chain neurotoxins from the venom of O. s. scutellatus. This could be
due to variations in protein expression between snakes from different studies. Also, these
toxins could be present, but in an abundance too low to detect relative to the other proteins
within the venom. The second thing to note is the paucity of sequence data for these
toxins, due to the limited number of investigations carried out for these venoms. Other
venoms have been investigated in far more depth (see Jackson et al., 2013 for a more indepth review).2 The long-chain toxins were far more prevalent in the venoms of
N. scutatus and A. antarcticus, compared to the taipans. This suggests that the lack of
long-chain toxins in the taipan venoms may be due to genetic factors. Mass differences
corresponding to a single amino acid difference with a published sequence data are
discussed below and summarized in Table 3.3.
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Table 3.2: Masses of proteins found in the size exclusion (Figure 3.5) which likely
correspond to long-chain neurotoxins (Figure 3.8, blue subsection).
Experimental
Literature
Venom
Literature proteins
mass (Da)
mass (Da)
188
8216.3 ± 0.1 Alpha-elapitoxin-Aa2b
8125.4*
8286.4 ± 0.4 Alpha-elapitoxin-Aa2d189
8376.9*
190
8314.7 ± 0.1 Alpha-elapitoxin-Aa2e
8751.2*
A. antarcticus
8764.4 ± 0.1
8888.4 ± 0.3
Alpha-elapitoxin7918.4 ± 0.1
8050.3+
Nss2a185
8045.6 ± 1.9
Notechis III-459
8060.4*
8083.1 ± 0.5
8134.8 ± 0.4
N. scutatus
8161.5 ± 0.8
8217.6 ± 2.2
8283.6 ± 0.1
8309.3 ± 0.1
7999.0 ± 0.1
Long neurotoxin 1185
8007.4+
Long neurotoxin 2185
7966.3+
O. microlepidotus
186
3FTx-Oxy1
7941.2+
3FTx-Oxy2186
7899.1+
Techniques used in the literature to obtain their sequence mass: Proteomics, *;
transcriptomics/genomics, +.
Multiple proteins from the green fraction had masses which could potentially correspond
to single amino acid variants of the published sequences (Table 3.3). Potential amino acid
changes in the toxic motifs would yield the largest differences in activity. In this data set,
potential changes of this nature include: Tigerin-4, F>N; α-EPTX-Aa2e, Q/K>D; αEPTX-Nss2a, F>N, W>T; 3FTx-Oxy1, G>D; α-EPTX-Aa2d, T>Y.2 The loss of a
cysteine (such as Tigerin-4, C>P) would likely reduce toxic activity, as the disulfide
bonds are necessary to maintain the structure of Kunitz-type serine protease inhibitors
and the short and long chain neurotoxins.2 The amino acid changes outside of the motif
have relatively small effects on cytotoxic potency. For example, the amino acid switch of
G>D for 3FTx-Oxy1 could reduce the potency of that toxin, given its proximity to Y21
and K23 of the binding motif.
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Table 3.3: Potential amino acid substitutions which could explain the identity of
experimentally observed masses from the blue subsection (Figure 3.8)
Potential
Corresponding
Experimental
amino
Literature
Toxin
Snake venom
mass (Da)
acid
protein
mutation
Tigerin-1
D>H
6703.1
Tigerin-4
F>N
KunitzTigerin-1
G>H
N. scutatus
type
Tigerin-3
T>H
protease
6761.9
S>L/I; C>E;
inhibitor
Tigerin-4
H>Y
6936.4
Taicotoxin
T>Y
O. s. scutellatus
6900.6
Aa-c
V>Q/K
A. antarcticus
Short
V>Y
6703.1
N. scutatus
neurotoxin 1
3FTx-Oxy3
C>P; H>M
6715.6
3FTx-Oxy4
G>E; N>W
L/I>P; C>S;
D>V;
3FTx-Oxy3
E>L/I;
6726.0
M>D; F>M;
Short
Y>F
chain
neurotoxin
3FTx-Oxy4
T>Y
O. microlepidotus
N>P;
6736.7
3FTx-Oxy3
Q/K>T;
R>E
3FTx-Oxy3
Y>G
V>A; D>S;
6815.7
3FTx-Oxy4
E>T; M>C;
R>Q/K
3FTx-Oxy6
G>C; T>F
8314.7
T>Y
α-EPTX-Aa2d
A. antarcticus
N>T;
8764.4
α-EPTX-Aa2e
Q/K>D
8083.1
F>N
α-EPTX-Nss2a
Long
N. scutatus
8134.8
α-EPTX-Nss2a R>A; W>T
chain
Long
neurotoxin
H>E
neurotoxin 1
Long
7999.0
O. microlepidotus
N>F
neurotoxin 2
3FTx-Oxy1
G>D; A>E
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Table 3.4: Masses of proteins from the size exclusion (Figure 3.5) that likely correspond
to PLA2, cysteine rich proteins and C-type lectins (Figure 3.8, red and green subsections).
Experimental
Literature
Protein Literature
Venom
mass (Da)
proteins
family mass (Da)
28
12950.3 ± 0.1
Acanthin-1
PLA2
12842.5*
A. antarcticus
28
13409.9 ± 0.1
Acanthin-II
PLA2
12869.6*
13068.5 ± 0.1
Notexin59
PLA2
13579.4*
148
13170.2 ± 0.1
Notechis 11’2
PLA2
12999.6*
60
13277.6 ± 0.1
Notechis 11’5
PLA2
13662.5*
191
13297.8 ± 0.3 Acidic PLA2 HTe
PLA2
14247.8*
13664.4 ± 0.1
Basic PLA2 h1192
PLA2
13318.9*
N. scutatus
13720.0 ± 0.1
14130.0 ± 0.1
14130.0 ± 0.1
14249.2 ± 0.6
14308.1 ± 0.1
β subunit
13431.0 ± 0.1
PLA2
13318.2+
of PDx180
α PDx
13444.6 ± 0.3
PLA2
13575.5+
analogue180
13451.7 ± 0.1
OM-1180
PLA2
14128.8+
O.
microlepidotus 13455.5 ± 0.1
OM-2180
PLA2
13396.2+
Pseudechetoxin
13632.0 ± 0.1
CRISP
23532.2+
-like180
14186.0 ± 0.1
28364.0 ± 0.7
13221.3 ± 0.1
OS-1180
PLA2
14086.7+
13229.6 ± 0.1
OS-2180
PLA2
13317.1+
13316.6 ± 0.2
OS-3180
PLA2
14077.7+
180
13327.6 ± 0.6
OS-4
PLA2
14365.2+
13357.4 ± 0.3
OS-5180
PLA2
13473.5+
13410.8 ± 0.7
OS-6180
PLA2
13746.6+
180
13506.5 ± 0.1
OS-7
PLA2
13248.0+
γ subunit
13550.4 ± 0.1
PLA2
14586.1*
O. s. scutellatus
of TPx65
β1 subunit
14086.0 ± 0.1
PLA2
13221.9*
of TPx78
β2 subunit
21997.7 ± 0.1
PLA2
13229.0#
of TPx140
α subunit
22063.6 ± 1.1
PLA2
13814.8*
of TPx77
Pseudechetoxin
27500.4 ± 3.3
CRISP
23555.2+
-like180
Techniques used in the literature to obtain their sequence mass: proteomics, *;
transcriptomics/genomics, +; crystallography,#.
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Multiple charge state series corresponding to proteins with masses of 12.9-14.5 kDa were
detected in each of these venoms, which is the expected mass range of monomeric PLA227
(Table 3.4). This was expected, as these venoms have been previously reported to have
these proteins as a major constituent of their whole venoms.4 A. antarcticus venom
contained fewer monomeric PLA2 compared to the other venoms tested in this study. The
precise cause of this unknown, but since there have only been two previously reported
sequences, this could be due to genetic factors. Further investigations are required to
obtain a definitive answer. There were more proteins of masses corresponding to
monomeric PLA2 found in the venom of N. scutatus than what has previously been
reported. This could be attributed to the lack of previous in-depth investigations
performed for this whole venom. Proteins with masses corresponding to CRISP and Ctype lectins were found in both taipan venoms analysed.193, 194 This was unexpected, as
the distribution of these proteins within the venoms studied in this work does not match
what was observed in Birrell et al. (2007).4 This was attributed to the variation in venoms
between the snakes used in these studies. These proteins could also be in a relatively low
abundance compared to the PLA2, thus, making them harder to detect. Due to the low
abundance of these proteins, they were excluded from the mass comparisons carried out
below.
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Table 3.5: Potential amino acids substitutions which could explain the identity of
experimentally observed masses from the blue/red sections in Figure 3.8.
Experimental
Literature
Potential amino
Snake venom
mass (Da)
protein
acid mutation
13068.5
Notechis 11’2
S>R
13277.6
Basic PLA2 h1
Q/K>S; R>D
Notexin
A>R; T>W
N. scutatus
13664.4
P>V; V>T; T>C;
Notechis 11’5
L/I>D; D>M
14249.2
Acidic PLA2 HTe L/I>N; N>D; Q>E
G>L/I/N; A>Q/K;
α subunit of PDx
13632.0
O. microlepidotus
V>R; E>W
analogue
Match
β1 subunit of TPx
13221.3
H>E
β2 subunit of TPx
OS-7
R>E; N>S
E>H
β1 subunit of TPx
Match
β2 subunit of TPx
13229.6
OS-2
V>W
OS-7
D>P; M>L/I; F>E
OS-2
Match
13316.6
O. s. scutellatus
OS-7
S>R
OS-2
C>L/I/N; H>F
OS-7
G>H
13327.6
G>Y
β1 subunit of TPx
Y>G; W>S
β2 subunit of TPx
OS-2
G>P; H>P
13357.4
G>W
β2 subunit of TPx
13506.5
OS-5
N>F
OS-1
Match
14086.0
OS-3
E>H
Masses for the monomeric PLA2 corresponded to potential single point mutations from
previously published amino acid sequences (Table 3.5). The O. s. scutellatus spectrum
contained monomeric PLA2 of masses which directly matched four previously published
sequences. Two of these matching sequences were for the β subunit of taipoxin (TPx), a
trimeric PLA2 from the venom of O. s. scutellatus. This suggests that some of the trimer
components are over-expressed in the venom. The sequences which matched the masses
of the previously published sequences have not been reported to have activity on their
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own,21, 64, 140 suggesting that the expression of these components is redundant in terms of
cytotoxic activity, and that they are present in the venom to assist in digestion.10 The lack
of cytotoxic data available for these toxins makes it impossible to determine what the
effect any of the point mutations will have on cytotoxic activity.

3.3.

Summary

The venoms of snakes are comprised of multiple components, which induce a variety of
cytotoxic effects. However, the complexity and variations between the whole venoms of
Australian snakes has yet to be elucidated. Characterizing these venom components could
provide a basis to launch in-depth investigations into the therapeutic potential contained
within each of these whole venoms. Therefore, a series of size exclusion chromatography
and mass spectrometry experiments were carried out to screen the whole venoms of: A.
antarcticus, N. scutatus, O. microlepidotus and O. s. scutellatus.
The whole venoms of the snakes mentioned above yielded multiple peaks when analysed
by size exclusion chromatography, corresponding to proteins of mass 6.5-250 kDa
(Figure 3.5). Based on previous investigations into the compositions of Viperidae and
Elapidae whole venoms, it is likely that these peaks are comprised of various cytotoxins
and digestive enzymes. All of the chromatograms visualized a similar distribution of
peaks, however, the peaks which reach an apex after approximately 13 minutes (mass
range 150-250 kDa) are unique to the taipan (Oxyuranus). The nanoESI-MS analysis of
these peaks revealed they contain protein of masses which are consistent with
prothrombinase complex FVa-FXa. Further mass analysis revealed that all the whole
venoms tested contained proteins with masses between 6-22 kDa, likely corresponding to
monomeric PLA2, three finger toxins and Kunitz-type serine protease inhibitors. A
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sizeable number of these proteins have not previously been reported, and the
characterization of them will be a key focus of future studies.
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Chapter 4 : Analysis of elapid trimeric PLA2
4.1. Introduction
The multi-subunit PLA2 (α, β and γ subunits) from the venoms of Oxyuranus spp. (taipan)
and Pseudonaja textilis (brown snake) are amongst the most potent snake venom presynaptic neurotoxins as judged in mouse models.20, 22 Previous investigations determined
that oligomerization of the elapid PLA2 venom toxins can enhance their cytotoxic
activities.63, 64, 69 In this Chapter, the whole venoms of multiple snake species from the
genera Acanthophis (death adder), Notechis (tiger snake), Oxyuranus (taipan) and
Tropidechis (rough-scaled snake) were screened for multi-subunit PLA2. Evidence was
obtained that demonstrated the existence of trimeric PLA2 in all the venoms tested.
Substantial variation in the number of subunit isoforms/glycoforms was observed
between species.
4.1.1. Prevalence and structure of elapid multi-subunit PLA2
Previous investigations have reported that trimeric PLA2 can be found in Acanthophis
and Oxyuranus venoms,17, 20, 21, 195 and that a hexameric PLA2 is present in the venom of
Pseudonaja textilis.19, 23 Full subunit sequences have been obtained for some of these
toxins.19,

65, 140, 180

Jackson et al. used these sequence data in conjunction with their

transcriptomic data set to perform a phylogenetic reconstruction to investigate how widespread multi-subunit PLA2 might be in elapid venoms.2 This analysis found homologous
sequences to the multi-subunit PLA2 in many elapid venoms, suggesting that multisubunit PLA2 are more prevalent than initially reported.

69

Several studies have used size exclusion chromatography to estimate the mass and subunit
stoichiometries of these toxins.18, 19, 196, 197 This low resolution approach makes it difficult
to accurately determine the quaternary structure of these toxins, especially when subunits
are small, and cannot be used to fully describe subunit isoform diversity. This can be seen
for textilotoxin; previous studies using chromatography underestimated the mass of this
protein as ~70 kDa, which led to it being incorrectly attributed as a pentamer.19, 197, 198 A
more complete picture of the subunit stoichiometry and subunit isoform diversity of
textiltoxin is described in section 4.1.2.
Cendron et al. generated a model for the three-dimensional structure of trimeric taipoxin
(TPx; PLA2 from the coastal taipan) using SAXS (Figure 4.1).140 Since three-dimensional
models are not available for the α and γ subunits, they used the crystal structure of the β
subunit of TPx as placeholders for the other subunits. It should be noted that using the β
subunits as a place holder to generate a three-dimensional structure TPx from SAXS data
has several drawbacks, such as, not taking into account the differences in in peptide length
between the β and γ subunits or the significant glycosylation present on γ subunit. These
data indicated that TPx was a globular protein, and that the structural elements involved
in trimer formation were located opposite the enzymatic face. This model was predicted
to contain six salt bridges. Fohlman et al. used multiple chromatographic techniques to
show that the majority of the electrostatic interactions between the subunits of TPx occur
between the α and γ subunits, and that the β subunit was held in place by hydrophobic
interactions.21 These interactions were also investigated in our laboratory using
nanoESI-MS (discussed in section 4.1.2).
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Figure 4.1: Three-dimensional structure of trimeric PLA2 and potential binding motifs.
A Three-dimensional structure of trimeric TPx taken from Cendron et al., which was
constructed from three β subunits using the SAXS data.140 This structure is shown in
cartoon form, with structural regions thought to be involved in toxicity and enzymatic
activity shown in red and blue. B Side and top views of TPx, shown as surface models.
The arrows indicate the enzymatic face of these proteins on each of the subunits.
The information provided above could be used to propose the amino acids involved in
trimer formation. This was achieved by looking at the amino acid composition of
proposed regions involved in oligomer formation on the three-dimensional models of
TPx’s subunits (Figure 4.2).140 The structures of the α and γ subunits were generated
based on their respective peptide sequences using the (PS)2-v2: Protein Structure
Prediction Server.66, 67 These proposed regions for oligomer formation contained multiple
basic (α subunit), hydrophobic (β subunit) or acidic (γ subunit) amino acids, which
correspond to the proposed nature of the subunit interactions of TPx: electrostatic
interactions binding the α and γ subunits, while the β subunit is held in place by
hydrophobic interactions (determined through a combination of chromatography
techniques).21 The synthesis of this structural information from the literature is compared
to the data set generated in this Chapter (Section 4.2.2, Table 4.11, page 108) for the
trimeric PLA2, which provides insight into trimer formation for these elapid toxins.
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Figure 4.2: Potential structural motifs of TPx subunits involved in trimer formation.
The A α, B β and C γ subunits of TPx are shown in cartoon form. Positive amino acids
are coloured blue, negative red, hydrophobic orange and aromatics are magenta.
Structural regions thought to be involved in trimer association from the SAXS model
(Figure 4.1) are contained in black boxes. The β subunit structure was obtained from its
crystal structure (pdb:3VC0).140 The three-dimensional structures of α and γ subunits
were generated using the (PS)2-v2: Protein Structure Prediction Server66, 67 from their
respective peptide sequences available on Uniprot (α; P00614 and γ; P00616).
One area in which there is a paucity of data for these toxins is the glycosylation which
can occur on the acidic subunits of these toxins. Harris and Maltin showed that the acidic
subunit (γ, glycosylated) of TPx enhances its myotoxic activity.64 However, the role
and/or effect of the glycan on the γ subunit has yet to be determined. Over two decades
after the Harris and Maltin study, TPx was found to have two glycoforms, with a mass
difference of approximately 1 kDa.25 These differences in glycosylation could have large
effects on the activity of these toxins.
4.1.2. Native MS analysis of elapid multi-subunit PLA2
The first native MS analysis of the elapid multi-subunit PLA2 was a preliminary
investigation carried out in our laboratory examining textilotoxin from the venom of P.
textilis.23 Prior to this work, this toxin was thought to be pentameric, consisting of
subunits denoted as A, B, C and a covalently linked D2 dimer.19, 197, 198 The MS analysis
of this toxin revealed textilotoxin is a hexamer, with two distinct subunit arrangements
(ABC2D2 and ABD2D2), with two D2 isoforms (D2a and D2b).23 The mass of the ABD2D2
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configuration (87 kDa) was in good agreement with the mass estimation as determined
by sedimentation equilibrium analytical ultracentrifugation experiments (88 kDa).198
MS analysis of the trimeric PLA2 toxins paradoxin (PDx, from O. microlepidotus venom)
and TPx (from O. s. scutellatus venom) revealed multiple, previously unreported subunit
isoforms for these toxins, including two major glycoforms on the γ subunit of TPx.25
Without this information it would be difficult to determine which structural features are
responsible for specific cytotoxic effects. This is underlined by the degree to which the
expression of toxin isoforms can vary between snakes, as highlighted in Chapter 3 of this
thesis and previous work.
Multi-subunit PLA2 also have an atypical dissociation pattern in CID (tandem mass
spectrometry) experiments, which can be primarily attributed to the stability of PLA2
(examined in Chapter 6). Specifically, the subunits of these toxins do not exhibit charge
state migration (charge moving to more unfolded subunit117) with the application of
collisional energy. An example of what this looks like during CID experiments is given
in Figure 4.3. The subunits of textilotoxin (upper spectrum, Figure 4.3) dissociated from
the hexameric complex have charge state distributions which are reflective of free
monomers in solution. An example of charge migration during CID experiments can be
seen with serum amyloid P (lower spectrum, Figure 4.3). The dissociated subunit unfolds
prior to ejection from the pentamer, which causes charge migration from the subunits
remaining in complex.

73

Figure 4.3: Dissociation patterns for the 17+ charge state of textilotoxin (hexamer, upper)
and the 24+ charge state of serum amyloid P (pentamer, lower).
The charge states present for the subunits of textilotoxin after dissociation match those
found for monomeric PLA2 which are free in solution (see Chapter 3 and Harrison and
Aquilina for details).25 This suggests that the subunits are not unfolding due during the
CID (MS/MS) experiments. The dissociation pattern of serum amyloid P is indicative of
charge state stripping caused by protein subunit unfolding in the gas phase, which has
been described elsewhere.117 Taken from Aquilina (2009).23
The dissociation pattern observed for textilotoxin was also observed in the nanoESI-MS
analysis of PDx and TPx.25 Only the β subunit (of these αβγ trimers) could be dissociated
through the application of collisional energy (Figure 4.4). The distribution of charges
obtained from the native and CID experiments in that study also gave insight into the
assembly of these proteins. For both PDx and TPx, the sum of the average charge of the
α (6) and γ (8) subunits in solution was six higher than that of the αγ dimer average (8).
This difference in charge matches the number of proposed salt bridges for TPx using
SAXS.140 These salt bridges would explain why the α and γ subunits did not dissociate
with the application of collisional energy; electrostatic interactions are proposed to
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become stronger in the gas phase. Venoms can be screened for trimeric PLA2 using this
technique, providing insight into the inter-subunit interactions of these toxins.

Figure 4.4: CID (MS/MS) spectrum for the 13+ charge state of PDx.
Peaks corresponding to the ions of the β subunit are shown as purple ellipses ( ), while
the αγ dimer are shown as the associated black ( , α) and light blue ( , γ) ellipses. The
peak corresponding to the PDx (trimer) precursor ion is depicted as a combination of the
subunits. Charge states are given in superscript with the peak name. Inset shows the
spectrum of the trimer prior to the application of collisional energy. Taken from Harrison
and Aquilina (2016).25
4.1.3. Proteomic analysis by tandem mass spectrometry
The earliest sequence data reported for snake venom PLA2 was obtained by Edman
degradation.28, 65, 77, 78 The limitations of this method include difficulties with modified
residues, difficulty of sequencing peptides over fifty amino acids in length, and the
requirement for relatively large amounts of sample compared to modern proteomics
techniques.199 One way of overcoming these limitations is peptide sequencing using MS.
In order to obtain the peptide sequence by MS, the protein of interest is denatured in the
presence of β-mercaptoethanol or dithiothreitol to reduce disulfide bonds, and then
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fragmented using a protease (typically trypsin). These peptides are separated via HPLC
and sprayed into an ESI mass spectrometer.200 Ions corresponding to individual fragments
are selected and subjected to CID.199 During CID the peptide encounters a neutral gas and
produces product ions related to sequence fragments. This fragmentation follows a
predictable pattern to produce sequence fragments from the N- and C-terminal amino
acids (named b and y ions, respectively).199 These tandem mass spectra (MS/MS) are used
to determine the amino acid sequences, which can then be compared to sequences in
protein databases for statistical analysis and reconstruction of the protein sequence.199
The main drawback of sequencing by MS is that it can be difficult to obtain full sequence
coverage for any given protein. This can be due missed proteolytic cleavages, large
hydrophobic peptides, and peptides without significant overlap. These issues can be
overcome by performing digestions with different proteolytic enzymes.201,

202

Furthermore, it is difficult to distinguish leucine from isoleucine without additional
analysis (such as IM).199, 203
4.1.4. Scope of Chapter
The goal of the experiments presented in this Chapter was to screen snake venoms from
the genera Acanthophis, Notechis, Oxyuranus and Tropidechis for trimeric PLA2. Toxins
were characterized using a variety of MS-based techniques in order to determine the mass
of individual subunits (nanoESI-MS in the presence of 1% formic acid and 50%
acetonitrile), the masses of the trimeric PLA2 (native MS), subunit stoichiometry (by
CID), and to compare the three-dimensional geometries (IM-MS) of each trimer. Trimer
subunit sequences and glycosylation were also investigated.
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4.2. Results and Discussion
The size exclusion chromatograms presented in Chapter 3 contained peaks corresponding
to proteins of masses consistent with those expected for the trimeric PLA2 (yellow
fractions, Figure 3.5).140 Previous investigations have used a combination of size
exclusion chromatography, Edman degradation, and colorimetric assays to identify
trimeric PLA2 from Acanthophis and Oxyuranus venoms.17, 20, 21, 195 Multi-subunit PLA2
have been predicted to exist in other Australian elapid venoms.2 However, there is a
paucity of data for the structures of these toxins, with only PDx and TPx being
investigated in detail using native MS (revealing the number of subunits)25 and TPx being
analysed using SAXS (revealing the overall shape).140
The whole venom chromatography analysis of Notechis scutatus showed that this venom
yielded size exclusion peaks with elution times that could correspond to trimeric PLA2
(Figure 3.5). However, FXa proteins have a similar mass and are a common feature of
Australian elapid venoms.2, 4 Other Notechis spp. venoms have yet to be screened for these
toxins. Therefore, size exclusion fractions which could correspond to trimeric PLA2 from
multiple Notechis and Tropidechis species were analysed by nanoESI-MS for the first
time. Trimers from Acanthophis and Oxyuranus s. canni were analysed in greater detail.
Both PDx and TPx were re-analysed to look for consistency between venom milks.
4.2.1. Screening elapid venoms from trimeric PLA2
Although previous studies have shown that trimers exist in the venoms of Acanthophis,17,
18

they may not be present in venoms from all individuals of the species due to variations

in expression between snakes (as shown for other toxins in Chapter 3, Tables 3.1 to 3.4).
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Furthermore, the subunit stoichiometries of these toxins have not been investigated in
detail. The Notechis venoms were chosen to be screened for multi-subunit PLA2 as there
has been little investigation of the higher mass components of these venoms.
For the initial set of experiments, each of the venoms was fractionated using size
exclusion chromatography using a Superdex 200 column (Figure 4.5). Each of these
chromatographs contained peaks which could correspond to trimeric PLA2 (elution
volumes of 15-17 mL). However, these peaks could also correspond to non-PLA2
proteins, such as FXa proteins, which are in the same mass range as the oligomers.4
Therefore additional analysis was required to determine if multi-subunit PLA2 were
present in these venoms.
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Figure 4.5: Whole venom size exclusion profiles (Superdex 200 10/300 column).
Chromatographic profiles for the venoms of the genera A Acanthophis and Tropidechis,
B Notechis and C Oxyuranus. See section 2.1.1 for full experimental conditions.
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To determine if PLA2 were present in the relevant size exclusion peaks (elution volume
15-17 mL), a colorimetric assay was used. The substrate for the colorimetric assay uses
phosphatidylcholine (PC) in which the ester oxygen is replaced by sulfur. When the PLA2
hydrolyse the sn-2 fatty acid chain it releases a thiol group which can react with DTNB
(5,5ʹ-dithiobis(2-nitrobenzoic acid), Ellman’s reagent). The change in absorbance
(release of yellow anion, 2-nitro-5-thiobenzoic acid (TNB)) can be recorded, then used to
calculate the enzymatic rate (section 2.6). The colorimetric assay showed that all fractions
tested from Acanthophis (Table 4.1), Notechis (Table 4.2), Oxyuranus (Table 4.3) and
Tropidechis (Table 4.1) contained active PLA2. Differences in activity could be mostly
attributed to different amounts of non-PLA2 proteins present in each sample, but also
possibly due to intrinsic enzymatic properties of the different PLA2 from each venom.
Size exclusion fractions exhibiting PLA2 activity were taken for analysis by nanoESI-MS
under denaturing solution conditions. Protein masses detected in these spectra were
broadly characterized into subunit classes based on the masses proposed for the subunits
from previous investigations. Specifically, subunits of masses between 13.5 to 14 kDa
were considered α subunits, 13-13.5 kDa were β subunits, and 14 to 20 kDa were γ
subunits.17, 18, 25 The subunit masses reported in this work were compared to previous
investigations of multimeric PLA2. This was done to determine if there were differences
in toxin expression between studies/snakes (as observed in Chapter 3). It should be noted
that previous MALDI-TOF investigations were incapable of sufficiently resolving the
individual γ glycoforms, thus direct mass comparisons could not be made in these
studies.17, 18, 195
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For the Acanthophis spp. (Table 4.1), only the βa subunit (13454.3 Da) of the trimeric
PLA2 from A. antarcticus was different from the literature mass (13516 Da).17, 18 This
mass difference matches a single amino acid switch of tyrosine to threonine. It should be
noted that, under denaturing conditions, the A. praelongus (northern death adder)
spectrum contained more peaks in the m/z region corresponding to the γ subunits, than
what is reported in Table 4.1. These additional peaks were of too low an abundance for
accurate mass measurements. This could be attributed to the lower response factors
(ability to be ionized and/or transmitted through the mass spectrometer to the detector)
for the glycosylated subunits of these toxins. It also suggests that there are more than two
trimer glycoforms present in this toxin.
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Table 4.1: Subunit masses and phospholipase activities of trimeric PLA2 size exclusion
fractions for the genera Acanthophis and Tropidechis.
Fraction specific
Proposed subunits
activity
Snake
identities
and masses (Da)
(µmol/min/A280)
αa; 13810.3 ± 0.1
βa; 13454.3 ± 0.1
36.5 ± 1.7
A. antarcticus
γa; 17641.7 ± 0.1
γb; 17845.5 ± 1.6
αa; 13810.6 ± 0.1
βa; 13328.9 ± 0.1
βb; 13442.1 ± 0.1
34.4 ± 6.5
A. praelongus
βc; 13496.1 ± 0.1
γa; 17527.5 ± 0.4
γb; 17548.9 ± 0.4
αa; 13653.0 ± 0.1
αb; 13708.8 ± 0.1
βa*; 13253.0 ± 0.1
βa; 13366.3 ± 0.1
22.2 ± 3.0
T. carinatus
γa; 14619.7 ± 0.1
γb; 16852.2 ± 0.9
γc; 17509.2 ± 0.7
γd; 17657.2 ± 0.7
Activity was obtained using the Cayman colorimetric assay for the relevant size exclusion
fraction. Subunit masses were taken from the nanoESI-MS spectra acquired with a spray
solution which contained 1% formic acid and 50% acetonitrile. Subunits from different
snake species which are within 1 Da are shown in red font.
The subunit diversity of the Notechis spp. was different to the other trimers investigated
(Table 4.2). Two of the Notechis spp. spectra contained charge state series for proteins of
masses of approximately 15484 Da, which was not observed for the other elapid trimer
fractions. This subunit mass could be reflective of a novel glycosylation pattern or
extended amino acid sequence for this proposed γ subunit. The nanoESI-MS analysis of
venoms of the Notechis genera revealed that, across snake species, the PLA2 subunits had
identical masses. These data suggest that the multi-subunit PLA2 for the Notechis species
have the same amino acid sequences. The N. a. niger spectrum did not show any charge
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state series in the range expected for β subunits, nor did it contain a peak series with a
calculated mass of approximately 15484 kDa. This may be attributed to the low
abundance of PLA2 within the relevant size exclusion sample and the relatively low ESIMS response factors of these subunits for the Notechis spp..
The number of peaks detected in this work (Table 4.3) for O. microlepidotus and O. s.
scutellatus matched the previous nanoESI-MS investigation conducted by this laboratory.
This shows that, for this toxin, there were not significant differences between the samples
from 201525,

204

and those measured in this work (Table 4.3, 2017-2018). This was

investigated further in the native and CID experiments (section 4.2.2). However, it should
be noted that the second β subunit isoform of PDx (trimeric PLA2 from O.
microlepidotus) was originally thought to be adducted by Na+, as the mass difference
measured in our original study was 22 Da.25, 204 The MS analysis of the O. s. canni trimer
(cannitoxin, CTx) under denaturing solution conditions revealed that this toxin has a
greater number of β subunit isoforms than previously reported.195 This may be due to
differences in expression between snakes.
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Table 4.2: Subunit masses and phospholipase activities of trimeric PLA2 size exclusion
fractions for the genera Notechis.
Fraction specific
Proposed subunits
activity
Snake
identities
and masses (Da)
(µmol/min/A280)
αa; 13677.7 ± 0.6
αb; 13774.5 ± 0.7
βa; 13117.1 ± 0.9
γa; 14504.4 ± 0.2
41.1 ± 1.8
N. scutatus
γb; 15484.2 ± 0.8
γc; 16140.4 ± 0.3
γd; 16710.6 ± 0.5
γe; 17366.7 ± 0.3
αa; 13774.7 ± 0.1
βa; 13115.6 ± 0.1
γa; 15483.7 ± 0.1
17.9 ± 0.1
N. a. serventyi
γb; 16140.4 ± 0.2
γc; 16710.1 ± 0.1
γd; 17366.8 ± 0.3
γe; 19749.6 ± 0.9
αa; 13774.6 ± 0.1
γa; 16140.6 ± 0.2
16.1 ± 1.4
N. a. niger
γb; 16710.0 ± 1.4
γc; 17366.7 ± 1.2
Activity was obtained using the Cayman colorimetric assay for the relevant size exclusion
fraction. Subunit masses were taken from the nanoESI-MS spectra acquired with a spray
solution which contained 1% formic acid and 50% acetonitrile. Subunits from different
snake species which are within 1 Da are shown in the same colour font (excluding black
font).
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Table 4.3: Subunit masses and phospholipase activities of trimeric PLA2 size exclusion
fractions for the genera Oxyuranus.
Fraction specific
Subunits identities
activity
Snake
and masses (Da)
(µmol/min/A280)
αa; 13862.6 ± 0.3
βa; 13316.8 ± 0.8
52.1 ± 9.9
O. microlepidotus
βb; 13337.0 ± 0.3
γa; 19228.7 ± 0.1
γb; 19309.0 ± 0.1
αa; 13818.6 ± 0.1
βa; 13202.9 ± 0.1
βb; 13222.0 ± 0.1
βc; 13263.0 ± 0.1
βd; 13335.1 ± 0.1
βe; 13376.7 ± 0.1
γa; 14703.6 ± 0.1
19.8 ± 0.6
O. s. canni
γb; 18490.9 ± 0.2
γc; 18571.0 ± 0.2
γd; 18774.7 ± 0.1
γe; 18855.4 ± 0.2
γf; 18936.8 ± 0.1
γg; 19148.2 ± 0.1
γh; 19228.4 ± 0.1
γi; 19308.6 ± 0.1
αa; 13759.4 ± 0.6
αb; 13814.6 ± 0.4
αc; 13989.7 ± 0.1
βa; 13220.9 ± 0.9
βb; 13262.5 ± 0.4
βc; 13304.1 ± 0.1
90.1 ± 5.8
O. s. scutellatus
βd; 13334.7 ± 0.1
γa; 18492.4 ± 0.1
γb; 18572.4 ± 0.1
γc; 19149.3 ± 0.2
γd; 19229.2 ± 0.1
γe; 19309.3 ± 0.1
Activity was obtained using the Cayman colorimetric assay for the relevant size exclusion
fraction. Subunit masses were taken from the nanoESI-MS spectra acquired with a spray
solution which contained 1% formic acid and 50% acetonitrile. Subunits from different
snake species which are within 1 Da are shown in the same colour font (excluding black
font). The trimeric PLA2 of O. microlepidotus, O. s. canni and O. s. scutellatus are known
as PDx, CTx and TPx, respectively.
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Size exclusion peaks which contained trimeric PLA2 were also separated using SDSPAGE (Figure 4.6) for subsequent sequence analysis. Trimers from the venom of
O. s. scutellatus were not analysed, as its subunits have already been sequenced.65, 140
Other investigations have shown that the trimeric PLA2 typically give rise to three bands
on a denaturing gel, corresponding to the α, β and γ subunits.204 The two lowest mass
bands (α and β subunits) are visualized around the 15 kDa marker protein; the other band
(γ subunit) arises between the 20-25 kDa markers. However, the 25 kDa bands are
typically less prominent (or stain less well) than the 15 kDa bands,204 making the γ subunit
difficult to isolate for sequencing by MS/MS.

Figure 4.6: SDS-PAGE of size exclusion fractions thought to contain trimeric PLA2.
The masses of proteins were estimated using a BioRad dual colour marker (left most lane,
M). Bands which were excised for tryptic digest and MS/MS analysis (section 2.4) are
outlined with red boxes. Gel regions expected to contain γ subunits are within the yellow
box, while those which would correspond to the α and β subunits are in the blue box.204
From left to right, the subsequent lanes correspond to trimer samples from the venoms of:
O. microlepidotus (1), O. s. canni (2), A. antarcticus (3), A. praelongus (4), N. scutatus
(5), N. a. serventyi (6), N. a. niger (7) and T. carinatus (8).
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Bands indicated in Figure 4.6 were extracted and treated with trypsin for sequencing by
MS/MS. Peptide sequences corresponding to previously characterized elapid PLA2 were
detected (Appendix, Table 8.1). Sequence data for the other prominent bands primarily
corresponded to FXa proteins, which have previously been shown to exist in these
venoms. The absence of FXa in the Oxyuranus spp. venoms is due to this protein forming
a complex with FVa, which elutes around 13 mL, as shown in Chapter 3. The peptide
sequence data are discussed in more detail later in this section, with the native MS data.
These data also show that multi-subunit PLA2 are present in the venoms of A. antarcticus
and N. a. niger, but were too low in abundance in the SEC samples to be visualized on an
SDS-PAGE.
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Figure 4.7: Mass spectra of PDx (trimeric PLA2 from O. microlepidotus venom) A
before, and B after, PNGase treatment.
Spectra were acquired in 100 mM AmOAc, 1% formic acid, 50% acetonitrile (v/v). Peaks
corresponding the glycosylated γ subunits are coloured yellow, while those corresponding
to deglycosylated γ subunits are coloured orange.
To obtain a better understanding of the glycosylation present on these toxins, multisubunit PLA2 from single snake species of each genus were deglycosylated using PNGase
F and analysed using MS. This resulted in the disappearance of peaks corresponding to
masses of glycosylated subunits. For example, Figure 4.7 shows the spectra for subunits
of PDx (trimeric PLA2 from O. microlepidotus venom) before (upper spectrum) and after
(lower spectrum) treatment with PNGase. Prior to PNGase treatment, the most prominent
γ subunit isoform had two charge sates (7+, m/z 2759 and 8+, m/z 2414), with a calculated
mass of 19309 Da. After treatment with PNGase F, the ions present for the most
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prominent γ subunit of PDx were the 6+ (m/z 2432) and 7+ (m/z 2085), with a calculated
mass of 14587 Da. This corresponded to a mass difference of 4722 Da.
The limited data available in the literature suggested that the deglycosylated proteins were
expected to have masses around 14.5 kDa, matching the γ subunits of TPx.65 Table 4.4
shows the subunit masses present in the spectra of A. antarcticus, N. scutatus, O.
microlepidotus and T. carinatus after treatment with PNGase F. The masses marked with
an asterisk denote subunits’ masses which were not present in Table 4.1 to 4.3. For A.
antarcticus, O. microlepidotus and T. carinatus these likely correspond to the
deglycosylated subunits of the trimeric PLA2. However, the spectra of the trimer from the
venom of N. scutatus also contained several novel charge state series with calculated
masses in the range of the β subunit for other trimers (13221.7 Da, 13278.9 Da and
13391.5 Da, respectively). This supports the hypothesis that multimeric PLA2 from the
Notechis genus have two glycosylated subunits. To further investigate this observation,
as well as confirm the stoichiometries of these toxins, their native structures were
investigated using nanoESI-MS. The proteins masses detected in the spectra of the
PNGase treated samples are reported in Table 4.4.
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Table 4.4: Deglycosylated masses of trimer subunits from each genus tested.
Subunit masses
Proposed glycan
Snake venom
(Da)
mass (Da)
αa; 13810.8 ± 0.1
−
βa; 13454.9 ± 0.2
A. antarcticus
−
(Table 4.1)
γa; 14635.1 ± 0.1*
3006.6/3210.4
γb; 14705.3 ± 0.1*
2936.4/3140.2
αa; 13677.5 ± 0.2
−
αb; 13774.6 ± 0.3
−
βa; 13115.6 ± 0.1
−
Multiple
βb; 13221.7 ± 0.6*
N. scutatus
Multiple
βc; 13278.9 ± 0.2*
(Table 4.2)
Multiple
βd; 13391.5 ± 0.3*
Multiple
γa; 14304.8 ± 0.1*
Multiple
γb; 14417.6 ± 0.2*
Multiple
γc; 14504.8 ± 0.3*
αa; 13861.8 ± 0.1
−
βa; 13318.2 ± 0.2
−
O. microlepidotus
βb; 13337.5 ± 0.1
−
(Table 4.3)
γa; 14258.1 ± 0.2*
4970.6/5050.9
γb; 14587.3 ± 0.1*
4641.4/4721.7
αa; 13652.7 ± 0.1
−
αb; 13708.8 ± 0.1
−
βa; 13252.7 ± 0.1
T. carinatus
−
(Table 4.1)
βb; 13365.9 ± 0.1
−
Multiple
γa; 14304.8 ± 0.1*
−
γb; 14620.1 ± 0.1
*Indicates subunits masses not detected before the addition of PNGase F. For the
proposed glycan mass, ‘Multiple’ indicates that there are several potential glycans.
4.2.2. Mass spectrometry analysis of native PLA2 complexes
To further investigate the structure of the potential trimers, relevant size exclusion
fractions from each of the genera were investigated using a combination of MS
techniques. Specifically, in this section, a combination of native MS and CID was used
to determine subunit composition of the native multi-subunit PLA2. The SDS-PAGE
(Figure 4.6) and sequence data (Appendix, Table 8.1) indicated that FXa proteins would
be present in the venoms with the exception of those from Oxyuranus. FXa ions would
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likely occupy the same m/z region as the multi-subunit PLA2 given their similar mass,
making it difficult to distinguish which peaks belong to which protein without additional
analysis. Multi-subunit PLA2 dissociate into their subunit constituents with the
application of collisional energy,25 while the FXa will likely not dissociate, as it consists
of two covalently-linked peptide chains.155, 157, 205, 206 Therefore, to distinguish between
these proteins, relevant ion populations were isolated and had collisional energy applied
to them to look for dissociation.
For the CID experiments, the 12+ ion of each peak series which could correspond to a
trimeric PLA2 was selected as the precursor ion for the CID experiments. More subunit
isoforms were detected for the γ subunits for the samples in formic acid/acetonitrile
spectra than in the native and CID spectra. This could be attributed to the difficulty in
distinguishing between glycoforms in native MS experiments, since the peaks were
broader. Differences were also found between the masses obtained from the formic
acid/acetonitrile spectra and those from the native and CID spectra. These mass
differences likely corresponded to water and cation adducts. Also, given the complexity
of the samples being worked with, in terms of subunit isoform complexity and ion peak
overlap, the CID and denatured spectra were given more weight for subunit assignment
of the trimer complexes than the native spectra.
4.2.1.1.

Acanthophis and Tropidechis

The Acanthophis and Tropidechis trimers were analysed together, due to their similarities
in glycosylation pattern, as shown in Table 4.1. The native and CID data for the size
exclusion fractions containing the trimeric PLA2 were separated into three sections. This
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separation was based on the mass of components within specific m/z regions of the native
spectra in Figure 4.8.
Analysis of the peaks from the blue region of the native spectra from Figure 4.8
The spectra of the A. antarcticus, A. praelongus and T. carinatus size exclusion fractions
contained multiple peaks, corresponding to the charge states of several venom proteins
(Figure 4.8). In the m/z region 1000-3000 (blue shading in Figure 4.8), peaks were found
with masses corresponding to monomeric subunits of PLA2 oligomers. Based on mass,
the peaks of the highest relative abundance corresponded to β subunit isoforms. For each
snake from the genera Acanthophis and Tropidechis, these masses were: A. antarcticus,
13455 Da (βa subunit); A. praelongus, 13329 Da (βa subunit) 13442 Da (βb subunit)
13496 Da (βc subunit); T. carinatus, 13365.2 Da (βa subunit). Some peaks with masses
corresponding to γ isoforms were also detected in the A. antarcticus spectrum (17643 Da
(γa subunit), 17844 Da (γb subunit)), albeit, in low abundance. In previous MS
experiments, monomers were observed in the native spectra of the trimeric PLA2 from
the venoms of O. microlepidotus and O. s. scutellatus.25 Differences in the relative
abundance of the subunit ions within these spectra could be due to differences in
ionization efficiency.25
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Figure 4.8: Native and CID spectra of Acanthophis spp. and T. carinatus trimers.
CID spectra were acquired using trap and transfer voltages of 60 V and 30 V, respectively.
The m/z region containing peaks corresponding to monomeric PLA2 in both the native
and CID spectra are highlighted blue (m/z 1900-3000). The trimer region within the native
spectra has been highlighted in yellow (m/z 3400-4100). Non-PLA2 peaks found in the
high m/z region within the native spectra have been highlighted red (m/z 4200-5700). For
the CID spectra, the m/z region which contained the dimeric PLA2 has been highlighted
green (m/z 3900-5400). The precursor ions used for the CID experiments are denoted with
an asterisk.
Analysis of the peaks from the yellow region of the native spectra from Figure 4.8
Between m/z 3000-4250, several peaks series were detected in each spectrum (yellow
shading in Figure 4.8), with calculated masses between 41-47 kDa. This is the mass range
expected for the trimeric PLA2, which have been previously shown to exist in the venoms
of A. antarcticus and A. praelongus,17, 18 and hypothesized to exist in the venom of T.
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carinatus.2 The most prominent ion (typically the 12+ ions) of each peak series located
between the m/z 3000-4250 was isolated and subjected to CID (Figure 4.8, asterisk,
yellow shading). The m/z values of each precursor ion selected for each of the trimer
isoforms analysed by MS/MS are given in Table 4.5. Each peak corresponding to a PLA2
complex primarily dissociated into β subunits (CID spectra, blue m/z region) and αγ
dimers (CID spectra, green m/z region), however, small amounts (~2% relative abundance
to the β subunit) of α subunit were detected in the blue m/z region each of the spectra
(Figure 4.8). The dissociation of the trimer ions into β subunits and αγ dimers matches
the dissociation pattern for the trimeric PLA2 from the venoms of O. microlepidotus and
O. s. scutellatus.25 This suggests that the binding structural motifs used to form the
trimeric PLA2 are of a similar nature. For the Acanthophis and Tropidechis trimers, there
were small amounts of α subunit present in the CID spectra. These data suggest that, for
these trimers, there is a second dissociation pathway (αβγ trimer dissociates into α
monomer and βγ dimer).
Table 4.5 shows the CID data for the trimeric PLA2 from the snake genera Acanthophis
and Tropidechis. Mass differences were observed between αγ dimers dissociated from
each of the trimers. These mass differences corresponded to the mass differences between
γ subunits. For example, the mass differences between the αγ dimer and γ subunits of the
A. antarcticus trimer are 201 Da and 202 Da, respectively. Comparisons in mass
differences between the trimers and their constituents could not be readily made for most
of the trimer ions, due to significant peak overlap within the spectra. However, the CID
data set combined with the γ subunit masses shows that the mass differences between the
major trimer isoforms are due to mass differences between γ subunit isoforms. Given the
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information for the glycan patterns observed in Table 4.4, and the typical mass of the
deglycosylated γ subunits, it is likely that these mass differences are due to variations in
glycosylation. Table 4.5 summarizes all of the results of the CID experiments for the
trimeric PLA2 from the venoms of the genera Acanthophis and Tropidechis analysed in
this study.
Table 4.5: Masses and protein identities of the CID spectra in Figure 4.8.
Identity and mass (Da)
Precursor ions
Snake
of dissociated
(charge and m/z)
constituents
αa; 13810.6 ± 0.2
P-EPTX-Aa1a
+
βa; 13454.9 ± 0.1
(12 , 3748)
A. antarcticus
P-EPTX-Aa1b
αaγa; 31454.0 ± 0.2
(12+, 3760)
αaγb; 31656.3 ± 0.2
αa; 13810.7 ± 0.2
βa; 13329.0 ± 0.1
P-EPTX-Ap1a
βb; 13442.0 ± 0.5
(12+, 3723)
βc; 13496.2 ± 0.1
P-EPTX-Ap1b
+
αaγa; 31207.3 ± 2.4
(12 , 3737)
A. praelongus
P-EPTX-Ap1c
αaγb; 31336.5 ± 1.4
(12+, 3778)
αaγc; 31664.2 ± 0.2
P-EPTX-Ap1d
α
aγd; 31905.8 ± 0.1
(12+, 3792)
αaγe; 31994.6 ± 0.5

T. carinatus

P-EPTX-Tc1a
(12+, 3479)
P-EPTX-Tc1b
(12+, 3662)
P-EPTX-Tc1c
(12+, 3717)
P-EPTX-Tc1d
(12+, 3773)

αa; 13652.6 ± 0.1
αb; 13708.3 ± 0.3
βa; 13365.6 ± 0.1
αγa; 28326.5 ± 0.7
αγb; 30534.5 ± 1.5
αγc; 30568.1 ± 1.0
αγd; 31190.4 ± 0.4
αγe; 31225.3 ± 0.3
αγf; 31347.5 ± 0.4

Novel toxins were named as per the recommendations made by King et al.207 CID
products which only appear for a given trimer isoform are colour coded. Those in black
font were found in all of the toxins from an individual snake species. Subunit isoforms
are denoted by subscripted letters and were assigned based on the data presented in Table
4.1. The absence of a subscript for the α subunit forming a dimer indicates that there was
more than one isoform present for that subunit.
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Only one of the peak series (protein mass of 46518 Da) in the native T. carinatus spectrum
did not dissociate with the application of collisional energy (13+ precursor ion, m/z 3579).
This protein likely corresponds to the SDS-PAGE gel band with a mass of ~45 kDa
(Figure 4.6, lane 8). The sequence data for this protein sequence closely matched that of
nocarin-D1, an FXa from the venom of N. scutatus (Appendix, Table 8.1).157, 205 From
this information it can be proposed that this protein is trocarin-D, an FXa toxin from
whole T. carinatus venom which has been characterised by Edman degradation (peptide
sequence) and HPLC (glycan composition).155, 206
Analysis of the peaks from the red region of the native spectra from Figure 4.8
Charge states series were detected between the region m/z 4000-5000 in the native spectra
for A. antarcticus and T. carinatus (Figure 4.8), both of which corresponded to ~80 kDa
proteins. A gel band of mass similar to this was found on the SDS-PAGE gel for A.
antarcticus (Figure 4.6, lane 3). Peptide sequence data for this band indicates that this
protein is either a metalloprotease or an acetylcholinesterase (Appendix, Table 8.1).
Further analysis is required to determine the identity of this protein. The masses and
proposed identities of all proteins detected in the Acanthophis and Tropidechis native
spectra are summarized in Table 4.6.
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Table 4.6: Masses and protein identities from the Acanthophis spp. and Tropidechis
nanoESI mass spectra.
Dissociates
Proposed Protein
Snake
Mass (Da)
via CID
Identity
13454.9 ± 0.1
No
Subunit βa
17643.1 ± 0.6
No
Subunit γa
17844.0 ± 0.7
No
Subunit γb
A. antarcticus
44949.0 ± 0.7
Yes
P-EPTX-Aa1a
45134.1 ± 1.5
Yes
P-EPTX-Aa1b
81753.7 ± 3.4
No
SVMP*
13329.1 ± 0.1
No
Subunit βa
13442.4 ± 0.1
No
Subunit βb
13496.3 ± 0.2
No
Subunit βc
A. praelongus
44668.7 ± 0.1
Yes
P-EPTX-Ap1a
44835.0 ± 0.5
Yes
P-EPTX-Ap1b
45332.1 ± 2.4
Yes
P-EPTX-Ap1c
45491.0 ± 0.2
Yes
P-EPTX-Ap1d
13365.2 ± 0.3
No
Subunit βa
41731.7 ± 2.0
Yes
P-EPTX-Tc1a
43902.5 ± 0.6
Yes
P-EPTX-Tc1b
T. carinatus
44594.3 ± 0.4
Yes
P-EPTX-Tc1c
44756.6 ± 1.8
Yes
P-EPTX-Tc1d
46518.1 ± 0.7
No
Trocain
79971.6 ± 2.1
No
Unidentified protein
Samples were analysed in 200 mM ammonium acetate (AmOAc). Subunit isoform were
denoted by subscripted numbers were assigned based on the data presented in Table 4.1.
*Identity of protein assigned based on the sequence analysis (Table 8.1). Snake venom
metalloprotease was abbreviated to SVMP.
This presents a similar question to the one asked in Chapter 3 for other toxins; how
prevalent are these toxins in elapid venoms, and what factors affect their expression?
Given the current literature (as explained in Chapter 3), it is likely some combination of
factors linked to the geographical location of these snakes (climate, diet etc.) and
evolutionary factors (positive and negative selection). No gel band with a mass of
approximately 80 kDa was found on the SDS-PAGE for T. carinatus, thus no identity can
be proposed for this protein. This is likely due to the low abundance of this protein within
the trimeric PLA2 size exclusion fraction.
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4.2.1.2.

Notechis

The Notechis trimers were grouped together, based on their genera-specific
characteristics given in Table 4.2. The native and CID data for the size exclusion fractions
containing the trimeric PLA2 were separated into three sections. This separation was
based on the mass of components within specific m/z regions of the native spectra in
Figure 4.9.
Analysis of the peaks from the blue region of the native spectra from Figure 4.9
The nanoESI mass spectra of the Notechis spp. size exclusion fractions contained multiple
peaks, corresponding to the charge states of several venom proteins (Figure 4.9). In the
m/z region 1000-1800, multiple peaks were found with masses corresponding to either a
short chain neurotoxin (SCN) or Kunitz-type serine protease inhibitor (KPI). The
identities of these proteins were tentatively assigned using the same methodology
presented in Chapter 3, where a more detailed description of these toxins can also be
found. These proteins were not found on the SDS-page gel due to their relatively low
mass (Figure 4.6). The small peptides detected in the trimer size exclusion fractions
(Figure 4.5, elution volume 15-17 mL) are too small to have eluted in this fraction as free
monomers, therefore, they were likely bound to one of the higher mass proteins, but
dissociated upon MS analysis. This suggests a novel interaction not yet reported for these
proteins. Given that these proteins were not found in the size exclusion fractions of other
snake species that predominantly contained trimeric PLA2, it is likely that their binding
partner is one of the other high mass proteins. Further investigations are required to
elucidate their binding partner.
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Figure 4.9: Native and CID spectra of the trimers found in the venoms of Notechis spp.
CID spectra were acquired using trap and transfer voltages of 60 V and 30 V, respectively.
The m/z region containing peaks corresponding to monomeric PLA2 in both the native
and CID spectra are highlighted blue (m/z 1900-3000). The trimer region within the native
spectra has been highlighted in yellow (m/z 3100-4200). Non-PLA2 peaks found in the
high m/z region within the native spectra have been highlighted red (m/z 4200-5700). For
the CID spectra, the m/z region which contained the dimeric PLA2 has been highlighted
green (m/z 4000-5500). The precursor ions used for the CID experiments are denoted with
an asterisk.
In the m/z region 1900-3000 (blue m/z region) of the native spectra, multiple peaks were
found with masses corresponding to monomeric PLA2 (Figure 4.9). Based on mass, the
peaks of the highest relative abundance corresponded to β subunit isoforms. Some ion
peaks with masses corresponding to γ isoforms were also detected (Table 4.8). The
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subunits detected in these spectra match the type found in the Acanthophis and
Tropidechis native spectra (Figure 4.8).
Analysis of the peaks from the yellow region of the native spectra from Figure 4.9
Between the m/z 3000-4250 (yellow m/z region), several peaks series were detected
within each native spectrum, with calculated masses between 44-47 kDa. Most of the
peaks investigated using CID likely corresponded to both trimeric PLA2 and FXa. This is
due to peak overlap, which is occurring because of the higher masses of the Notechis spp.
trimeric PLA2. The protein with a mass of 45969 Da (12+, m/z 3832) in the native
spectrum of N. a. serventyi was of too low abundance to be analysed using CID.
Table 4.7 shows the CID data for the trimeric PLA2 from the snake genera Acanthophis
and Tropidechis. The Notechis PLA2 complexes had a unique dissociation pattern
compared to the other trimers investigated in this work. Given the subunit identities and
masses from the formic acid/acetonitrile spectra (Table 4.2), the CID data show that the
Notechis spp. trimers primarily dissociated into α subunits and γγ dimers (Table 4.7). The
α subunits and γγ dimers can be observed in the blue (m/z region 2000-3500) and green
(m/z region 4000-5500) regions of the CID spectra, respectively (Figure 4.9). The initial
assignment of subunit identities was based on each subunit mass, as described in section
4.2.1, but is discussed in more detail below. The dissociation of these toxins suggests they
have a modified arrangement of the structural motifs involved in trimer formation; the α
subunit is primarily held in place primarily by hydrophobic interactions while the
glycosylated γ subunits likely associate via electrostatic interactions. It was difficult to
accurately determine the dimer mass from the CID spectra. In these cases, the subunits
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masses were used in conjunction with trimer masses to deduce their subunit
stoichiometry. However, this is not the complete story for the Notechis spp. trimers.
Table 4.7: Masses and protein identities of the CID spectra in Figure 4.9
Parent ions
Identity and mass
Snake
(charge and
(Da) of dissociated
m/z)
constituents
αa; 13677.3 ± 0.2
αb; 13774.2 ± 0.2
A
P-EPTX-Ns1a
γ
a/bγc/d; 32142.5 ± 2.0
+
A
(12 , 3844.8)
γb/cγd/e; 32892.0 ± 7.7B
P-EPTX-Ns1b
N. scutatus
γc/dγe/d; 33544.2 ± 0.7C
(12+, 3889.4)B
P-EPTX-Ns1c
(12+, 3944.3)C

N. a. serventyi

P-EPTX-Nas1a
(12+, 3886.5)A
P-EPTX-Nas1b
(12+, 3941.2)B

αa; 13774.4 ± 0.1
γcγe; 32558.7 ± 2.5A

αa; 13676.2 ± 0.1
P-EPTX-Nan1a
+
(12 , 3899.6)
αb; 13774.3 ± 0.6
Novel toxins were named as per the recommendations made by King et al.207 CID
products which only appear for a given trimer isoform are colour-coded. Those in black
font were found in all the toxins from a particular snake species. Subunit isoforms are
denoted by subscripted letters assigned based on the data presented in Table 4.2.
N. a. niger

The N. scutatus PNGase F data set (Table 4.4) suggested that its trimeric PLA2 has a
unique glycan pattern; with both the β and γ subunits glycosylated. The subunit masses
detected during the formic acid/acetonitrile experiments of the other Notechis spp.
indicated that their trimers may also exhibit this glycosylation pattern. From the data set
presented in this work, it was impossible to ascertain which glycan mass belonged to
which subunit type. Therefore, the subunit assignment has been tentatively left as αγγ for
the tiger snake trimers until further investigations into the glycosylation of these toxins
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can be undertaken. The likely subunit stoichiometry of the Notechis spp. based on trimer
and subunit masses was as follows: P-EPTX-Ns1a, αγaγd, αγbγe; P-EPTX-Ns1b; αγbγd,
αγcγe; P-EPTX-Ns1c, αγcγe, αγdγd; P-EPTX-Nas1a, αγaγf, αγbγc; P-EPTX-Nas1b αγbγf,
αγcγd, αγcγe. The subunit stoichiometry of P-EPTX-Nan1a could not be determined. To
confirm the subunit arrangement of these toxins, a combination of peptide sequencing, as
well as subunit isolation and characterization by glycan analysis could be used.
Analysis of the peaks from the red region of the native spectra from Figure 4.9
Charge state series were detected between the region m/z 4000-5000 (red m/z region) in
the native spectra for N. scutatus and N. a. niger (Figure 4.9), which had masses of
89426 Da and 93714 Da, respectively. The peptide sequencing from the SDS-PAGE gel
revealed no protein of a corresponding mass (Figure 4.6, lanes 4 and 6). This could be
due to its low abundance in the N. scutatus spectrum, and that no sequence data were
obtained from the N. a. niger sample. Identifying these proteins should be a focus of
future investigations. The masses and proposed identities of all proteins detected in the
Notechis spp. native spectra are summarized in Table 4.8.
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Table 4.8: Masses and protein identities from the Notechis spp. native spectra.
Dissociates
Proposed protein
Snake
Mass (Da)
via CID
identity
6675.1 ± 0.1
No
SCN/KPI
6695.6 ± 0.3
No
SCN/KPI
6733.0 ± 0.2
No
SCN/KPI
6807.3 ± 0.1
No
SCN/KPI
13115.9 ± 0.1
No
Subunit βa
13222.5 ± 0.1
No
Subunit βb
45876.7 ± 1.2
Yes
P-EPTX-Ns1a or FXa
45969.9 ± 0.4
Yes
P-EPTX-Ns1a or FXa
N. scutatus
46533.6 ± 0.3
Yes
P-EPTX-Ns1b or FXa
46627.3 ± 0.5
Yes
P-EPTX-Ns1b or FXa
46661.5 ± 0.4
Yes
P-EPTX-Ns1b or FXa
46737.6 ± 0.3
Yes
P-EPTX-Ns1b or FXa
47189.5 ± 0.8
Yes
P-EPTX-Ns1c or FXa
47282.8 ± 1.4
Yes
P-EPTX-Ns1c or FXa
47318.8 ± 0.9
Yes
P-EPTX-Ns1c or FXa
89426.1 ± 2.0
No
Unidentified protein
6694.3 ± 0.1
No
SCN/KPI
13115.2 ± 0.1
No
Subunit βa
N. a. serventyi
45969.1 ± 0.1
unknown
Not determined
46626.6 ± 0.7
Yes
P-EPTX-Nas1a or FXa
47282.6 ± 0.4
Yes
P-EPTX-Nas1b or FXa
6674.8 ± 0.3
No
SCN/KPI
13196.4 ± 2.3
No
Subunit βa
N. a. niger
46778.6 ± 3.7
Yes
P-EPTX-Nan1a or FXa
93713.6 ± 5.3
No
Unidentified protein
Samples were analysed in 200 mM ammonium acetate (AmOAc). Subunit isoforms
denoted by subscripted numbers were assigned based on the data presented in Table 4.2.
Short chain neurotoxin was abbreviated to SCN and Kunitz-type serine protease inhibitor
was abbreviated to KPI.
4.2.1.3.

Oxyuranus

The Oxyuranus trimers based on their genera-specific characteristics given in Table 4.3.
The native and CID data for the size exclusion fractions containing the trimeric PLA2
were separated into three sections. This separation was based on the mass of components
within specific m/z regions of the native spectra in Figure 4.10.
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Analysis of the peaks from the blue region of the native spectra from Figure 4.10
The spectra of the Oxyuranus size exclusion fractions contained multiple peaks,
corresponding to the charge states of several venom proteins (Figure 4.10). In the m/z
region 1000-3000 (blue m/z region), multiple peaks were found with masses
corresponding to monomeric subunits of PLA2 oligomers (Table 4.10). These peaks
corresponded predominantly to β subunit isoforms, with γ isoforms also detected in low
abundance, as observed previously for PDx and TPx.25 This difference in ion abundance
between subunit types could be due to differences in ESI-MS response factor.
Analysis of the peaks from the yellow region of the native spectra from Figure 4.10
Between the m/z 3000-4250 (yellow m/z region), several peak series were detected within
each spectrum, with calculated masses between 44-47 kDa, the CID patterns of which all
corresponded to trimeric PLA2. The masses detected in the CID spectra, as well as the
stoichiometry assignment for each precursor ion are summarized in Table 4.9. Each PLA2
complex primarily dissociated into β subunits and αγ dimers, which could be observed in
the blue and green regions of the CID spectra, respectively (Figure 4.10). These mass
differences corresponded to those detected between γ subunits and their precursor ions.
Given the information for the glycan patterns observed in Table 4.4, and the typical
sequence mass of the γ subunits, it is likely that mass differences between trimers are
mostly due to differences in glycosylation. This matches the observations made for PDx
and TPx by this laboratory in previous work.25
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Figure 4.10: Native and CID spectra of the trimers found in the venoms of Oxyuranus
spp.
CID spectra were acquired using a trap and transfer voltages of 60 V and 30 V,
respectively. The m/z region containing peaks corresponding to monomeric PLA2 in both
the native and CID spectra are highlighted blue (m/z 1900-3300). The trimer region within
the native spectra has been highlighted in yellow (m/z 3300-4200). Non-PLA2 peaks
found in the high m/z region within the native spectra have been highlighted red (m/z
4200-5700). For the CID spectra, the m/z region which contained the dimeric PLA2 has
been highlighted green (m/z 4000-5500). The precursor ions used for the CID experiments
are denoted with an asterisk.
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Table 4.9: Masses and protein identities of the CID spectra in Figure 4.10.
Parent ions
Identity and mass (Da)
Snake
(charge and
of dissociated
m/z)
constituents
βa; 13318.0 ± 0.2
PDx
O. microlepidotus
βb; 13337.2 ± 0.2
(12+, 3881.6)
αaγa; 33170.9 ± 1.0
βa; 13202.5 ± 0.4
βb; 13221.6 ± 0.3
βc; 13262.2 ± 0.2
βd; 13278.2 ± 0.3
βe; 13495.2 ± 0.4
αaγb; 32310.6 ± 0.8A
CTxa
αaγb∗; 32346.0 ± 2.7A
(12+, 3808.0)A
αaγc; 32392.3 ± 1.5A
CTxb
O. s. canni
(12+, 3832.0)B αaγc∗; 32429.0 ± 1.3A, B
CTxc
αaγd; 32515.1 ± 0.4B
+
C
(12 , 3867.0)
αaγe; 32593.3 ± 0.9B
αaγe∗; 32631.6 ± 1.2B
αaγf; 32677.3 ± 2.4B
αaγg; 32968.0 ± 0.6C
αaγh; 33047.9 ± 0.5C
αaγi; 33127.5 ± 0.4C
βa; 13222.1 ± 0.8
TPxa
βb; 13262.6 ± 0.1
(12+, 3810.8)A
O. s. scutellatus
βc; 13303.0 ± 0.1
TPxb
αγa; 32014.2 ± 0.4A
(12+, 3867.5)B
αγb; 32305.5 ± 0.3B
CID products which only appear for a given trimer isoform are colour coded. Those in
black font were found in all the toxins from a particular snake species. Subunit isoform
letters were assigned based on the data presented in Table 4.3. The absence of a subscript
for the α subunit forming a dimer indicates that there was more than one isoform present
for that subunit.

Analysis of the peaks from the red region of the native spectra from Figure 4.10
In the native spectra between the range m/z 4200-5800 (red m/z region), peaks
corresponding to non-PLA2 proteins were detected in Oxyuranus spp. spectra. However,
an accurate mass for the peaks in the cannitoxin (CTx) spectrum could not be determined.
Further analysis need to be done to elucidate the identity of these proteins. The masses
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and proposed identities of all proteins detected in the native spectra for the Oxyuranus
spp. are summarized in Table 4.10.
Table 4.10: Masses and protein identities from the Oxyuranus spp. native spectra.
Dissociates
Proposed protein
Snake venom
Mass (Da)
via CID
identity
13318.1 ± 0.1
No
Subunit βa
13337.2 ± 0.1
No
Subunit βb
O. microlepidotus 19308.5 ± 0.7
No
PDx γ
46539.9 ± 1.1
Yes
PDx
98954.6 ± 3.4
No
Unidentified protein
13916.8 ± 0.9
No
Subunit αa
13221.2 ± 0.1
No
Subunit βa
13262.2 ± 0.4
No
Subunit βb
14044.9 ± 2.0
No
Subunit γa
O. s. canni
14101.5 ± 0.5
No
Subunit γb
14998.6 ± 1.1
No
Subunit γc
45688.9 ± 1.1
Yes
CTxa
45972.0 ± 0.5
Yes
CTxb
46390.8 ± 3.4
Yes
CTxc
13221.7 ± 0.1
No
Subunit βa
13263.0 ± 0.1
No
Subunit βb
13303.6 ± 0.2
No
Subunit βc
O. s. scutellatus
45645.7 ± 1.5
Yes
TPxa
46344.4 ± 2.1
Yes
TPxb
92129.7 ± 6.0
No
Unidentified protein
Samples were analysed in 200 mM AmOAc. Subunit isoform numbers were assigned
based on the data presented in Table 4.3.
4.2.3. Investigating the electrostatic interactions between trimers
Snake genera could be categorised by the dissociation pattern of their trimers;
Acanthophis and Tropidechis, α/β subunits with αγ dimer, Notechis α subunits and γγ
dimers, Oxyuranus β subunits and αγ dimers. However, the CID data can yield more
information about trimer architecture. By using the same methods previously applied in
this laboratory,25 it is possible to calculate the average charge between these subunits
(discussed in Chapter 1, section 1.3.3). The average charge state calculated for the
107

subunits detected in the CID and native spectra could be compared to provide insight into
the nature of the inter-subunit interactions for these toxins.25, 117
Table 4.11: Comparison of average charge for trimers of each snake genera.
Average charge
calculated from
Snake
Protein
Native
CID
spectra spectra
5.5
α
5.9
5.2
β
A. antarcticus
7.3
γ
7.2
αγ
5.3
α
6.7
β
N. scutatus
γ
βγ
α
5.7
5.3
β
O. microlepidotus
7.3
γ
6.9
βγ
5.4
α
6.0
5.1
β
T. carinatus
γ
7.2
αγ
The average charge was calculated from the average charge
subunit class from the native and CID spectra.

Trap/Transfer
energy required
to see dissociated
subunits (V)
36/18

54/27

48/24

36/18
of all isoforms for a given

The average charge of the subunits was calculated using the equation shown in section
1.3.3 on page 22. Except for N. scutatus, there was no significant difference in the average
charge of the more readily dissociated subunits between the native and CID spectra
(Table 4.11). Both the αγ and γγ dimers from the CID experiments did not dissociate
under any collisional energy tested in this work. This information suggests that there is a
general trend in how these toxins form, and is consistent with the proposal that the dimers
are primarily held in place by electrostatic interactions, while the dissociated utilizes
hydrophobic interactions for association (as seen with TPx).21, 25, 140 The main difference
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between trimers of different elapid genera evident from the dissociation patterns was
which subunits are connected by salt bridges.
These toxins required different amounts of collisional energy to induce subunit
dissociation. The trimers could be separated into three categories, based on the amount of
collisional energy required to induce dissociation (least to most energy required): A.
antarcticus and T. carinatus, O. microlepidotus and N. scutatus. This stability could
reflect differences in the toxicological profile of these toxins. This can be seen with the
dimeric toxin crotoxin (from the venom of the South American rattle snake), where dimer
stability is positively correlated with toxicological activity.69 Further investigations using
techniques such as X-ray crystallography have to be performed to determine the origins
of the different stabilities of these trimers.
4.2.4. Ion mobility analysis of trimeric complexes
The differences in trimer arrangement for different snakes likely has an effect on their
three-dimensional structures. To determine if the trimers were of a similar conformation,
each of the charge states subjected to CID was also examined using travelling wave ion
mobility MS (TWIM-MS). The drift times from the experiments were converted into CCS
distributions using the methods presented in Chapter 6. These data showed that, for the
most part the trimers had similar CCS distributions (Figure 4.11). More substantial
differences in CCS were detected for the trimers from the Notechis spp., however, these
spectra also contained several impurities whose charge states overlap with the trimers.
Another explanation could be that the additional glycosylation on these trimers affects
their drift times. This could be further examined by deglycosylating the trimers and
analysing them again using TWIM-MS. Overall, this indicates that the trimeric PLA2
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have similar gas phase geometries, suggesting that their solution structures have similar
three-dimensional layouts.

Figure 4.11: Comparison of ATD of the 12+ ions of the trimeric PLA2 of each venom.
Spectra were acquired using the methods described in section 2.2.2, except with a transfer
velocity of 200 m/s. The drift times for each of the 12+ charge states were converted to
CCS using the calibration curves presented in section 2.2.2. The ATD are grouped by
snake genera: A Acanthophis and Tropidechis, B Notechis and C Oxyuranus.
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4.3. Summary
The data presented in this Chapter have provided insight for the evolution of the multisubunit toxins. Each of the trimers could be broadly categorized by snake genera, due to
differences in: apparent glycosylation (nanoESI-MS and PNGase treatment) subunit
dissociation pattern (CID) and three-dimensional geometries (IM-MS). The generaspecific variations in the trimeric PLA2 are likely recent evolutionary adaptations. These
data support the earlier hypothesis presented in the introduction of this thesis: the rapid
evolution of these toxins may lead to genera-specific subunit configurations for the multisubunit PLA2. This highlights the need to expand upon these investigations, broadening
the scope to include other, closely related snake genera.
The SDS-PAGE indicated that the abundance of trimers within these venoms varied
between species (Figure 4.6). By examining the venoms of multiple snakes from the same
species, it may be possible to elucidate the causes for the differences in expression. Also,
closely related snakes of the same genera examined in this study, should be re-examined
to look for low abundance trimers. The low levels of toxin in these venoms could have
pharmacological implications in determining the toxicological activity of these venoms
(discussed in Chapter 7).
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Chapter 5 : Continuous mass spectrometry assay for PLA2
activity
5.1.

Introduction

Many enzymes are found in elapid venoms. These include the L-amino oxidases and
prothrombinase complex, which induce a variety of pharmacological effects (See Chapter
3 for details). The most prominent protein group found within elapid venoms which has
enzymatic activity is the phospholipase A2 (PLA2), which hydrolyse lipids of cell and
organelle membranes, disrupting normal cellular functions.32 Specific examples of this
activity include neurotoxic elapid PLA2 which hydrolyses neuronal membranes, enters
the neuron, and then targets mitochondria.42, 43, 46, 47 The precise relationship between the
enzymatic activity and the toxicity of these enzymes is not well understood. Without this
understanding, it is difficult to develop novel treatments for the treatment of snake bites
or to harness their cytotoxic effects for use as therapeutics.
The reason why the structure-function relationship has not been elucidated is two-fold:
(i) the cellular target(s) of these enzymes have yet to be determined, and (ii) there is little
data on the enzyme kinetics for these oligomeric toxins using native-like substrates (lipid
bilayers). Addressing the latter issue is a key focus of this Chapter.
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5.1.1. Structure-function relationships in elapid phospholipase A2
Secreted PLA2 are found ubiquitously throughout nature and are involved in many
biological processes such as inflammation and digestion.27 These enzymes hydrolyse the
sn-2 ester bond of phospholipids, leading to the formation of lysophospholipids and fatty
acid. These products can act as signal molecules or be utilized by other processes. Lipids
form bilayers in cell membranes, and vesicles, such as exosomes, in normal cellular
processes. PLA2 likely interact with multiple structural motifs to co-ordinate binding to
the lipid interface leading to hydrolysis. This was supported by a study by Burke et al.
using hydrogen deuterium exchange (HDX) mass spectrometry, which highlighted
multiple structural features that play a role in the enzymatic activity of elapid PLA2.208
Lipid bilayers formed in vitro are called liposomes. The enzymatic pathway of PLA2
acting against phospholipid liposomes can be written as follows209, 210:
𝐾𝐾𝑉𝑉

𝐾𝐾𝑃𝑃

𝑘𝑘𝐻𝐻

𝑃𝑃𝑃𝑃𝑃𝑃2 + 𝑉𝑉 �
� 𝑃𝑃𝑃𝑃𝑃𝑃𝑉𝑉2 + 𝑃𝑃𝑃𝑃𝑃𝑃 �
� 𝑃𝑃𝑃𝑃𝑃𝑃𝑉𝑉2 + 𝑃𝑃𝑃𝑃𝑃𝑃 �� 𝑃𝑃𝑃𝑃𝑃𝑃𝑉𝑉2 + 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 + 𝐹𝐹𝐹𝐹

Where: PLA2 is phospholipase A2, V is phospholipid liposome, PLP is phospholipid,
LysoPLP is lysophospholipid, FA is fatty acid, KV is the dissociation constant for the
liposome, KP is the dissociation constant for the phospholipid, and kH is the rate constant
of phospholipid hydrolysis.
The first step involves the PLA2 interacting with a phospholipid liposome. There are two
mechanisms that have been proposed by which the PLA2 can interact with phospholipid
liposomes: scooting and hopping (Figure 5.1A).210 In the scooting model, the PLA2
moves along the liposome surface hydrolysing phospholipids. In the hopping model, the
PLA2 bounces around or between liposomes. Enzyme kinetics studies show that the
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degree to which PLA2 follow these models depends on how tightly these enzymes bind
to a liposome.211, 212 Snake venom PLA2 are thought to also bind to specific membrane
proteins in order to hydrolyse the lipids comprising the cellular membrane, thus, allowing
them to target specific tissues.32 It is likely that the PLA2 follow the hopping model until
they interact with their cellular target. The degree to which they can follow the scooting
model once bound is unclear. In both these models, amino acids on the enzymatic face of
the PLA2 are partially inserted into the lipid bilayer, bringing the enzyme into a position
where it can start hydrolysing phospholipids (Figure 5.1B).

Figure 5.1: Proposed mechanisms for PLA2 interaction with phospholipid liposomes.
A Scooting and hopping mechanisms for PLA2. Scooting: The PLA2 (black sphere) binds
to a liposome (green sphere) and moves around its surface (indicated by the dashed
arrow). Hopping occurs when the PLA2 ‘hops’ between liposomes. Adapted from Berg
et al. (2001).210 B Model of how group Ia (elapid) PLA2 bind to a phospholipid lipid
membrane based on hydrogen deuterium exchange data, taken from Burke et al.
(2008).208 The amino acids which have a role in interacting with a phospholipid bilayer
are shown as purple sticks. The Ca2+ ion is shown as a pink sphere.
HDX mass spectrometry has been used to investigate a monomeric PLA2 from cobra
(Naja naja naja) venom.208 Amino acids 3-8, 18-21 and 56-64 of this enzyme are
responsible for interacting with the liposome, where Tyr3, Trp61, Trp63 and Phe64 are
thought to penetrate the lipid bilayer. This study also found that this toxin has a second
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calcium binding site, coordinated by residues 103-110, but its role is unknown (discussed
in section 5.2.3). Amino acids Phe5 and Trp19 are thought to bind to the fatty acyl tails
of phospholipids. Molecular dynamics simulations indicate that the amino acids in these
structural regions are responsible for attaching the PLA2 to the liposome.213 Toxicological
data for mutants of ammodytoxin, a monomeric PLA2 from the venom of the horned viper
(Vipera ammodytes ammodytes, found in North Africa and the Middle East) indicates that
the amino acids found in these liposome-binding motifs affect toxicity.48, 50-53, 214
Once the PLA2 is bound to the liposome, the aromatic amino acids on the interface with
the PLA2 interact with a lipid, positioning its sn-2 bond near the catalytic site.215 The
regions of the group Ia (elapid) PLA2 specifically involved in hydrolysing the sn-2 ester
bond of the phospholipid are the catalytic dyad (His48 and Asp93) and calcium-binding
loop (Tyr28, Gly30, Gly32 and Asp49) (Figure 5.2). Two catalytic mechanisms have been
proposed for the PLA2, a review of which can be found elsewhere.216
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Figure 5.2: Structural motifs that Australian elapid PLA2 use for catalytic activity.
A The PLA2 used in this diagram is notexin from N. scutatus (pdb: 1AE7).55 The regions
relating to enzymatic activity are the Ca2+ binding loop (inset B) and the catalytic site
(inset C). The key amino acids within these regions are shown in stick form, with the
residues involved in binding Ca2+ shown in blue (Tyr28, Gly30, Gly32, Asp49) and those
which form the catalytic dyad shown in orange (His48 and Asp93). Disulfide bonds are
shown in yellow.27, 152, 208
How readily a PLA2 can access the sn-2 ester bond of the lipids in a liposome significantly
affects the rate of hydrolysis.217 This access is determined by the structure of the liposome
in question. PLA2 may exhibit a low activity phase and a burst phase against liposome
substrate; hydrolysis commences with a slow rate of product formation, which gradually
changes the liposome structure until a critical point, which once passed, gives rise to an
increase in the rate of hydrolysis.218, 219 It should be noted that within the literature, the
low activity phase is referred to as the lag phase. The reason why the term lag phase is
not used in this work is because in some assays the initial phase of the hydrolytic reaction
may be below detection limits of the method, so the lag phase represents this aspect in
conjunction with a change in liposome structure. This is described in section 5.2.2.
Structural factors that affect access to the lipids comprising a liposome include: size220
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(the length of the ‘low activity phase’ increases with liposome size, but does not affect
enzyme turnover rates), composition47, 221, 222 (PLA2 preferentially hydrolyse certain types
of phospholipids; the presence of cholesterol makes it harder for PLA2 to penetrate a lipid
bilayer), and temperature223 (temperatures outside the lipid bilayer transition temperature
make it more difficult to penetrate). Other experimental factors that disrupt the liposomes
can eliminate the low activity phase. For example, the addition of lysolipids13,

14

or

inducing osmotic shock223, 224 will disrupt the liposome bilayer, making it easier for PLA2
to access lipids. Lipid analysis of different mixtures of neurotoxic snake PLA2 acting on
cerebellar granular neuron cell cultures showed no signs of a burst phase in enzymatic
activity,47 suggesting that rearrangement of lipids in the cell membrane is not as extensive
as the case in artificial liposomes.42
5.1.2. Methods for measuring PLA2 activity
Understanding the structure-function relationships for the enzymatic activity of trimeric
PLA2 from Australian snake venoms is crucial to developing new antivenoms and
therapeutics. Previous studies have relied upon a colorimetric assay to determine
activity.17, 70, 140, 225, 226 The most commonly used assay kit used to measure the enzymatic
rate in the literature is the Cayman colorimetric assay.17, 70, 140 This kit utilizes a sulfursubstituted phospholipid, which when hydrolysed reacts with DTNB. The change in
absorbance is used to determine the rate of hydrolysis catalysed by secreted PLA2. The
other colorimetric method uses 4-nitro-3-(octanoyloxy)benzoic acid as substrate, where
absorbance of the product is measured.225, 226 These studies showed that the activity of
PLA2 is highly dependent on pH and the cations present. They also showed that the
optimum temperature for hydrolysis is between 40-45oC. However, the rates of enzymatic
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activity obtained in these studies did not match the rate of hydrolysis measured in nerve
cell assays.47 The most probable reason for this is that the colorimetric assay is not
performed using physiologically-relevant conditions and substrates. Other studies have
used LC-ESI-MS or a pH stat assay to measure the activity against of PLA2 against
phospholipid liposomes and micelles.
The pH stat method was used by Lathrop and Bilotnen to investigate activity of App49,
a monomeric PLA2 toxin from the venom of cottonmouth viper (Agkistrodon piscivorus
piscivorus; south eastern United States) against PC liposomes and micelles.227, 228 The
rate of hydrolysis was determined by measuring the rate of change in the abundance of
fatty acid chains measured discontinuously at various time points. The drawback of this
method is that there is difficulty measuring the initial rate (v0) of hydrolysis in the low
activity phase described above.218, 224, 228 A technique which does not have this limitation
is liquid chromatography ESI-MS (LC-ESI-MS). This technique has been used
extensively to analyse lipids229-233 and has been used to measure the activity of snake
venom PLA2 against various lipids in nerve cultures and liposomes.47, 234 The LC-ESIMS assays work by incubating the PLA2 with the substrate, then discontinuously
measuring the formation of product ions and loss of substrate ions at multiple time points
(taking samples for assay at various time points).47,

234

Product and substrate are

quantified by comparing ion counts with a set of internal standards. However, these assays
also have a drawback – they are discontinuous time point assays, thus, they may miss
some of the important features of the reaction, such as lag-burst mechanisms. It may be
possible to overcome this by developing a continuous ESI-MS assay.
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5.1.3. Mass spectrometry and enzyme kinetics
ESI-MS is not limited to the sequence and mass analysis of proteins; it can also be used
to detect the products of enzymatic activity and binding interactions of proteins with
ligands and other proteins. A review paper by Northrop and Simpson highlighted the
potential of MS as a technique for measuring enzymatic activity by stopped-flow MS.235
Since this review, multiple studies have been undertaken to measure enzymatic activity
using MS.232,

236-240

This previous work on MS-based enzymatic assays shows the

quantitative and qualitative considerations that need to be addressed for these
experiments.
When monitoring enzymatic activity using MS, the substrate or product (preferably both)
need to readily ionized. Activity can then be measured by comparing the loss of ion counts
for the substrate/gain for the product. The ion counts from solutions containing product
or substrate of known concentration (standards) are compared with those being measured
in the assay to determine activity.238 Another way the activity can be measured is by
looking at the change in relative abundance of substrate and product. In both cases, assays
are validated by comparing their results with other methods for detecting activity or by
using standardized solutions.241-243 If there are difficulties in distinguishing between the
ions of multiple substrates and products, this can be overcome by using additional
separation methods. For example, liquid chromatography mass spectrometry (LC-MS)
can be used to fractionate a complex mixture of lipids.238 Another possible solution is to
use IM-MS to distinguish between components. Multiple systems can be used in
conjunction, allowing, in principle, for structural and enzymatic elements to be tested in
one experiment.244
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5.1.4. Scope of Chapter
This Chapter aims to identify experimental conditions under which the activity of
Australian elapid PLA2 can be measured in a continuous ESI-MS assay. The goal of this
was to use this assay to measure the enzymatic activity of paradoxin (PDx, trimeric PLA2
from the inland taipan) under a variety of conditions: different phosphatidylcholine
concentrations, temperature and group II metal ions. These data were then used to
examine the enzymatic characteristics of PDx. Results were compared to previous
toxicology experiments to determine whether the data produced were informative, and
further experiments are proposed to generate a more physiologically-relevant view of the
enzymatic properties of Australian elapid PLA2.
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5.2.

Results and Discussion

A study by Paoli et al. (2009) has shown that, for PLA2 neurotoxins they tested (notexin,
β-bungarotoxin, TPx and textilotoxin), the enzymatic specific activity obtained from a
commonly used colorimetric assay kit (84, 76, 75 and 12 nmol s-1 nmol-1, respectively)
did not match the specific activity against nerve cells (0.82, 0.68, 0.32 and 0.25 nmol s-1
nmol-1, respectively).47 There may be several contributing factors to this, including that
the lipids used as a substrate in the colorimetric assay (modified PC in detergent) are not
reflective of the snake PLA2 physiological targets. Owing to the low rate of lipid
hydrolysis in the nerve cell assay, it may be difficult to accurately measure the slow rate
of hydrolysis using previously developed methods. For example, it is difficult to measure
the rate of phospholipid hydrolysis by PLA2 in the low activity phase using the pH stat
method.218
5.2.1. Development and validation of the continuous PLA2 enzyme assay
The substrate chosen for testing the PLA2 activity was 100 nm liposomes prepared as
described in section 2.2.3. The presence of a lipid bilayer better (but not entirely)
represents a cell membrane than isolated lipids used in previous colorimetric and MS
based assays.47, 245
In order to utilize ESI-MS for the continuous analysis of enzymatic activity, instrument
conditions need to be determined which give, accurate and reproducible data. This
requires the evaluation of multiple facets of the ESI-MS experiment, including:
maintenance of a constant syringe temperature, consistent reproduction of charge state
distributions for the ion populations being measured, and determining the range for which
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product and substrate ions scale linearly with concentration. The first step was to establish
a method by which the temperature of the syringe (and by extension, the enzyme assay
solution it contains) could be maintained. This was achieved by using a New Era Pump
Systems Syringe Heater Kit. The syringe temperature was set to 40 °C, as this is
temperature is where viper PLA2 are most active against 4-nitro-3-(octanoyloxy)-benzoic
acid.225, 226
Prior to investigating whether ESI-MS could be used to continuously monitor elapid
PLA2 (PDx) activity against liposomes, instrument conditions had to be determined which
would generate spectra predominantly populated with individual lipid ions, instead of
multi-lipid complexes. Conditions used in these experiments were primarily deduced
from a previous time point assay LC-MS assay designed to measure the enzymatic
activity of PLA2.234 As a first step, positive ion ESI mass spectra were acquired of PC
liposomes in 100 mM AmOAc, 1 mM CaCl2. This solution condition was chosen as it
was used when measuring PDx activity.

Figure 5.3: Mass spectra of PC in 100 mM AmOAc and 1 mM CaCl2 acquired with
different source and desolvation gas temperatures.
The red spectrum was acquired using a source temperature of 120 °C and a desolvation
gas temperature of 300 °C. The black spectrum was acquired using a source temperature
of 20 °C and a desolvation gas temperature of 80 °C.
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It should be noted that, although 100 mM AmOAc was adequate for this assay, there may
be other AmOAc concentrations which are optimal for this assay, will be the focus of
future work. The sampling cone and extraction cone had a minor effect on the lipid ion
counts. The highest ion counts were obtained using a sampling cone and extraction cone
of 50 and 4 V, respectively. A low pressure trap gas was applied to improve ion
transmission (4.7x10-3 mbar). Higher gas pressures significantly reduced the ion counts
for the lipids.
The most important settings were the source temperature (120 °C) and desolvation gas
temperature (300 °C). Figure 5.3 compares a spectrum acquired using a source
temperature of 120 °C and a desolvation gas temperature of 300 °C (red spectrum) to one
acquired using a source temperature of 20 °C and a desolvation gas temperature of 80 °C
(black spectrum). Under the latter conditions ion counts for single PC ions were
approximately halved. It is likely that an increase in temperature improves the desolvation
of the ions and increases liberation of lipids from the liposomes for analysis.
In order to be able to determine kinetic parameters for PDx it was important to determine
the

total

concentration

of

phosphatidylcholine

(PC,

substrate)

and/or

lysophosphatidylcholine (lysoPC, product) in a sample of lipids, including liposomes
which were used as the PC substrate for PLA2. Liposomes prepared via extrusion (section
2.2.3) were characterized with respect to their composition by preparing standard curves
to quantify the amount of PC and/or lysoPC present. Standard solutions of both PC and
lysoPC were prepared by weighing the lyophilized solids and dissolving in 10 mM
AmOAc and 90% (v/v) MeOH (see section 2.2.3). These solvent conditions disrupted the
liposomes and maximized detection of single lipids. In all of these spectra, ions
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corresponding to Na+ adducts were present in low abundance (Figure 5.4C and D). The
source of this contaminant could not be determined. Since these adducts were of low
abundance, and of a low, but consistent relative abundance compared to their respective
ions without adducts, these spectra could still be used to estimate the concentration of
lipids.

Figure 5.4: Standard curves for PC and lysoPC in 10 mM AmOAc and 90% (v/v) MeOH
A Standard curve for PC. B Standard curve for lysoPC. Standard curves were generated
by combining 60 seconds of scans (30 acquisitions) of the stable spray for each sample.
The error bars show ± 1 standard deviation (n = 6). C Spectrum for 1 µM PC D Spectrum
for 1 µM lysoPC. The background noise in these spectra was not corrected for to
determine the detection limit for these conditions.
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The ion counts were taken from the apex of the peak corresponding to the most abundant
isotope. Under experimental conditions, a linear relationship was observed for lipid
concentrations between 0.1 to 2.0 µM (Figure 5.4A and B). The ionization efficiency was
very similar for both PC and lysoPC, which was expected, as they have the same head
group.
These curves were used to determine the concentration of PC liberated from liposomes
(extrusion) and from lysoPC micelles (formed in solution). Aliquots from these mixtures
were diluted to be approximately in the standard curve range, with 10 mM AmOAc and
90% (v/v) MeOH as the spray solution. The ion counts from these sprays were used to
quantify the amount of PC and lysoPC within their respective mixtures. The standard
curves presented throughout this Chapter have not been corrected for background noise.
This was done to gain a better understanding of what the detection limit (in terms of lipid
concentration) was in each of these experiments. This becomes important when
discussing the low activity phase for PDx at the end of section 5.2.2.
Standard curves were also obtained for lysoPC and PC in 100 AmOAc. These
experiments also needed to be conducted to determine whether the ionisation responses
for PC and lysoPC would remain similar in the absence of organic solvent. Under the
continuous assay conditions, a linear relationship between concentration and ion counts
was observed for PC and lysoPC in 100 mM AmOAc up to concentrations of 480 µM
(Figure 5.5A) and 30 µM (Figure 5.5B), respectively. The relative increase in ion counts
with concentration was significantly higher for lysoPC than PC. This was attributed to a
greater solvent accessibility to the lipid head group in lysoPC micelles compared to PC
liposomes for ionization.
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Figure 5.5: Standard curves for PC and lysoPC under continuous assay conditions.
A Standard curve for PC in 100 mM AmOAc. B Standard curve for lysoPC in 100 mM
AmOAc. Standard curves were generated by combining 60 seconds of scans (30
acquisitions) of the stable spray for each sample. The error bars show ± 1 standard
deviation (n = 6). C Spectrum for 240 µM PC which was used to generate the standard
curve. D Spectrum for 15 µM lysoPC which was used to generate the standard curve. The
background noise within these spectra was not subtracted in order to determine the
detection limit for these conditions.
Only a small amount of PC dimer was detected in the PC spectra (Figure 5.5C). This
suggests that the conditions proposed above would give spectra predominantly populated
by single PC ions from a spray solution containing PC in the form of liposomes. In lysoPC
spectra, significant amounts of Na+ adduct ion were detected. Given the absence of Na+
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adducts within the PC liposome mixture, it was unlikely that lysoPC formed by the
hydrolysis of PC by PDx in the continuous assay would have Na+ adducts. Therefore, to
convert lysoPC ion counts into a concentration, another set of standard curves would have
to be generated, which accounted for the detection of PC and lysoPC in a mixture. This
is discussed below (page 131).
The next step was to determine whether the hydrolysis of PC by PDx could be monitored
continuously using ESI-MS. The initial tests were conducted with 60 µM PC (liposomes)
and 6 nM PDx in the presence of 100 mM AmOAc and 1 mM CaCl2. The temperature of
the syringe and the spray solution was set to 40 °C using a syringe heater kit (described
in section 2.2.3). The reason for this was to mimic the lipid concentrations and
temperatures used in previous investigations but using a toxicologically relevant
concentration of PDx.47, 70 For example, other studies have used lipid concentrations
between 50 and 1000 µM, but have used a wide range of PLA2 concentrations
(7-300 nM).227, 228 Under the instrument conditions mentioned at the start of this section,
it was possible to monitor the conversion of PC (in the form of liposomes) into lysoPC
(Figure 5.6). Several ion populations that did not arise from the lipid being analysed were
also detected in this spectrum (m/z < 750). These most likely correspond to small amounts
of efficiently ionized contaminant present in the AmOAc and/or CaCl2.
It should be noted that CaCl2 interferes with electrospray ionization, as Cl- ions suppress
ionization, thus reducing ion counts. This salt was used because previous work
investigating the enzymatic activity of PLA2 use chloride salts in their assays.218, 224, 227,
228

It is recommended that acetate salts should be used in future ESI-MS work. This

should significantly reduce the effects of ion suppression.
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Figure 5.6: ESI mass spectra and chromatogram of PC hydrolysis by PDx.
A Representative mass spectrum of the reaction mixture (combined 40 to 50 seconds),
which contained 6 nM PDx and 60 µM of PC as liposomes in 100 mM AmOAc and
1 mM CaCl2. The spray solution in the syringe was 40 °C. Peaks corresponding to PC
ions are coloured red (see B). Most of the other peaks observed in the spectrum
correspond to impurities. The impurities detected within the spectrum arise from the
CaCl2 (observed in a spectrum of CaCl2 alone (not shown)). Figure 5.5C shows a
spectrum of the same lipid (without CaCl2) and most likely correspond to plasticizers
from the CaCl2 container. B Ion chromatogram of the reaction acquired over a 300 second
time period, with spectra acquired every two seconds. The red section represents the time
delay until a stable spray was obtained; the blue region represents the part of the
chromatogram corresponding to a stable spray, which was used to determine PLA2
activity. C LysoPC ion counts after 100 seconds. D LysoPC ion counts after 300 seconds.
Peaks in the m/z range 524-530 correspond to impurities within the spectra and are
observed in all of the continuous assay spectra.
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A consistent spray is necessary to measure the change in abundance of the product and
substrate ions. To see if this could be achieved, the change in relative abundance for PC
and lysoPC at an initial concentration of 60 µM PC and 6 nM PDx was measured. This
concentration of PDx was chosen as it is approximately its toxicological saturation
concentration when inducing nerve inhibition in mouse models.70
Figure 5.6A shows the mass spectrum of the reaction mixture (combined 40 to 50
seconds), which contained 6 nM PDx and 60 µM of PC as liposomes in 100 mM AmOAc
and 1 mM CaCl2. The first 20 seconds of these reactions could not be observed
(Figure 5.6B). This is due to the amount of time it took to analyse the sample from when
PC was added, mixed with PDx and injected into the mass spectrometer. Once the spray
stabilized, the standard deviation in ion counts between measurements was typically
within ~5%. Previous LC-MS studies investigating the enzymatic activity of snake PLA2
measured the rate of hydrolysis by measuring the change in the relative abundance of
lysoPC with PC over time.47, 234
Figure 5.6C and D show the ESI mass spectra at time points of 100 and 300 s, respectively
after the reaction started. Ion counts for lysoPC increase over time, which was expected,
as this is the product from hydrolysis of PC by PLA2. The changes in ion counts for PC
and lysoPC were examined more closely in Figure 5.7. Figure 5.7A shows the increasing
ion counts for lysoPC. However, the ion counts for PC also appeared to increase slightly
(Figure 5.7B), which was unexpected, as the ion counts for the substrate should decrease
as it is hydrolysed.
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Figure 5.7: Change in the chromatograms of lysoPC and PC in the presence of PDx.
Experiment was carried out using the same conditions given in Figure 5.6. A Extracted
ion chromatogram for lysoPC ions (product, m/z 522.4), showing the abundance
overtime. B The extracted ion chromatogram for singularly charged PC ions (substrate,
m/z 786.6), showing the change in abundance of PC ions over time. Horizontal red dashed
line shows the baseline for the initial ion counts in each chromatogram. Vertical red
dashed line with red arrow heads indicate the change ion counts over time.
A possible explanation is that the generation of lysoPC causes conformational changes in
the liposome that enhance overall ionization or access to the ionization process. To
examine this hypothesis, known amounts of lysoPC were added to the liposome mixture
to determine whether the PC ion count increased (Figure 5.8). These experiments showed
that the ion counts for PC increased in proportion to the amount of lysoPC up to a
concentration of 7.0 µM, where it reaches a saturation point (Figure 5.8A). These data
indicate that a simple relationship between lysoPC and PC cannot be used to measure the
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rate of lipid hydrolysis, as was applied in previous assays.47, 234 Therefore, the change in
lysoPC ion count alone will be used here to determine the PDx activity. Further
experiments utilizing cryogenic transmission electron microscopy could be used to
examine this relationship, as previously done by Callisen and Talmon (1998).246 This
paper showed that the lysoPC produced in the low activity phase changes the
conformation of the liposomes.

Figure 5.8: Effect of addition of lysoPC to PC liposomes and standard curve for ESI-MS
of lysoPC.
A Change in PC ion count with the addition of lysoPC to PC liposomes. B The
relationship between ion counts and concentration of lysoPC. These experiments were
conducted in the presence of 60 µM PC in the form of liposomes, in a solution of
100 mM AmOAc and 1 mM CaCl2 at 40 °C. Standard curves were generated by
combining 10 seconds of scans (5 acquisitions) of the stable spray for each sample. The
error bars show ± 1 standard deviation (n = 3). The background noise within these spectra
was not corrected in order to determine the detection limit under these conditions.
The ion counts for lysoPC were significantly lower in the presence of PC than for the
pure lysoPC micelles (compare the gradients of Figure 5.8B and Figure 5.5B). This
decrease in ionization efficiency is attributed to the lysoPC being inserted into the
liposomes, reducing exposure to the spray solution, therefore, reducing the ion counts for
lysoPC. LysoPC generated by PDx activity would also be integrated into the liposome
bilayer. Therefore, to estimate the concentration of lysoPC present in the sample, and
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therefore the rate of PC hydrolysis in the continuous assay, the standard curve for lysoPC
in the lysoPC/PC mix was used (Figure 5.8B).
The next step was to determine the time intervals used to measure the rate of lysoPC
formation. While the reaction mixture was continuously infused into the mass
spectrometer, and lysoPC count increased with time, it was convenient to integrate the
data at various times from the chromatogram. This optimization was done using a PC
concentration of 20 µM. This PC concentration was chosen for this optimization step
because it was the lowest substrate concentration used in this work; thus, it would be the
most challenging concentration at which to measure the formation of lysoPC by PDx
using ESI-MS. For these measurements, the sum of ion counts over 10 second intervals
were found to be best; the linear rates of hydrolysis which were reproducible (Figure 5.9).
Under these conditions, a low activity (or lag) phase was evident. The measurement at
10 s intervals adds a constraint to this assay; any sudden shifts in activity can only be
well-defined if they occur over a time period equal to or longer than 20 seconds. This, as
well as the potential lag phase of PDx acting against PC liposomes, is discussed at the
end of section 5.2.2. The next step was to show that the results obtained using this method
were reproducible. The standard deviation between runs at each time point was typically
less than 5% of the ion count (Figure 5.9), which is lower than measurements made using
colorimetric assays or cell extracts.47
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Figure 5.9: Time course for the formation of lysoPC by PDx over 500 seconds.
Measurements were carried out at 40 °C to determine the activity of 6 nM of PDx against
20 µM of PC (liposomes, diameter 100 nm). The spray solution consisted of 100 mM
AmOAc and 1 mM CaCl2. Ion counts shown are the sum of 10 seconds of spray time.
Error bars show ± 1 standard deviation (n = 3). The background noise within these spectra
was not corrected to enable determination of the detection limit for these conditions.
5.2.2. Enzyme kinetics of paradoxin
The methods described above were used to investigate the enzyme kinetics of PDx. In
these experiments, the activity of PDx was measured at increasing PC concentrations in
order to determine the kinetic parameters of this toxin (Figure 5.10A). The rate of increase
in lysoPC ion count (v0) was measured after the apparent inactive phase (discussed in
more detail at the end of this section) prior to the low activity phase. The rate of reaction
was determined by converting ICs-1 (ion counts per second) to nMs-1 using the standard
curve shown in Figure 5.8B. The rate of lysoPC formation at different concentrations of
PC gave rise to a saturation curve, typical of Michaelis-Menten kinetics (Figure 5.10B).
These values were then converted into a Hanes-Woolf plot in order to determine the
kinetic parameters of PDx (Figure 5.10C).
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Figure 5.10: Enzyme kinetics of PDx with a PC substrate.
The activity of 6 nM PDx was measured against increasing concentrations of PC
(substrate) in liposomes with diameters of approximately 100 nm. The reaction was
carried out at 40oC in a reaction solution which consisted of 100 mM AmOAc and 1 mM
CaCl2. A The change in lysoPC ion counts over time with increasing substrate
concentration. Dashed lines show the linear rate after the apparent inactive phase. The
standard deviation between measurements is given as error bars (n ≥ 3). B Initial rate (v0)
of PDx at each PC concentration was converted from ion counts (IC)s-1 to nMs-1 using
the graph in Figure 5.8, and plotted to give a Michaelis-Menten saturation curve. C
Hanes-Woolf plots were generated from repeat measurements for the v0 of PDx at each
PC concentration (run 1, ; run 2, ; run 3, ), which were used to determine the kinetic
parameters of PDx (see Table 5.1). Error bars that show ± 1 standard deviation (n = 3).
The background noise within these spectra was not subtracted in order to determine the
detection limit for these conditions.
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Table 5.1: Kinetic parameters derived from the Hanes-Woolf plots (Figure 5.10C) and v0
at different temperatures.
Temperature (°C)
Hanes-Woolf
v0 (nMs-1)
Parameter
Value (± 1SD)
25
3.46
-1
Vmax
14.9 ± 1.8 nMs
30
4.69
Km
35
5.24
97.1 ± 13.6 µM
-1
kcat
2.5 ± 0.3 s
40
5.45
Measurements for the effect of temperature on enzymatic activity were carried out against
60 µM PC in the form of liposomes.

The Hanes-Woolf plots (Figure 5.10C) were used to calculate the kinetic parameters for
the hydrolysis of PC liposomes (100 nm diameter) by PDx (Table 5.1). The Km (97 µM)
obtained for PDx was in the range (60-140 µM) observed in previous studies for the
activity of AppD49 against small unilamellar vesicles composed of PC.227, 228 The rates
of PC hydrolysis by PDx in the kinetics experiments of this work were higher than those
observed for the analogous toxin, TPx, against granular cerebellar neurons (0.32 nmol s1

nmol-1). This may be due to multiple factors not controlled for in the current assay, such

as differences in liposome shape and composition compared to the granular cerebellar
neurons, as well as not factoring in the cellular targets of these enzymes. This will be a
focus of future investigations.
The activity of PDx increased slightly with temperature, beginning to plateau around
40 °C (right side of Table 5.1). Previous investigations have shown that, at temperatures
outside the transition temperature for liposomes (were the liposome transitions from a gel
like state to a fluid state), the “low activity” phase (described on page 116) of the PLA2
is significantly increased, but turnover rate is not affected.223, 247 However the transition
temperature for the lipid used in this study (PC, 18:1c9) is -17 °C, and does not explain
the effect of increasing activity with temperature, and likely represents the
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thermodynamic effect of increasing reactivity with temperature. The effect of temperature
reported here is reflective of PLA2 activity against 4-nitro-3-(octanoyloxy) benzoic acid,
with maximum rate of product formation occurred between 40-45 °C.225, 226
The enzyme’s inability to access the sn-2 position of the phospholipids when present in
membranes may explain why it is difficult to correlate enzymatic activity with
pharmacological activity. The composition of a cell membrane (presence of cholesterol)
makes it too rigid for the toxin PLA2 to penetrate effectively.47 By binding to a membrane
protein, the venom PLA2 can be positioned to hydrolyse the lipids within. This would
make the binding affinity and number of the cellular target(s) the primary determinant of
toxin potency. This hypothesis explains the specificity of the venom PLA2, and is in
agreement with the observations made by Paoli et al. (2009),47 as well as the mechanism
shown in a review by Montecucco et al. (2008).32
There was an apparent inactive phase for the hydrolysis of PC in liposomes, which
decreased with increasing PC concentration (see Figure 5.10A). This relationship is
shown in Figure 5.11. This inactive phase could represent the time it takes for lysoPC to
become detectable under the ESI-MS conditions rather than a lag relative to accessibility
of PC in liposomes or both. This was tested by multiplying the duration of the inactive
phase (s) at each PC concentration (shown in Figure 5.11) by its respective v0 for lysoPC
in ion counts per second. This gave lysoPC ion counts between 126 (20 µM PC) to 165
(240 µM PC) IC. The background ion count for the lysoPC peak ranged between 120 to
150 IC (background signal increased with PC concentration), which is in good agreement
with the estimated lysoPC generated by PDx. This shows that, if rate of lysoPC formation
was to be extrapolated backwards for each PC concentration, the lysoPC ion count would
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reach zero at approximately t = 0. Therefore, it can be concluded that, under these
experimental conditions, there is no measurable period were the enzyme is inactive, but
a period of time for which the lysoPC ion counts are too low to be detected. This
highlights the need for care to be taken when interpreting the results of continuous ESIMS enzyme assays.

Figure 5.11: Apparent inactive phase for detecting PDx activity against PC at different
lipid concentrations.
The time period for the ‘inactive’ phase observed with different initial PC concentrations
in the ESI-MS assay of PDx activity from Figure 5.10A.
5.2.3. Effects of divalent metals on the activity of paradoxin
The concentration of Ca2+ (especially below 1 mM) significantly influences the rate of
lipid hydrolysis by AppD49 (a monomeric PLA2 from the venom of the eastern
cottonmouth from North America).227 Also, the presence of other divalent metals have
been shown to either enhance (Mg2+) or inhibit (Ba2+ and Sr2+) the activity of PLA2.225-227
The effects of these divalent metals on enzymatic activity correlate with their respective
effects on PDx’s ability to causes twitch inhibition in mouse phrenic nerve assays.70
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Therefore, the effects of these metals on the activity of PDx were tested using the
continuous ESI-MS assay.
The rate of PC hydrolysis by PDx was measured at three CaCl2 concentrations: 0.1, 0.5
and 1 mM. The results show that the rate of activity increases with CaCl2 concentration
up to ~0.1 mM, then more gradually increasing at high CaCl2 concentrations (Figure
5.12). The same trend was observed for AppD49 by Lathrop and Biloten using the pH
stat method.227 However, further investigation is required to determine the precise
relationship of metal ion concentration and enzymatic activity. This was outside the scope
of this work and is currently being determined.

Figure 5.12: The effects of divalent metal ions on the activity of PDx.
Each bar represents the relative v0 for PDx against PC in liposomes compared to 1.0 mM
Ca2+. Bars 1-3 show the effects of Ca2+ (0.1-1.0 mM); bars 4-6 show the effect of other
divalent metal ions compared to CaCl2 (1 mM); bars 7-9 show the activity of PDx in the
presence of Ca2+ (1 mM) and other metal ions (1 mM). These experiments were carried
out using 24 nM PDx. Error bars that show ±1 standard deviation (n = 3).
Previous studies have shown that Mg2+ increases activity while other group II metal ions
can act as inhibitors.225-227 This is important to investigate further, as there is some
evidence that suggests the presence of these other metal ions reduce the rate at which PDx
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can induce twitch inhibition in a mouse phrenic nerve assay.70 The first set of experiments
was performed to determine whether PDx would have measurable activity in the presence
of Ba2+, Mg2+ or Sr2+ and how that activity compared with the effect of Ca2+. These
experiments showed that PDx had very little activity without Ca2+ (Figure 5.12), which
is in good agreement with the literature.227 When Ca2+ was present with either Ba2+, Mg2+
or Sr2+, both Ba2+ and Sr2+ reduced the activity of PDx in the presence of Ca2+ by similar
amounts, which is consistent with the literature. Mg2+ greatly increased the activity of
PDx in the presence of Ca2+, which is in good agreement with the work by Lathrop and
Bilotnen using small unilamellar vesicles.227 Since PLA2 requires Ca2+ for activity, and
is enhanced by Mg2+, this is suggestive of two metal binding motifs. These metal ion
binding sites could be those detected in HDX experiments by Burke et al. (Figure 5.13),
which will be the focus of future investigations.208

Figure 5.13: Proposed metal binding motifs for elapid PLA2 from Burke et al. (2008).208
Crystal structure (pdb: 1POA) is of a monomeric PLA2 from the venom of the Chinese
cobra (Naja atra).248 Ca2+ ions are shown as yellow spheres, with interacting amino acids
shown as sticks.
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5.3.

Summary

This work demonstrates that ESI-MS can be used to investigate the enzyme kinetics of
elapid PLA2 using liposomes as substrate. This technique is capable of continuously
following the hydrolysis of lipids by these enzymes at toxicologically relevant
concentrations; however, the first 20 seconds of the reaction are not observable, as lysoPC
generated in the liposomes is not detectable at low concentrations.
The research contained in this Chapter has provided a starting point for measuring other
parameters which may affect the enzymatic activity of these toxins. For example, the
effects of liposome size and composition will be investigated using this technique. It may
also be possible to couple this enzyme with ion mobility MS to further investigate the
enzymatic activity of the PLA2. For example, it may be possible to investigate whether
placement of double bonds within fatty acid chains (disrupting liposome structure)
change the likelihood of the lipid being hydrolysed. It could also be used in conjunction
with the assay described by Singh and Ranganathan (2014) to investigate the PLA2
interactions with the PC membranes; PLA2 are inactive against D-enantiomers of lipids,
therefore, adding specific amounts of D-enantiomers into the liposomes, may render it
possible to investigate the surface dilution kinetics of the PLA2.209
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Chapter 6 : Comparative CCS analysis of native-like proteins:
DTIM-MS vs TWIM-MS with stable calibrants
6.1.

Introduction

Electrospray ionization mass spectrometry (ESI-MS) and its complementary techniques
have been increasingly used for analysing the native structures of biomolecules.114, 249
One of these techniques, ion mobility mass spectrometry (IM-MS) has increased in its
applications over the last 15 years.118 IM-MS measures the time it takes an analyte of a
given charge and mass to transverse a gas-filled tube under the influence of an electric
field (the ‘drift time’). This information can be used to calculate the rotationally averaged
collisional cross section (CCS) for an ion of interest. This can provide researchers with
useful information about the three-dimensional shape of a protein119-121, 125, 126 and has
been used to investigate protein folding123, 124, as well as the conformation of membrane
proteins with and without bound lipids.128-130, 134 The two most common types of IM used
in protein structural analysis are drift tube ion mobility mass spectrometry (DTIM-MS)
and travelling wave ion mobility mass spectrometry (TWIM-MS), usually interfaced with
an ESI source.
An issue within the field of IM for investigating native-like proteins is the inability to
readily compare DTIM-MS results with those obtained using TWIM-MS, which can be,
in part, attributed to the dearth of stable calibrants available for TWIM-MS analysis.
These issues could be resolved by using stable proteins as the calibrants for TWIM-MS
CCS calculations. PLA2 from Australian snake venoms are very stable and may be
suitable as calibrants for this application.
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Chapter 4 highlighted the stability of these proteins; there was no evidence of charge state
migration in the CID spectra at trap and transfer voltages of 60 V and 30 V, respectively,
thus there was likely no substantial conformational change under these conditions. The
stability of these toxins means it is likely that they are less susceptible to conformational
changes in the gas phase compared to other proteins. This property makes them an
excellent benchmark for comparison between IM systems and as calibrants for the
TWIM-MS experiments. Thus, experimentally validating this hypothesis is a key focus
of this Chapter.
6.1.1. Drift tube ion mobility
DTIM-MS utilizes a uniform electric field to push ions through the drift tube. The
resulting drift time can be used to directly calculate the CCS of an analyte via the MasonSchamp equation118:
1

3ze 2π 2 1
Ω=
�
�
16N μkB T k0
In this equation Ω is the CCS, z is the charge on the analyte, e is the elementary charge,
N is the number density of the drift gas, µ is the reduced mass of the ion-neutral drift gas
pair, kB is the Boltzmann constant, T is the gas temperature and k0 is the reduced mobility
at standard temperature and pressure. For the native-like structures of proteins,
measurements have been mostly carried out on custom devices. In recent years a modified
version of the Waters Synapt G1 HDMSTM (henceforth will be referred to as the ‘Synapt’)
has been used by the Bush and Robinson laboratories.250-253 In 2014, Agilent released a
mass spectrometer with DTIM-MS capabilities called the Agilent 6560 ion mobility Q-
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TOF (henceforth referred to as the ‘Agilent 6560’, Figure 6.1A). This device has
primarily been used to investigate small proteins and DNA quadruplexes.135, 254-257

Figure 6.1: Schematics of: A Agilent 6560 ion mobility Q-TOF and B Waters Synapt G1
HDMSTM.
The
schematics
have
been
adapted
from
the
Agilent
website
(https://www.agilent.com/cs/library/technicaloverviews/public/5991-3244EN.pdf) and
previous literature for the Waters Synapt.258 The orange line shows the path the ions take
through these mass spectrometers. Stacked ring ion guides involved in ion mobility
separation are coloured in blue. Those belonging to ion traps are coloured in red.
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6.1.2. Travelling wave ion mobility
Since its development in 2006, the TWIM-MS (Figure 6.1.B) has been used extensively
to investigate protein complexes.23, 25, 106, 107, 118, 259, 260 TWIM-MS uses a moving electric
field generated by a stacked ring ion guide to move ions. An electric current is passed
through each ring sequentially, giving rise to a ‘travelling wave’ electric field, which
pushes the ions through the drift tube. Ions within the tube ‘surf’ on this ‘wave’. Ions may
tumble over the waves due to collisions with the drift gas (Figure 6.2).118 The size of the
analyte and the number of charges it carries will determine how many times it rolls over
this wave, thus how long it spends in the drift tube (drift time). Since the electric field is
not constant, the Mason-Schamp equation cannot be applied. Therefore, CCS estimations
using TWIM-MS can only be made by comparing drift times to those of calibrant ions of
known CCS.
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Figure 6.2: Separation of ionized proteins by TWIM-MS.
A The coloured dots represent different amounts of unfolding, and therefore collisional
cross sections (CCS), for a protein of a given charge. B Shows different protein
conformations being separated by the wave, with the conformations of greater CCS being
pushed back by collisions with the drift gas (small grey spheres).
To make measurements on this system as accurate as possible, calibrants that are of a
similar average charge and mass to the analyte are used.119,
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The CCS values for

calibrants are typically taken from previous DTIM-MS investigations.119, 252 However,
this presents a problem which can affect the accuracy of CCS measurements made using
TWIM-MS. Sometimes direct comparisons between systems cannot be made. One reason
for this is because different drift gases have been used between studies. Jurnecezko et al.
showed that protein CCS increases with polarizability of the gas, and that gases of higher
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mass may more readily unfold proteins.261 Therefore, direct comparisons between CCS
measurements made in He, N2, Ne or Ar cannot be made. Secondly, TWIM-MS
experiments can be more disruptive to fragile protein structures than DTIM-MS, due to
additional energy that proteins experience within the travelling wave cell.118,

262, 263

Therefore, protein calibrants (whose CCS has been measured using the same drift gas)
used in these experiments should have highly stable structures. This would help reduce
the uncertainty of comparing CCS measurements between instruments, as these proteins
would not readily change conformation over a range of conditions. Ideally, these
calibrants would also be capable of forming multimeric complexes. This would allow
them to be used as calibrants for a wider range of biomolecules across a wider range of
instrument conditions. A group of proteins that may match this description are the
phospholipase A2 (PLA2) from Australian snake venoms.
6.1.3. Stability of venom proteins
Snake venoms are composed of highly stable proteins, capable of retaining full
pharmacological activity for more than 80 years when stored correctly.264 Examples of
these highly stable proteins are PLA2. These proteins are highly resistant to denaturation
by chemicals and heat, which can be attributed to the 6-8 disulfide bonds that maintain
their tertiary structure.27, 265 The PLA2 found in Australian snake venoms are also capable
of forming hexamers and trimers, which can be held together by a combination of
disulfide bonds, salt bridges and hydrophobic interactions.17, 18, 20, 21, 23, 25, 34, 140, 266 These
characteristics suggest that the PLA2 will likely maintain their structural integrity during
IM experiments. The oligomer with the lowest subunit diversity, thus easiest to analyse
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and test as a calibrant, is the trimeric PLA2 paradoxin (PDx). However, the CCS of this
trimer and its constituent subunits is unknown.
6.1.4. Scope of this Chapter
The goals of the work presented in this Chapter were to: (1) optimize settings for the
Agilent 6560 ion mobility Q-TOF for measuring the CCS of proteins, including large
non-covalent protein complexes, under native-like (folded) conditions, (2) measure the
CCS of trimeric PDx and its individual subunits, (3) investigate their solution and gas
phase stabilities, and (4) demonstrate the utility of these proteins as calibrants for TWIMMS experiments.
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6.2.

Results and Discussion

The instrument parameters for both IM-MS used in this work (Agilent 6560 and Waters
Synapt) were optimized for analysis of native-like protein structures.
6.2.1. Initial optimization of the Agilent 6560 for native analysis
To analyse the native structure of a protein using MS, researchers need to consider
instrument and solution conditions. In this work, snake venom proteins were analysed in
200 mM ammonium acetate (AmOAc), as this is a common spray solution used in native
nanoESI-MS experiments. Instrument settings required optimization to maximize
sensitivity, and minimize ion peak width while still maintaining the structural integrity of
the biomolecule. The Agilent 6560 has been available since 2013, and a few studies have
been aimed at using it for native protein analysis.135, 254, 255, 257, 267 However, the spectra
reported in these investigations contained ions corresponding to unfolded protein (see
section 6.2.2 for details)254, 257, 268, indicating those settings may not be optimal for native
analysis. In the current work, the CCS results and Agilent 6560 settings from previous
native-like protein analysis were compared with the results and settings from the Synapt
(TWIM-MS) and Agilent 6560 (DTIM-MS) ion mobility mass spectrometers.94, 254, 257
This was done to elucidate the settings that would most likely give rise to native ions in
the spectra. Where possible, CCS calculations were compared with results from
molecular dynamics reported in the literature for cross validation. For the analysis of
native proteins by mass spectrometry, the parameters for gas pressures, source, internal
voltages and trap fill/release times need to be considered.
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The gas pressure needs to be sufficiently high for ‘collisional focusing’. The Agilent 6560
ion trapping funnel gas operates at a fixed pressure of 3.75 torr; this cannot be changed
without having a post-factory modification for gas pressure adjustment. However,
3.75 torr is higher than what has been required for the analysis of larger analyte ions in
other studies using Waters devices.105, 107, 252, 269 So, despite not being able to adjust the
gas pressure in the trapping funnel, the default pressure means that this setting would be
sufficient to enable native-like protein analysis.
The next conditions that were optimized were those of the source, which affect the
ionization and desolvation of an analyte. On the Agilent 6560, these are the capillary
voltage, drying gas temperature and flow rate. The capillary voltage was set to 1.5 kV to
match the capillary voltage used on the Waters Synapt in this study (see section 2.1.1).
This condition has been shown to work well for many venom proteins in this thesis
(Chapter 3), as well as proteins used in other studies.133, 270 A combination of settings
from previous Agilent 6560 studies was used for the drying gas temperature and flow
rate.254, 257 Specifically, the drying gas was left at room temperature, as shown by May et
al.254 to give rise to mass spectra which reflect native-like ions, and are consistent with
many previous nanoESI-MS and ESI-MS studies of folded proteins, with a desolvation
gas flow rate of 1.5 L/min, which was shown by Gabelica et al. to improve ion counts in
DTIM-MS studies of DNA.257 Now that the initial source settings had been settled upon,
the next step was to optimize the internal voltages.
The internal voltages in a mass spectrometer need to be properly optimized to ensure the
native-like structures move through the device without unfolding. The internal voltages
optimized on the Agilent 6560 in this study were the fragmentor, high pressure funnel
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delta, trap funnel RF and trap funnel exit voltage. The fragmentor accelerates ions to the
ion funnel, and can be adjusted for pre-IM collision induced unfolding/dissociation.257
Therefore, this setting was kept relatively low to prevent the proteins from unfolding. The
voltages applied to the high-pressure funnel delta and trap funnel RF were reduced to
prevent loss of protein structural integrity due to ion heating.254, 257 The trap funnel exit
voltage was increased to assist the larger biomolecules in leaving the trap. The last
settings changed were the trap fill and release times, which were increased in this
investigation to improve ion accumulation, and to allow larger biomolecules more time
to exit the ion trap.257, 271
The Agilent 6560 parameters were compared to the default factory settings. Figure 6.3
shows the nanoESI-MS spectra of cytochrome c analysed using the default (Figure 6.3A)
and the optimized settings (Figure 6.3B). The specific conditions are shown in Chapter 2,
Table 2.1. The distribution of charge states in the default spectrum of cytochrome c is
characteristic of a multimodal distribution of mostly denatured and some native-like ions.
Ions carrying fewer charges are likely from more folded structures, as increased charge
is reflective of more exposed positive amino acids during ionization. This unfolding is
reflected by increasing CCS with charge, which can be seen in the IM spectra of May et
al. acquired on the Agilent 6560 when using an organic solvent in the spray solution.254
Therefore, the 7+ (m/z 1766.4) ion in the spectrum corresponds to more native-like
structures, while the 12+ (m/z 1030.9) ion corresponds to unfolded protein (Figure 6.3).119,
252

In the optimized spectrum (Figure 6.3B), the 7+ charge state was the most abundant,

followed by the 6+ charge state. Also present in this spectrum were equally very small
amounts of the 8+ and 5+ ions (~1%). This charge state distribution is consistent with the
Rayleigh limit of cytochrome c in its globular form (maximum of eight charges),272, 273
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indicating that cytochrome c was not being denatured under these conditions. The next
step was to compare DTIM-mass spectra and CCS measurements for a variety of proteins
to the DTIM-MS literature.

Figure 6.3: NanoESI mass spectra of cytochrome c in 200 mM ammonium acetate
acquired using the Agilent 6560.
Mass spectra of cytochrome c acquired using the Agilent 6560: A The default settings
with the exception that the trap fill and release times were 10000 µs and 1000 µs,
respectively B The optimized settings developed in this work.

6.2.2. DTIM-MS analysis of small native-like proteins
In this work, spectra acquired on the Agilent 6560 and Waters Synapt under gentle
conditions were compared. This is important, as a small change in the charge state
distribution between instruments can be (but not always) indicative of significant
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differences in CCS, owing to a difference in the extent of protein unfolding between the
two instruments. This can be seen in the study by Camacho et al. (2019),268 where an
increase in the average charge corresponded to a ~9% difference in CCS measurements
made between an Agilent 6560 and a Waters Micromass Ultima Global Q-TOF mass
spectrometer, modified for DTIM-MS with a 25.05 cm long drift tube and an extended
m/z range.
Ubiquitin, cytochrome c and myoglobin were chosen for analysis because they are
routinely used in IM-MS as standard proteins, and they have previously been investigated
using the Agilent 6560.254, 257 Spectra acquired using optimized settings on the Agilent
6560 and Waters Synapt for these proteins contained the same number of peaks and had
similar charge state distributions (Figure 6.4). The range of charge states for these proteins
were all within the predicted range for their solution structures.273 This indicates that the
ions present in these spectra correspond to native-like structures. For example, the
predicted maximum charge for folded cytochrome c is 8+, which is the highest observed
charge state in the Agilent 6560 spectrum (Figure 6.4C). The number of charge states
observed for these proteins is also in good agreement with other investigations on Waters
Synapt (G1 and G2) modified to contain a RF-confining drift tube, endowing them with
DTIM capabilities.250, 252
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Figure 6.4: Comparison of the spectra obtained for proteins of mass <25 kDa using the
Agilent 6560 and Waters Synapt under optimized conditions.
Native spectra acquired using the Agilent 6560 (DTIM-MS) for A ubiquitin, C
cytochrome c and E myoglobin, and on the Waters Synapt (TWIM-MS) for B ubiquitin,
D cytochrome c and F myoglobin.
The similarity of spectra using the two instruments supports that, under the proposed
Agilent 6560 experimental conditions, proteins are similarly folded during the analysis
by the two instruments. This is a pre-condition for comparing CCS measurements. For
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these investigations, CCS measurements that were within 3% of each other were
considered similar, as this has been previously proposed as the absolute margin of error
for this technique.274 The reconstructed arrival time distributions (ATD), which were
generated using the methods described in Marchand et al. (2017)135, and show the
different conformations observed in the Agilent 6560 spectra, are presented in section
6.2.6 (Figure 6.19).
The nanoESI-DTIM-MS of ubiquitin shown in May et al. displayed the same charge
states as the one acquired in this study (Figure 6.4A).254 However, their conditions
preference the formation of the 6+ charge state (most abundant ion, with the 5+ and 4+
charge states having relative abundances of ~75% and ~5%, respectively) compared to
the spectrum acquired in this study in which the 5+ ion was the most abundant. This
suggests that the conditions applied in this Chapter give rise to more native-like structures
than those used in the May study. To investigate this proposal, the CCS values obtained
for this protein were compared between studies.
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Table 6.1: Comparison of literature CCS values with those measured under optimized
condition using an Agilent 6560.
Literature
Measured
Protein
z
DTIM-MS
Agilent
CCS (Å2)
CCS (Å2)
949 (2.2)A
967 (1.6)
4
1116 (1.4)A 1116 (1.6)
Ubiquitin

5
6
6

Cytochrome c

7
8

Myoglobin

1011 (1.7)A
1221 (1.9)A
1222 (1.2)A
1474 (1.2)A
1628 (0.8)A
1360 (0.9)A
1477 (0.4)A
1490B
1536 (1.3)A
1590B
1793 (1.6)A
2114 (1.4)A
2441 (1.0)A

1139 (0.9)
1196 (1.7)
1330 (1.3)
1449 (1.8)
1508 (0.9)
-

7

1697 (1.7)A
1863 (1.7)A

1709 (1.6)
1908 (0.9)

8

1937 (1.6)A

1953 (1.0)

A

9
2085 (1.8)
2038 (1.0)
The %RSD is given in brackets next to the CCS measurement. A Values reported by May
et al.254 with relative standard deviation percentage reported. B Bush et al.252 did not report
a RSD% for each protein measured, but stated that the margin of error was smaller than
3% for all proteins.
Substantial differences in CCS were observed for the 5+ and 6+ charge states of ubiquitin
(Table 6.1). May et al. reported two distinct CCS (conformers) for the 5+ charge state
(Figure 6.5) although these are not evident in the figure. The conformer of lower CCS
was of very low relative abundance (~1%), thus it wasn’t used for comparison with CCS
measured in this work. The conformer of greater CCS for the 5+ charge state reported by
May et al. had a CCS that was approximately 7% larger than the single peak observed
here, consistent with the CCS of the 5+ ion of ubiquitin reported in May et al. being more
unfolded. Only one major conformer was observed for the 6+ charge state of ubiquitin.
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May et al. reported three conformations, the smallest of which had a CCS matching the
single conformation observed in this study. The larger conformations reported by May et
al. had a relatively low abundance (~3% of the major conformation). Gabelica et al.
produced a ubiquitin spectrum on the Agilent 6560 which contained a 7+ charge state in
low abundance, which had a CCS of 1337 Å2, which is larger than any of the CCS
observed for ubiquitin in this study.257 This charge state is greater than the maximum (6+)
predicted for the globular form of ubiquitin based on the Rayleigh limit.273 Therefore, the
ions for the 7+ charge state likely correspond to partially unfolded protein.

Figure 6.5: Comparison of ATDs for ubiquitin in this study and May et al.254
The black line corresponds to the ATDs obtained in this study which were acquired at a
drift voltage of 1200 V, the red line corresponds to ATDs from May et al.254
The molecular dynamics work published by the Konermann and co-workers on ubiquitin
showed that its gas phase structure had an average CCS of ~1000 Å2, which is within 3%
of the lowest CCS conformation observed for the 4+ charge state of ubiquitin in the
Agilent 6560 spectrum reported in this work.273 This is consistent with a proposal that the
other conformers for ubiquitin detected in this work belong to ions that have undergone
some unfolding. The increase in CCS for ubiquitin with charge is indicative of the native
conformation being disrupted by Coulombic repulsion of the positive charges.
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For cytochrome c, May et al. reported a spectrum containing higher charge states than the
one shown here (Figure 6.4C). The 8+ charge state was the second-most prominent ion
peak in their spectrum, with only relatively small amounts of the 6+ charge state
present.254 Two major conformations were observed for the 6+ charge state and one for
the 7+ charge state of cytochrome c in the current work. The measured CCS for these
conformations (1330 and 1449 Å2, respectively) is in good agreement with those made
previously on the Agilent 6560 by May et al. and CCS estimates based on gas phase
models generated using molecular dynamics simulations.254, 273, 275 Three conformations
were observed for the 8+ charge state of cytochrome c by May et al. (Figure 6.6), all of
which had greater CCS than the 7+ charge state reported in this thesis (19, 48 and 62%
larger). These results suggest that some of the ions for the 8+ charge state reported by
May et al. have undergone significant unfolding.

Figure 6.6: Comparison of ATDs for cytochrome c from this study and May et al.254
The black line corresponds to the ATDs obtained in this study which were acquired at a
drift voltage of 1200 V, the red line corresponds to ATDs from May et al.254
Different results for cytochrome c have been reported in studies using a modified Waters
Synapt, where the travelling wave cell has been replaced with a RF confining drift tube
(Waters DT-Synapt). The earlier results obtained on the Waters DT-Synapt showed only
one conformation for each charge state.252 The CCS reported on the Waters DT-Synapt
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for the 6+ charge state (14.9 nm2) matched the largest conformation seen on the Agilent
6560 in this study (14.5 nm2). The CCS of the 7+ ions obtained on the Waters DT-Synapt
was approximately 5% larger (15.9 nm2) than measured here (15.1 nm2). These
differences may indicate that the IM conditions within the RF confining drift tube are
more likely to unfold proteins than those of the Agilent 6560. Follow up studies on the
Waters DT-Synapt have indicated that the degree of change in the CCS was dependent
upon the amount of energy experienced by the ions in the mass spectrometer.250 The CCS
reported for the 7+ charge state in this study matched the measurements on the Agilent
6560 (within 3%).250
The myoglobin spectrum reported in the study by May et al.,254 exhibited a different
charge state distribution compared to the spectrum obtained in this project. The first major
difference was that the 9+ ion of myoglobin was the most prominent charge state in the
previous work254, while the 8+ was the most prominent ion in this work (Figure 6.4.E).
Despite this difference in charge state distribution, the CCS values and ATDs obtained
for myoglobin under the optimized conditions for the 7+, 8+ and 9+ charge states closely
matched those reported by May et al. (Table 6.1, Figure 6.7).254 The smallest
conformation for the lowest charge state of myoglobin reported in the current study had
a CCS (17.1 nm2, Table 6.1) that was in good agreement with the gas phase structure of
myoglobin generated using molecular dynamics by McAllister et al..273
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Figure 6.7: Comparison of ATDs for myoglobin from this study and May et al.254
The black line corresponds to the ATDs obtained in this study which were acquired at a
drift voltage of 1200 V, the red line corresponds to ATDs from May et al.254
The second major difference between the myoglobin spectrum presented in this work
compared to that of May et al.254 is that the latter contained multiple peaks, with a relative
abundance of up to ~10 % of the most abundant peak of holo-myoglobin (9+), which
corresponded to unfolded holo- and apo-myoglobin (charge states 10+ to 19+).254 CCS
were not reported for the higher charge states (≥10+) under native solution conditions.
These charge states exceed the maximum number predicted for the native structure of
myoglobin (Rayleigh limit, 9+), thus, they likely correspond to denatured protein.273 Since
the ions corresponding to the unfolded protein were not observed in the spectrum
produced in this study, it can be argued that the optimized Agilent 6560 conditions are
‘gentler’ than those used previously.254 Therefore, the next step was to see if these settings
were adequate for analysing larger proteins.
6.2.3. DTIM-MS analysis of larger proteins
In these experiments, carbonic anhydrase, human serum albumin (HSA), haemoglobin
and glutamate dehydrogenase (GDH) were investigated using the Agilent 6560. The
charge state distributions observed in the nanoESI mass spectra acquired using the
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Agilent 6560 were compared to those acquired on the Waters Synapt, as well as those
obtained for the same or similar proteins in other studies to determine conditions. The
first two of these proteins investigated were the monomeric proteins, carbonic anhydrase
and HSA.
The Agilent 6560 mass spectra for carbonic anhydrase and HSA (Figure 6.8A and C)
contained the same number of charge states as those obtained on the Synapt (Figure 6.8B
and D). The charge states present in these spectra were also in good agreement with
previous research using the Waters Synapt.252, 276 However, the carbonic anhydrase and
HSA analysed using the Agilent 6560 had higher average charges than those analysed
using the Synapt.
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Figure 6.8: Comparison of nanoESI mass spectra obtained for proteins of mass >25 kDa
using the Agilent 6560 and Waters Synapt under optimized conditions.
Native spectra acquired using the Agilent 6560 (DTIM-MS) for A carbonic anhydrase
and C HSA, and on the Waters Synapt (TWIM-MS) for B carbonic anhydrase and D
HSA.
Mass spectra of the monomeric (carbonic anhydrase and HSA, Figure 6.8) and multimeric
proteins (haemoglobin and GDH, Figure 6.9) acquired using the Agilent 6560 and Waters
Synapt were compared against each other and with other studies to determine conditions
that resulted in similar charge state distributions and presumably similar extents of
unfolding/maintenance of fold. Leney and Heck observed charge states ranging from 14+
to 16+ for serum albumin on an Orbitrap extended mass range mass spectrometer.249
Clarke and Campopiano used a Bruker SolariX Fourier transform ion cyclotron resonance
mass spectrometer fitted with an nanoESI source to acquire a native BSA spectrum, in
which the 17+ ions were the most abundant and ions for the 18+ charge state were also
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present.277 Variations in charge state distribution are due to differences in ionization
efficiency between mass spectrometers as well as the solvents used, and other instrument
parameters that may affect the extent of unfolding in the source.
The haemoglobin spectrum acquired using the Agilent 6560 (Figure 6.9A) contained
more peaks than the spectrum from the Waters Synapt (Figure 6.9B). Both DTIM-MS
and TWIM-MS spectra contained four peaks in the region m/z 3400-4100 which
corresponded to the haemoglobin tetramer. The other peaks not corresponding to the
tetramer that were detected in this region corresponded to other blood proteins, such as
serum albumin. The charge state average for the tetramer in the DTIM-mass spectrum
was greater than the TWIM-mass spectrum. An additional charge state (19+) was also
observed in the Agilent 6560 spectrum for the haemoglobin tetramer. This is consistent
with the tetramer being partially unfolded. To see if the additional charge states were due
to activation or differences in ionization for the large proteins, the results here were
compared to the literature. The 19+ charge state was present in other native MS studies,
especially those performed at higher salt concentrations (200 mM AmOAc).262, 278-280
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Figure 6.9: Comparison of the spectra obtained for multimeric proteins using DTIM-MS
(Agilent 6560) and TWIM-MS (Waters Synapt) under optimized conditions.
Spectra acquired for haemoglobin on A Agilent 6560 and B Waters Synapt. The GDH
Spectra were acquired on the C Agilent 6560 with a trap release time of 10 000 µs and
the D Waters Synapt. Charge states for the haemoglobin tetramers are shown in black,
while those for the dissociated dimers are shown in red.
The most abundant ions detected in the m/z region 2000-3500 corresponded to an αβ
dimer, the presence of which has been attributed to the dissociation of α2β2 haemoglobin
tetramer in solution.281 As with the tetramer, the current instrument settings on the Agilent
6560 preferenced ions carrying a greater number of charges. Previous ESI-MS studies of
haemoglobin have shown large differences in charge state distribution and abundance of
αβ dimer.262, 278-280 Therefore, the maintenance of the tetramer structure at each charge
state cannot be ascertained from these spectra alone.

163

The initial optimized conditions (Table 2.1) gave a low ion count for GDH, making it
difficult to analyse by DTIM-MS. The low ion counts could be due to the trap release
time not being sufficient. To determine whether this was the case, the trap release time
was incrementally increased. The results showed that increasing the release time increase
the ion counts for GDH (Figure 6.10). The higher mass protein ions need more time to
exit the trap for analysis. This has significant implications for measuring the CCS of very
large proteins using the Agilent 6560 with an extended (m/z 20000) mass range. The
advantages of extending the trap release time need to be weighed against a possible
disadvantage that longer trap release times may increase the IM peak width.257
Furthermore, if the trap release time required exceeds the maximum time that can be spent
in the drift tube in the Agilent 6560 (100000 µs), ion carry over is observed within the
drift spectrum. This issue may be overcome with a modification to the trap funnel exit
voltage that would allow it to exceed 50 V. The ion count could be increased by having
longer acquisition times. In any case, this observation means that the instrument
parameters for the Agilent 6560 proposed here will have to be optimized further for
proteins of higher mass (≥300 kDa). To acquire a spectrum of GDH on the Agilent 6560,
a trap release time of 10 000 µs was used to avoid the issues described above.
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Figure 6.10: The effect of trap release time on the ion count of GDH in DTIM-MS.
The spectra were acquired for 15 seconds with trap release times of 2000 µs, 5000 µs,
10000 µs and 100000 µs. The acquisitions were acquired using a drift voltage of 1600 V.
The GDH spectra acquired on the Waters Synapt had a charge state distribution which
was in good agreement with previously published GDH ESI mass spectra acquired using
the Waters Synapt series.125, 252, 282 The Agilent 6560 GDH spectrum contained four
additional charge states, located between m/z 7800-8800 (40+-43+), compared to the
Waters Synapt spectrum (Figure 6.9C and D). The higher average charge of GDH when
analysed using DTIM-MS suggests that it may have partially unfolded during analysis.
However, the charge state distribution for GDH on the Agilent 6560 matches the results
obtained on a 15 Tesla Bruker SolariX Fourier transform ion cyclotron resonance mass
spectrometer.283
The presence of higher charge states was observed in all spectra acquired using the
Agilent 6560 for all of the proteins of masses greater than 25 kDa compared to the spectra
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acquired using the Synapt series acquired in this study. As pointed out earlier, differences
in the charge state distribution can be indicative of the extent of folding/unfolding. To
determine the extent to which the optimized conditions are maintaining the ‘native-like’
structure of the proteins, the CCS of carbonic anhydrase, HSA, haemoglobin and GDH
were determined and compared with previous DTIM experiments.252
Table 6.2: Comparison of literature CCS values and CCS measured under optimized
conditions using an Agilent 6560 for carbonic anhydrase, HSA, haemoglobin and GDH.
Protein

Carbonic anhydrase

Human serum albumin

Haemoglobin

Glutamate dehydrogenase

z

Literature
DTIM-MS
CCS (Å2)

Measured
Agilent
CCS (Å2)

9

-

2309 (1.1)
2520 (1.1)

10

-

2580 (1.4)

11

-

2615 (1.2)

14

4490252

4467 (2.2)

15

4490252

4404 (1.5)

16

4470252

4521 (1.9)

17

4490252

4576 (1.8)

16

-

-

17

-

4188 (0.8)

18

-

4226 (0.3)

19

-

-

39

13400252

12614 (1.8)

40

13400252

12781 (1.3)

41

13500252

12673 (2.0)

42

-

12745 (2.3)

43
12865 (1.0)
The %RSD is given in brackets next to the CCS measurement. Values reported by Bush
et al.252 for BSA and GDH were taken from measurements given in nm2 (to one decimal
place) and no %RSD were reported.
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The first protein from Figure 6.8 which had its CCS measured was carbonic anhydrase.
There are no CCS data reported in the literature using DTIM-MS acquired using N2 as
the drift gas. However, the CCS of this protein has been measured using He as the drift
gas by the Bush and co-workers using a modified Waters Synapt.251 A comparison of this
measurement with the experimental data acquired here showed that the N2 measurements
were slightly larger than those made using He (~2430 Å2). This is to be expected, as the
apparent CCS increases with gas size.261 The exception to this was the species of lowest
CCS detected for the 9+ charge state, which had a CCS of 2309 Å2 (Table 6.2). The CCS
measured for carbonic anhydrase increases with charge. The same pattern was observed
for the smaller proteins analysed in section 6.2.2, suggesting that the 10+ (2580 Å2) and
11+ (2615 Å2) charge states of carbonic anhydrase more likely corresponded to slightly
unfolded structures. These CCS differences may be attributed to conformational changes
in the gas phase, as the same trend was observed for both cytochrome c and myoglobin.
The CCS values obtained for the charge states of HSA closely matched those obtained by
Bush et al. for BSA.252 This would be expected, as based on crystal structure, these
proteins have similar three-dimensional structures and are similar in mass.284, 285 There
was no significant change in CCS with increasing charge for HSA, indicating that there
are no significant conformational rearrangements of this protein with increasing charge.
This is likely due to the stability afforded by 17 disulfide bonds maintaining the structure
of this protein in the gas phase. Since there were no signs of substantial loss of structure
for carbonic anhydrase and HSA, these instrument conditions were used to analyse
haemoglobin and GDH.
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There are no DTIM-MS data reported in the literature for haemoglobin using a
commercial instrument, so no comparison could be made. However, there have been
several studies of this protein using TWIM-MS.262, 278-280 There is substantial variation in
the TWIM-MS data for haemoglobin, with CCS ranging from 3700-4600 Å2. The lack of
consistent data highlights the need for further investigations using DTIM instruments as
well as molecular dynamics models for this protein. The CCS of haemoglobin did not
increase with charge. This may be due to the quaternary structure of this protein protecting
its subunits from unfolding in the gas phase. The CCS of haemoglobin ions are examined
further using TWIM-MS in section 6.2.6 of this thesis.
The CCS measurements obtained for the ions of GDH in this study were approximately
127 nm2 (Table 6.2). These values are smaller than the CCS measurements shown in Bush
et al. (~134 nm2)252, and are much closer to their He CCS measurements.251, 252 The 5.4%
difference between the N2 measurements may indicate that the structures obtained in this
study on the Agilent 6560 are more native-like than those obtained on the modified
Waters Synapt. However, the possibility that the current Agilent 6560 conditions are
causing compaction cannot be ruled out. In either case, more investigations need to be
done on the Agilent 6560 for larger proteins and protein complexes to resolve this issue.
6.2.4. Drift tube ion mobility analysis of paradoxin
The optimized conditions for the Agilent 6560 were shown to produce CCS data that were
in relatively good agreement with the literature for proteins of masses around 65 kDa and
lower. Therefore, the CCS of PDx (~ 46550 Da) and its subunits could now be measured.
In these experiments, spectra were acquired on both the Agilent 6560 (DTIM-MS) and
Waters Synapt (TWIM-MS) instruments. This was done to ensure that comparable results
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could be achieved using both IM mass spectrometers. The PDx spectra in both cases
contained three prominent peaks in the region m/z 3250-4250 (Figure 6.11A and B).
These correspond to the charge states of the αβγ trimer (12+ to 14+), which has a
calculated mass of 46550 Da. These numbers are in good agreement with previous mass
spectra obtained for this toxin.25

Figure 6.11: Mass spectra of PDx extracted from IMS drift plots acquired using the A
Agilent 6560 (DTIM-MS) and B Synapt HDMSTM (TWIM-MS).
Ions labelled 12+, 13+ and 14+ are the charge states of trimeric PDx (composed of a α, β
and γ subunits). Ions labelled γ7+, γ8+, β7+ are from the corresponding monomeric
subunits and ions from contaminant proteins are unlabelled. The contaminant proteins are
not sufficiently abundant to be visualized on a SDS-PAGE gel25, but ionize and are
transmitted highly efficiently in the mass spectrometer; they can be removed by
purification of venom using an additional ion exchange step.
Peaks were also observed in the range m/z 1600-3000 in these spectra, which
corresponded to the subunits of PDx.23, 25 The β subunit had two isoforms, with masses
of 13318 and 13338 Da. The γ subunit had a broad peak for which the mass was calculated
to be 19385 Da. The masses observed here for this toxin are in good agreement with the
literature masses based on subunit peptide sequences and native mass spectrometry, as
well as the work presented in Chapter 4 of this thesis.25, 180 It should be noted that the
abundances of ions for the γ subunit of PDx were far greater in the Agilent spectrum
compared to the Synapt. This could be attributed to differences in ionization between the
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two instruments. No unfolding was detected for the PLA2 in these spectra. The CCS of
PDx and its subunits were measured.
Table 6.3: Measured CCS values obtained for snake venom PLA2 on an Agilent 6560.
Synapt G1
Agilent 6560
(Cone: 120 V)
Protein
Measured
m/z
z mass
m/z
z
Mass
CCS (Å2)
PDx

3372 (0.7)
3438 (1.2)
3466 (0.7)

3895.1 12 46729 3880.7
3595.5 13 46729 3581.7
3338.7 14 46728 3326.1

12
13
14

46549
46549
46551

β subunit

1551 (1.2)*
1561 (0.7)
1607 (0.2)*

2224.0
1906.5
1668.5

6
7
8

13338
13335
13339

6 13338 2224.0
7 13339 1906.0
8 13340 1668.4

1717 (1.0) 2770.3 7 19385 2772.0 7 19387
1815 (0.9)
1848 (1.0) 2424.2 8 19386 2425.4 8 19395
Table contains the measured CCS for PDx and its subunit constituents, as well as
comparison of ion charge, m/z and calculated masses for measurements performed on the
Agilent 6560 and Waters Synapt (cone voltage of 120 V). The full list of parameters used
are given in Table 2.1. Measured CCS for ions of each charge state are an average of six
measurements, with the %RSD shown in brackets. Ions denoted with an * only had their
CCS measured three times.
γ subunit

The CCS of the β subunit of PDx increased slightly with charge (Table 6.3), which ranged
from 1551-1607 Å2. The similarity in CCS between PLA2 charge states is likely due to
the rigidity of PLA2 due to its 8 disulfide bonds, which helps to resist unfolding in the gas
phase. The slight increase in CCS for the 8+ charge state of the β subunit is likely due to
unfolding of the N-terminus α helix, as it is the only major secondary structure not held
in place by a disulfide bond.140 The 8+ charge state of the γ subunit had a CCS of 1850
Å2, while the 7+ charge state had two conformations with CCS of 1731 and 1811 Å2.
These conformational differences between charge states are most likely due to changes
in the glycan, since the tertiary structure of PLA2 is rigid.265 The CCS of PDx ions 12+,
13+ and 14+ were approximately 3400 Å2 (Table 6.3), indicating there is little change in
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conformation in response to the number of charges. Differences in mass measurements
between the Agilent 6560 and Synapt for the PDx trimer were attributed to variation in
peak widths relating to the high cone voltage used when acquiring the Synapt spectrum.
The higher cone voltage reduced the number of adducts present on PDx during analysis.
Now that the CCS of these proteins had been measured, the next step was to investigate
their stability.
6.2.5. Stability of paradoxin in solution and in the gas phase
Previous research has indicated that monomeric PLA2 (such as bovine pancreatic PLA2)
have stable and rigid structures, primarily due to the presence of 7-8 disulfide bonds
within each subunit.27, 265 However, there are few experiments that focus on the stability
of the trimeric PLA2 found in Australian snake venoms. To be used as calibrants for
TWIM-MS experiments, the stability of PDx and its subunits had to be confirmed. This
was achieved by using a combination of circular dichroism (CD) spectroscopy and
TWIM-MS to investigate the stability of these complexes in the presence of organic
solvent is solution and on transfer to the gas phase.
To look for unfolding in solution, PDx samples which were in 200 mM AmOAc were
prepared with a 1:1 mixture of either: Milli-Q water, acetonitrile, methanol (MeOH) or
isopropanol prior to spraying. The final concentration of PDx was 5 µM. The abundance
of the dissociated β and γ subunits substantially increased in the presence of organic
solvent, compared to the trimer, as judged by nanoESI-MS (Figure 6.12). Peaks
corresponding to trimeric PDx were still prominent in these spectra, albeit with a higher
average charge in the MeOH and isopropanol than in 100 mM AmOAc alone. These data
show that PDx can maintain parts of its quaternary structure in the presence of organic
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solvents. To examine how well these proteins were maintaining their structure in the
presence of these solvents, they were analysed using TWIM-MS.

Figure 6.12: Mass spectra of PDx in different organic solvents acquired on the Waters
Synapt.
Spectra were acquired for PDx after a 1:2 dilution with (blue) Milli-Q water, (red)
acetonitrile, (green) MeOH and (purple) isopropanol.
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In the TWIM-MS experiments, aliquots of PDx were prepared in 100 mM AmOAc with
organic solvents mentioned above to concentrations of 10, 20, 30 40 and 50% (v/v). The
drift times of the 12+ ions of PDx trimer and 6+ ions of β PDx were measured at each
solvent concentration. The drift times of these ions were converted into heat maps using
CIUsuite (Figure 6.13). In all solvents, the monomer (β) and the trimer were stable. Only
minor changes in drift time were detected for acetonitrile at concentrations ≥ 40%. This
supports that the quaternary architecture of these charge states is maintained in the
presence of organic solvent. To further test the stability of PDx, CD were acquired in the
presence of organic solvents.

Figure 6.13: CIU plots of PDx under various organic solvent concentrations.
Stability heat maps (TWIM-MS) of β subunit of PDx (6+ ion) and PDx trimer (12+ ion)
as a function of solvent concentration (% v/v): acetonitrile (ACN), isopropanol (IPA),
MeOH (methanol).
The CD spectra of PDx were acquired in the presence of 100 mM AmOAc alone or with
50% acetonitrile, MeOH or isopropanol (Figure 6.14). The only solution that showed
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some loss of secondary structure was the PDx in 100 mM AmOAc, 50 % (v/v) MeOH.
The absolute decrease in signal at 206-228 nm was relatively similar, suggesting that the
secondary structure being lost corresponds to α helical structures.286 From this
information it can be concluded that PDx and its constituent subunits can retain their
structural elements in the presence of organic solvent. The next step was to investigate
the gas phase stability of these proteins.

Figure 6.14: CD spectra of PDx in the presence of organic solvents: acetonitrile (ACN),
methanol (MeOH), isopropanol (IPA).
To investigate the stability of PDx and its subunit constituents in the gas phase, their ions
were subjected to increasingly energetic mass spectrometry conditions to look for
changes in drift time. The changes in CCS with increasing energy were visualized using
the CIUsuite software.132 This allows for the easily visualization of changes in drift time
with increasing voltage, as well as the ability to measure variation in drift time between
runs. These protein ions were the 7+ ions of the β subunit, the 8+ ions of the γ subunit and
the 12+, 13+ and 14+ ions of PDx trimer. The 6+ and 8+ ions of the β subunit were not
used, as the CCS values of these ions were only measured three times. This is an
insufficient number of measurements for reproducibility in IM experiments.287 The 7+
charge state of γ subunit of PDx was not used as it was difficult to resolve its two
conformations in the TWIM-MS experiments.
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The first condition that was used to examine the stability of these ions was the cone
voltage (Figure 6.15). The left hand panels show the change in drift time of a given ion
with cone voltage, while the right hand panels shows the change in RSD between
measurements. The peaks corresponding to the 7+ ions of the β subunit broadened slightly
and had little variance between runs with increasing cone voltage (Figure 6.15A and B).
This was most likely due to the high stability of PLA2 afforded by the 7-8 disulfide bonds
maintaining the tertiary structure of these enzymes.27, 265 The 8+ ions of the γ subunit was
only detectable up to a cone voltage of 160 V; the reduction in ion count for voltages
greater than 160 may be due to fragmentation. Variations in the drift times observed for
this ion once the cone voltage was ≥ 40 V (Figure 6.15) may be due to the large amount
of glycosylation on this protein. The variation observed in Figure 6.15D due to the large
glycan is also observed for the trimer (Figure 6.15F, H, J) and most likely arises from the
γ subunit. The 12+ and 13+ ions of PDx remained consistent until the cone voltage was ≥
140 V (Figure 6.15E, F, G and H). The variation can be attributed to the lower ion count
of the trimers due to dissociation and fragmentation of the glycan. The 14+ ions of PDx
were less consistent than the other two charge states (Figure 6.15I and J). Most of the
variation in drift time between measurements occurred away from the apex of the
calibrant ion peaks, and at cone voltages > 120 V. This indicates that, when these proteins
are used as calibrants, a cone voltage of less than 120 V should be used. Now that the
stability during ionization had been investigated, the next step was to see how stable these
proteins were when subjected to increasing trap voltages.
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Figure 6.15: Stability heat maps (TWIM-MS) of 7+ ion of the β subunit, the 8+ ion of the
γ subunit, and the 12+, 13+ and 14+ ions of PDx as a function of cone voltage.
Left hand panels (A, C, E, G, I): relative abundance of protein species (conformers,
dissociation products) at different drift times (average of 6 measurements). Right hand
panels: (B, D, F, H, J): variation (shown in RSD, 6 measurements) of protein species
(conformers, dissociation products) at different drift times.
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The drift time of the 7+ ions of the β subunit of PDx did not change significantly under
increasing trap voltages (Figure 6.16A and B). The γ subunit exhibited more variation
between its spectra (as shown by the RSD in Figure 6.16D), which may be due to the
large amount of glycosylation on this protein. Once the trap voltage was ≥ 60 V, the drift
time of the PDx ions begins to vary much more significantly (Figure 6.16E, F, G, H, I
and J). This is due to the reduced ion count as the complex dissociates, and other proteins
begin to pass through its drift spectrum. This information indicates that the PLA2
mentioned above are more stable in the gas phase than most other proteins.122 Finally, the
arrival time distributions (ATD) of these proteins were investigated to compare their
relative peak width to other proteins used as calibrants for TWIM-MS experiments.
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Figure 6.16: Stability heat maps (TWIM-MS) of 7+ ion of the β subunit, the 8+ ion of the
γ subunit, and the 12+, 13+ and 14+ ions of PDx as a function of trap voltage.
Left hand panels (A, C, E, G, I): relative abundance of protein species (conformers,
dissociation products) at different drift times (average of 6 measurements). Right hand
panels: (B, D, F, H, J): variation (shown as RSD, 6 measurements) of protein species
(conformers, dissociation products) at different drift times.
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A good calibrant for TWIM-MS experiments would ideally show peaks for its ions of
interest with narrow arrival time distributions (ATD). A narrow ATD makes it easier to
determine the drift time of a given ion. Compared to other proteins of similar mass and
of the same charge, the subunits of PDx have a narrower ATD, which can be attributed
to their rigid structure (Figure 6.17). None of the ‘standard’ proteins analysed in this
investigation were of a comparable mass and charge state distribution to the trimeric PDx
ions, thus, an appropriate comparison was not available for the trimer. However, the 12+
charge state of PDx had a similar ATD to the 16+ charge state of HSA which is stabilized
by 17 disulfide bonds. These results show that PDx and its constituent subunits were
found to have relatively narrow ATDs compared to other proteins due to their stabilized
structure. The next step was to generate calibration curves using ions of these venom
proteins.
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Figure 6.17: Drift plots showing the TWIM-MS arrival time distribution (ATD) for
charge states of PDx and other native proteins.
A ATD for the 7+ ion of the β subunit (solid line; m/z 1906.5) and cytochrome c (dashed
line; m/z 1766.5). B ATD for the 8+ ion of the γ subunit (solid line; m/z 2424.2) and
myoglobin (dashed line; 2196.5 m/z). C ATD for the 12+ ion of the PDx (solid line; m/z
3895.1) and the 16+ charge state of HSA (dashed line; 4198.7 m/z).
6.2.6. TWIM-MS calculations using PLA2 calibrants
The only way to calculate the CCS of a protein using TWIM-MS is by comparison with
the drift time of ions of known CCS. The methods for this calculation were established
by Robinson and co-workers (see section 2.2.2).119 This study also indicated calibration
curves with an R2 value > 0.98 to be desirable for obtaining CCS for TWIM-MS
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experiments which were comparable to those obtained using DTIM-MS. This was built
upon in later work by the Robinson group, which suggested that the calibrants should also
be of a similar mass and charge.127, 133 Konermann suggested that stable calibrants should
be used for calculation, to prevent variations in measurements between studies.262 The 7+
ions of the β subunit, 8+ ions of the γ subunit and 12+, 13+ and 14+ ions of PDx fit these
conditions and cover the m/z for ubiquitin, cytochrome c, myoglobin, carbonic anhydrase,
HSA and haemoglobin; thus, they were used to estimate their CCS. These results were
then compared with the DTIM-MS results to determine the reliability of the TWIM-MS
measurements.
Good separation of ions was found for most of the calibrant ions at a wave speed of 380
m/s and wave heights of 10.5, 11.0 and 11.5 V (Figure 6.18). The 14+ charge state was
not used in the 11.5 V calibration curve as it did not fit well, likely due to its low ion
count in the spectrum. The DTIM-MS CCS was used to plot ubiquitin, cytochrome c,
myoglobin, carbonic anhydrase, HSA and haemoglobin on the first calibration curve. The
full ATDs for each ion are shown later in this Chapter (Figure 6.19 on page 185). The 4+
and 6+ ions of ubiquitin, 8+ ion of myoglobin and the 10+ ion of carbonic anhydrase were
all significantly off the curve, and are noted in Figure 6.18.
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Figure 6.18: PLA2 Calibration curves for the TWIM-MS CCS calculations as described
by Ruotolo et al. (2008)119 and Salbo et al. (2012).133
Methods are described in section 2.2.2. Myoglobin is labelled as Mb while carbonic
anhydrase is labelled as CA.
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Table 6.4: Comparison of CCS values obtained on DTIM-MS (Agilent 6560) and
TWIM-MS (Waters Synapt) ion mobility mass spectrometers.
Measured
Literature
Calculated
Protein
z
Agilent
TWIM-MS TWIM-MS
CCS (Å2)
CCS (Å2)
CCS (Å2)
967 (1.6)
904 (2.0)
4
1116 (1.6)
1003 (0.8)
Ubiquitin
5
1139 (0.9)
1117 (0.9)
B
6
1196 (1.7)
986
1314 (2.5)
1330 (1.3)
1398 (0.5)
6
1449 (1.8)
Cytochrome c
7
1508 (0.9)
1533 (0.8)
1709 (1.6)
7
1788 (0.5)
1908 (0.9)
Myoglobin
8
1953 (1.0)
1839 (1.8)
9
2038 (1.0)
1782B
2011 (0.9)
2309 (1.1)
2004 (0.4)A
2425 (0.5)
9
2520 (1.1)
Carbonic
Anhydrase
10 2580 (1.4)
2003 (0.8)A
2491 (0.8)
A
11 2615 (1.2)
2049 (1.1)
2559 (0.9)
14
4191 (1.3)
15
4320 (1.1)
C
Haemoglobin 16
3615
4273 (1.1)
17 4188 (0.8)
3759C
4244 (0.5)
B
18 4226 (0.3)
4552
4307 (0.9)
14 4467 (2.2)
4518 (0.8)
15 4404 (1.5)
4506 (1.0)
HSA
16 4521 (1.9)
4494 (1.2)
17 4576 (1.8)
4532 (1.2)
A
The %RSD is given in brackets next to the CCS measurement. Values reported by Leary
et al.276 with the RSD% reported. B Values reported by Sun et al.262 C Values reported by
Muralidharan et al.278
Table 6.4 shows the TWIM-MS CCS values obtained for ubiquitin, cytochrome c,
myoglobin, carbonic anhydrase haemoglobin and HSA when using PDx and its subunits
as calibrants. The CCS obtained for most proteins during the TWIM-MS experiments
closely matched (<3% difference) most of the DTIM-MS measurements (Table 6.4). The
agreement between TWIM-MS and DTIM-MS suggest the global CCS of haemoglobin
is ~4200 Å2, while carbonic anhydrase is ~2500 Å2. This supports the results in section
6.2.1, showing that the Agilent 6560 will maintain the quaternary structure of multi183

subunit protein complexes (e.g. haemoglobin). However, there were significant
differences between the TWIM-MS results obtained in this and previous studies for
carbonic anhydrase and haemoglobin. These differences could be attributed to previous
studies using denatured calibrants, which have previously been shown give inaccurate
results for native-like proteins.133 The use of denatured calibrants may also explain the
significant differences in CCS reported for haemoglobin (CCS ranging from
~3700-4600 Å2).262, 278, 280
For most ions on the calibration curve, the ATDs for the TWIM-MS were less resolved
than for DTIM-MS (Figure 6.19). The ATD of the 7+ ion of cytochrome c was
substantially broader on TWIM-MS than DTIM-MS, suggesting some unfolding. This
could indicate that the TWIM-MS is harsher than the DTIM-MS. This has previously
been reported for the 7+ ion of cytochrome c, where the TWIM-MS was found to heat the
ions, unfolding fragile structures.263 The Waters Synapt was unable to resolve the two
conformations for the 7+ ion of myoglobin, and 9+ ion of carbonic anhydrase.
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Figure 6.19: Comparison of ion mobility resolving power for measurements made on the
Agilent 6560 and Waters Synapt.
TWIM-MS plots (solid lines) were made using the results from the 10.5 V wave height
while the DTIM-MS plots (dotted lines) were taken from the ATD at a drift tube voltage
of 1200 V. Each protein is given a different colour: green for cytochrome c, orange for
HSA, black for ubiquitin, red for myoglobin, and blue for carbonic anhydrase.

6.3.

Summary

The parameters for for the Agilent 6560 were optimized to allow for the IM analysis of
native-like structures. However, this instrument will most likely require further
optimization for the analysis of proteins with masses ≥300 kDa. The CCS results of this
work indicate that care needs to be taken when reconstructing a multi-subunit protein
using IM. Three-dimensional assignment of a multimeric protein done with the CCS of
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partially-unfolded components lead to incorrect assessments. This highlights the need for
further experimental refinement of this technique, in order to maintain the structural
elements of a protein.
The TWIMS-MS analysis of PDx and its constituent subunits showed that these proteins
are highly stable and are capable of resisting unfolding. Changes in the drift spectra
mostly occur at higher collisional energies. The loss of structure occurred at organic
solvent concentrations greater than 40% (v/v). The stability of these proteins in the gas
phase means that a substantial proportion of the sample retains its structure irrespective
of IM technique used. This makes these proteins effective calibrants for TWIM-MS
experiments. The CCS estimates for the TWIM-MS experiment using PLA2 as calibrants
were mostly in good agreement with the DTIM-MS results. The variation in results within
the literature highlights the need for more in-depth investigations to fully understand the
appropriate application of TWIM-MS.
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Chapter 7 : Conclusions and future directions
The data presented within this thesis has contributed to our understanding of the mature
protein composition of elapid snakes venoms (Chapter 3), in particular the prevalence and
structural characteristics of the trimeric phospholipase A2 (PLA2). This thesis also gives
insight into the applications of mass spectrometry (MS) to investigate the properties of
PLA2, including determination of enzyme kinetic parameters using an MS-based
continuous assay (Chapter 5). The usefulness of the trimeric PLA2 and their constituents
as calibrants for travelling wave ion mobility MS (TWIM-MS) experiments is also shown
in this work (Chapter 6).
In Chapter 3, the protein composition of Acanthophis antarcticus, Notechis scutatus,
Oxyuranus microlepidotus and Oxyuranus scutellatus scutellatus whole venoms were
investigated. Understanding the composition of these venoms has three main benefits: it
can give insight into the evolution elapid venoms, assist in the development of novel anti
venoms and help identify venom proteins for potential use as therapeutics. An example
of the potential therapeutics that may be derived from elapid venoms can be found in
Samy et al. (2007), which showed that many elapid and viper venoms have antimicrobial
activity comparable to chloramphenicol, streptomycin and penicillin (paper disc
inhibition radius).151
In the current work, the compositions of these venoms were investigated using a
combination of size exclusion chromatography (SEC) and nanoelectrospray ionisation
MS (nanoESI-MS). The size exclusion chromatograms of these venoms contain multiple
peaks, which corresponded to venom components of varying mass. The largest proteins
found in this study were of masses around 230 and 180 kDa, and were only found in the
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Oxyuranus venoms. These proteins were most likely the factor Va like protein (FVa, 180
kDa) and the factor Xa like/factor Va like complex (FXa:FVa, 230 kDa). It was not
expected that FVa would be found in such high abundance, as it is the non-catalytic
subunit of prothrombinase complex, and is not capable of activating mammalian (bovine)
FXa.156 This raises additional questions about the composition of these venoms: how
prevalent is this trend amongst species and individual snakes which contain these
proteins? Do other toxins have similar over expression patterns? Is the overexpression, in
part, due to the relatively recent evolution of this component?
For the first question raised above, the over expressions of FVa was observed in both
species of Oxyuranus (Chapter 3). However, the over expression of FVa in the venoms
of the Pseudonaja and other Oxyuranus venoms has yet to be investigated. To further
examine this phenomenon, venoms from multiple individual snakes from each of the
different species of Pseudonaja and other Oxyuranus will be investigated using the
methods outlined in Chapter 3 and 4. By carrying out cross-venom evaluation and more
detailed sequence analyses it will be possible to distinguish the variations between
individuals of the same species from inter-species/genera variation.
The most abundant peaks in the size exclusion chromatography were found to
predominantly contain monomeric PLA2 (composition determined by native MS).
Substantial variations in the masses of the monomeric proteins in the venoms of A.
antarcticus, N. scutatus, O. microlepidotus and O. s. scutellatus venoms were detected
between this investigation and previous studies. This was proposed to arise from the
variation between individual snakes of the same species. The nature of these changes will
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be investigated using protein sequencing. These data could then be compared with
genomics sequence data to help determine the cause of these differences.
The focus of Chapter 4 was to investigate the prevalence of trimeric PLA2 within the
elapid venoms. The reasons for this investigation were three-fold: these toxins are
amongst the most potent pre-synaptic neurotoxins found in snake venoms, which could
explain, in part, the high neurotoxic potency of some elapid venoms. The second reason
is that these toxins may have therapeutic properties. Poulson et al. (2005) showed that
taipoxin (TPx), the trimeric phospholipase A2 (PLA2) found in the venom of O. s.
scutellatus had activity against multiple small lung cancer cell lines, with IC50 values in
the range of 3 to 130 nM.61 Finally, these very stable proteins could be useful as calibrants
for travelling wave ion mobility (TWIM-MS) experiments, which is discussed below.
Trimeric PLA2 were found in all the venoms tested of snakes from the genera
Acanthophis, Notechis, Oxyuranus and Tropidechis. The nanoESI-MS investigations
showed that the trimeric PLA2 exhibited multiple toxin isoforms. The number of isoforms
detected in this study were greater than what has been proposed in in earlier
investigations. This discrepancy is likely due to the inability to distinguish between
subunit glycoforms of intact subunits using matrix assisted laser desorption/ionization
time of flight (MALDI-TOF) mass spectrometry. This highlighted the power of using
nanoESI-MS to investigate these complexes. Travelling wave ion mobility MS (TWIMMS) was used to investigate the three-dimensional architecture of the trimeric PLA2.
These data suggested that the trimers from the different elapid genera have similar
quaternary geometries.
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Preliminary investigations involving treatment of the trimeric PLA2 with PNGase F
indicated that mass variation between trimers was mostly due to differences in
glycosylation. This information also indicated that the tiger snake trimers have two
glycosylated subunits and that the lowest mass isomer from the venom of T. carinatus
was not glycosylated. These data are consistent with the proposal that the glycan pattern
observed for Notechis (two glycosylated subunits) and Oxyuranus (larger glycans) trimers
are recent evolutionary events. This highlights the importance of performing glycan
analysis for these toxins. Future investigations of these toxins will also include screening
for O-glycosylation (our preliminary work, not reported here, suggests that all the glycans
are N-linked). The application of MS/MS and CID showed that most of these toxins were
all heterotrimers. The subunit dissociation pattern of these toxins could be broadly
characterized by genera; Acanthophis and Tropidechis (αβγ to β + αγ or α + βγ (low
abundance)), Notechis (αβγ to α + γγ) then Oxyuranus (αβγ β + αγ). These dissociation
patterns suggest that the trimeric PLA2 may have genera-specific quaternary
architectures, such as, variations in salt bridge coordination between subunit types for
different toxins.
The differences in glycosylation patterns raise questions with regards to their composition
and function, which will be a focus of future investigations. The structural
characterization would most readily be achieved by doing a glycomics investigation using
mass spectrometry. These studies are in progress. By isolating the individual glycan trees
and subjecting them to CID, the glycan sequence for each of the trimers could be
elucidated. Since the glycans can be readily liberated from the native trimers, it should be
possible to compare the relative toxicity of native trimers to those which are
deglycosylated. By synthesizing the data from these experiments, it may be possible to
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elucidate how glycan composition and three dimensional position of the glycan affects
toxicity.
The deglycosylated trimers are also currently being investigated using X-ray
crystallography. If a three dimensional structure can be obtained, sequence and glycomics
data will be used to model the glycans on the three dimensional structure. For the large
toxins within these venom, cryo-electron microscopy experiments are currently under
way to obtain their three dimensional structures.
Another aspect of these venoms which requires further investigation is the
pharmacological context of the low abundance toxins. The trimeric PLA2 which had
previously been toxicologically characterized have had low LD50 values (1-2 µg/kg).20
Therefore, low amounts of toxin may still play an important pharmacological role,
especially if it works synergistically with other toxins. An example from this work could
be the low abundance of trimers in the venom of N. a. niger, which may have a low LD50,
thus, may still play an important role.
The development of a continuous electrospray ionisation MS (ESI-MS) assay which
could be used to investigate the enzymatic activity of PLA2 was described in Chapter 5.
This work provided a base from which a technique capable of measuring the activity of
PLA2 against liposomes composed of toxicologically relevant lipids could be developed.
The goal of the work in Chapter 5 was to find instrument conditions for the mass
spectrometer (Water G1 HDMSTM Synapt) which allowed for the measurement of PLA2
activity against phosphatidylcholine (PC) liposomes. For these experiments, paradoxin
(PDx), the trimeric PLA2 from O. microlepidotus venom was the only enzyme tested.
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This toxin was chosen due to its relative purity and its limited number of subunit isoforms,
compared to the other elapid PLA2 after a single step purification using size exclusion
chromatography.
It was possible to measure the activity of PDx continuously by ESI-MS under the
conditions presented in Chapter 5. However, there are still significant issues which need
to be overcome for this assay. This first issue is the spray solution used for this assay. The
absence of a good buffer in the spray solution prevents the control of pH for the reaction.
This is important for measuring rate of activity in the burst phase, as the product (fatty
acids) would be produced in sufficient quantities to significantly lower the pH of the spray
solutions. This may be overcome by using a spray salt which is a buffer at the tested pH
ranges or by adding a small amount of buffer to the spray solution. However, this should
be approached with care, as the buffer could lead to the formations of significant amounts
of adduct ions, which could complicate determining the rate of reaction. The second issue
was the inability to measure the first 20 seconds of activity for this reaction. It may be
possible to overcome this issue by fitting the mass spectrometer with a stopped-flow
device.
Despite the drawbacks stated above, it was possible to measure the activity of PDx. The
activity data for PDx was comparable to the results obtained using the pH-stat technique.
However, this technique will still require optimization. The first thing to do will be to
repeat the experiments using acetate salts instead of chloride. This should improve ions
counts, thus, reducing the variability between time point measurements. Future
experiments should also use a combination of lipid types in order to better simulate cell
membranes. Furthermore, the activity against liposomes of different sizes will be
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examined to see if it has any effect on the activity of these toxins. This assay could also
be used to measure the activity of multiple toxins, and the results could then be compared
to toxicology assays in order to determine the relationship between enzyme activity and
toxicology.
The IM work presented in Chapter 6 of this thesis gives instrument conditions for the
Agilent 6560 ion mobility Q-TOF which can be used for the analysis of multi-subunit
native-like protein complexes. The collisional cross section (CCS) obtained in these
investigations were for the most part, within three percent of previous investigations for
range of proteins. However, the ion counts obtained for glutamate hydrogenase (GDH)
using the Agilent 6560 ion mobility Q-TOF indicated that further optimization may be
required for the analysis of proteins of masses equal to or greater than 300 kDa. The
relatively low ion counts for the larger protein complexes in these venoms means that
further optimization is likely required for the analysis of larger protein complexes. These
conditions were then used to measure the CCS of PDx and its constituent subunits.
The TWIM-MS analysis of PDx revealed that this toxin is highly resistant to unfolding
in the presence of organic solvent. It was also shown that this toxin and its subunits are
highly resistant to unfolding with increasing trap collisional and cone voltages. This was
attributed to the multiple disulfide bonds and salt bridges which hold this toxin together.
These results indicated that PDx is an excellent candidate for use as a calibrant in TWIMMS experiments for CCS measurements. However, it should be noted that the extensive
glycosylation present on this toxin may lead to slight variations in CCS between
measurements. This is reflected in the standard error present in the heat maps for the
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glycosylated γ subunit and PDx trimer. This issue will be overcome by obtaining the drift
time measurements using deglycosylated PDx.
When PDx was used as a calibrant for the TWIM-MS, it gave CCS which were within
three percent of the DTIM-MS measurements for proteins in the mass range of 12-70
kDa. The protein charge states which were the exceptions were myoglobin 8+ and
carbonic anhydrase 10+. These ions are the ‘middle’ charge states observed for these
proteins, indicating the differences in measured CCS are not due to conformational
changes in the gas phase. The more likely hypothesis is that the difference in CCS has to
do with how these ions move relative to the calibration ions. This phenomenon needs to
be investigated in more detail. One way of investigating this would be to use DTIM-MS
to measure the CCS of the PLA2 and other highly stable venom proteins in the presence
of either charge reducing or supercharging agents. Many venom proteins contain multiple
disulfide bonds, which would make them highly resistant to conformational charge in the
gas phase, thus, their CCS should remain relatively constant over a range of conditions.
By comparing the drift time and CCS data for multiple stable proteins, it may be possible
to better characterise how ions move during TWIM-MS.
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Chapter 8 : Appendix
Table 8.1: Peptide sequences for SDS-PAGE bands for the yellow SEC fractions (PLA2 sequences have been shaded blue).
Protein sequence
Gel
used for
Sequence
band
Unique peptides detected for each sample used for
Snake venom
identification
Coverage
mass
identification
(Uniprot accession
(%)
(kDa)
number)
Carboxylic ester
hydrolase
(Fragment)
(R4FKE6)

A. antarcticus

75
SVMP-Aca-4
(R4G2D3)

K.NGAWPTYTASR.P
K.N(+.98)GAWPTYTASR.P
K.N(+.98)GAWPTYTASRP.Q
K.NGAWPTYTASRPQYVQLNTQPLATQPSLR.A
K.N(+.98)GAWPTYTASRPQYVQLNTQPLATQPSLR.A
R.NDNAQLLTGIDFN(+.98)GATVGR.A
R.RNDNAQLLTGIDFN(+.98)GATVGR.A
R.NDNAQLLTGIDFNGATVGR.A
R.RNDNAQLLTGIDFNGATVGR.A
R.NDN(+.98)AQLLTGIDFN(+.98)GATVGR.A
R.N(+.98)DNAQLLTGIDFN(+.98)GATVGR.A
R.AYVGTLC(+71.04)SPEK.S
K.SVAVIQDYSK.R
R.NDN(+.98)AQLLTGIDFNGATVGR.A
R.NDNAQ(+.98)LLTGIDFNGATVGR.A
C.VDGPDYR.M
R.RIPC(+71.04)AAK.D
Y.RMVEPGTK.C

31

21

195

A. praelongus

17

9SAUR PLA2-Aca38 ( R4G7E3)

Venom
prothrombin
activator notecarinD1 (P82807)

N. scutatus

50

Venom
prothrombin
activator trocarin-D
(P81428)
Venom
prothrombin
activator notecarinD2 (Q58L94)

R.NDNAQ(+.98)LLTGIDFN(+.98)GATVGR.A
R.AAIC(+71.04)FAQNPYNNANWNINTK.T
R.AAIC(+71.04)FAQNPYN(+.98)NANWNINTK.T
F.AQNPYNNANWNINTK.T
N.PYNNANWNINTK.T
R.YGC(+71.04)YPYWTLYSWK.C
Y.NNANWNINTK.T
C.FAQNPYNNANWNINTK.T
R.FVC(+71.04)AC(+71.04)DSR.A
N.NANWNINTK.T
R.YGC(+71.04)YPYWTLY.S
R.FKEPTSNTLK.V
R.IRFKEPTSNTLK.V
R.FKEPTSN(+.98)TLK.V
F.KEPTSNTLK.V
R.FKEPTSN.T

41

69

I.QFKQ(+.98)PTSNTLK.V

69

R.HTCMLSSNFR.I
M.LSSNFR.I
R.TQSIGYTSN.I
R.HTC(+71.04)M(+15.99)LSSNFR.I
C.M(+15.99)LSSNFR.I
N.SYYQNIDR.F
C.MLSSNFR.I
R.HTC(+71.04)MLSSNFR.I

51

196

17

N. a. serventyi

50

PLA2-7
OS=Tropidechis
carinatus
(B5G6G1)
Venom
prothrombin
activator notecarinD1 (P82807)
Venom
prothrombin
activator trocarin-D
(P81428)

K.KFVPPNSYYQN.I
K.KFVPPNSYYQNIDR.F
P.ACLPTADFAK.E
K.KFVPPN(+.98)SYYQNIDR.F
K.FVPPNSYYQNIDR.F
R.TQSIGYTSNILK.V
K.FVPPN(+.98)SYYQNIDR.F
Q.SIGYTSNILK.V
R.TQSIGYTSN(+.98)ILK.V
K.VSNFIPWIKK.I
R.M(+15.99)KTPIQFSENVVPAC(+71.04)LPTADFAK.E
R.FAYDYDIAIIR.M
R.MKTPIQFSENVVPAC(+71.04)LPTADFAK.E
K.TPIQFSENVVPAC(+71.04)LPTADFAK.E
L.NLLQFAFM(+15.99)IR.C
K.IHDDC(+71.04)YAR.A
R.FVC(+71.04)DC(+71.04)DSK.A

45

L.NLLQFAFM(+15.99)IR.C

No unique peptides

I.QFKQ(+.98)PTSNTLK.V

69

69

197

PLA2-7 (B5G6G1)

Venom
prothrombin
activator hopsarinD (P83370)

Venom
prothrombin
activator notecarinD2 (Q58L94)

PLA2-Aca-38
(R4G7E3)

R.RPVWHYM(+15.99)NYGCYCGKGGSGTPVDELDRC(+71.04)CK.I
R.RPVWHYM(+15.99)NYG.C
K.C(+71.04)YGN(+.98)GPTCNSK.T
R.RPVWHYMNYGCYCGKGGSGTPVDELDRCC(+71.04)K.I
D.ELDRC(+71.04)C(+71.04)KIHDDCYAR.A
K.IHDDC(+71.04)YAR.A
R.FVC(+71.04)DC(+71.04)DSK.A
K.IHDDCYAR.A
L.NLLQFAFMIR.C
L.NLLQFAFM(+15.99)IR.C
K.SYSC(+71.04)APYWTLYSWK.C

64

V.NGMDSKLGECPWQAVLINEK.G

53

K.TPIQFSENVVPAC(+71.04)LPTADFAK.E
K.FVPPNSYYQNIDR.F
R.FAYDYDIAIIR.M
R.HTC(+71.04)MLSSNFR.I
K.TPIQFSENVVPACLPTADFAKEVLM(+15.99)K.Q
R.TQSIGYTSNILK.V
R.HTC(+71.04)M(+15.99)LSSNFR.I
K.KFVPPNSYYQNIDR.F
R.HTCMLSSNFR.I
K.C(+71.04)YGSGPYC(+71.04)NSK.T
R.RRPVWHYMDYG.C
A.AICFAQNPYNNANWNIN(+.98)TK.T
Y.VHQN(+.98)FDR.V

52

34

198

Venom
prothrombin
activator notecarinD1 (P82807)
37

Venom
prothrombin
activator hopsarinD (P83370)

K.FVPPNYYYVHQNF.D
Y.VHQ(+.98)NFDR.V
K.FVPPNYYYVHQNFD.R
V.PPNYYYVHQ(+.98)N(+.98)FDR.V
Y.VHQNFDR.V
K.FVPPNYYYVHQN(+.98).F
Y.YVHQ(+.98)NFDR.V
Y.YVHQN(+.98)FDR.V
K.FVPPNYYYVHQN.F
K.FVPPNYYYVH.Q
Y.YVHQNFDR.V
K.FVPPNYYYVHQ.N
Y.YYVHQNFDR.V
N.YYYVHQNFDR.V
K.FVPPNYYYVHQN(+.98)FDR.V
K.FVPPN(+.98)YYYVHQNFDR.V
K.FVPPNYYYVHQ(+.98)NFDR.V
R.DTHFITGIISWGEGC(+71.04)AR.K
K.FVPPNYYYVHQNFDR.V
Y.VHQN(+.98)FDR.V
K.FVPPNYYYVHQNF.D

67

V.NGMDSKLGECPWQAVLINEK.G

55
N.PSPDIRIVNGM(+15.99)DSKLGEC(+71.04)PWQAVLINEK.G
R.HTCMLSSNFR.I
R.TQSIGYTSN.I

48
199

Venom
prothrombin
activator notecarinD2 (Q58L94)

PLA2-7 (B5G6G1)

Venom
prothrombin
activator porpharinD (Q58L93)

17

Venom
prothrombin
activator notecarinD1 (P82807)

R.HTC(+71.04)M(+15.99)LSSNFR.I
R.HTC(+71.04)MLSSNFR.I
K.KFVPPNSYYQNIDR.F
R.TQSIGYTSNILK.V
K.FVPPN(+.98)SYYQNIDR.F
K.FVPPNSYYQNIDR.F
R.TQ(+.98)SIGYTSNILK.V
K.FVPPNSYYQ(+.98)NIDR.F
R.FAYDYDIAIIR.M
K.TPIQFSENVVPAC(+71.04)LPTADFAK.E
L.NLLQFAFM(+15.99)IR.C
K.IHDDC(+71.04)YAR.A
K.SYSC(+71.04)APYWTLYSWK.C
Y.WTLYSWK.C
R.ITPN(+.98)M(+15.99)FCAGYDTLPRDACQGDSGGPHITAYR.D
R.ITPNM(+15.99)FCAGYDTLPRDACQ(+.98)GDSGGPHITAYR.D
R.ITPN(+.98)MFCAGYDTLPRDACQGDSGGPHITAYR.D
R.ITPN(+.98)M(+15.99)FCAGYDTLPRDACQ(+.98)GDSGGPHITAYR.D
R.ITPNMFCAGYDTLPRDACQGDSGGPHITAYR.D
R.ITPNMFCAGYDTLPRDACQ(+.98)GDSGGPHITAYR.D
R.ITPN(+.98)MFCAGYDTLPRDACQ(+.98)GDSGGPHITAYR.D
R.ITPN(+.98)M(+15.99)FCAGYDTLPRDACQGDSGGPHITAYR.D
R.ITPNM(+15.99)FCAGYDTLPRDACQ(+.98)GDSGGPHITAYR.D
R.ITPN(+.98)MFCAGYDTLPRDACQGDSGGPHITAYR.D
Y.VHQNFDR.V
R.FKEPTSN(+.98)TLK.V
R.FKEPTSNTLK.V
K.IYVHTK.F

37

27

37

200

Venom
prothrombin
activator notecarinD2 (Q58L94)
PLA2-7 (B5G6G1)
N. a. niger

O.
microlepidotus

N/A

N/A
Acidic
phospholipase A2
homolog taipoxin
gamma chain
(P00616)

17
Basic
phospholipase A2
taipoxin alpha
chain (P00614)

K.FVPPNYYYVHQN(+.98)FDR.V
R.VAYDYDIAIIR.M
R.DTHFITGIISWGEGC(+71.04)AR.K
K.FVPPNYYYVHQ(+.98)NFDR.V
K.FVPPNYYYVHQNFDR.V
R.TQSIGYTSNILK.V
K.FVPPN(+.98)SYYQNIDR.F
K.FVPPNSYYQNIDR.F
R.FAYDYDIAIIR.M
K.TPIQFSENVVPAC(+71.04)LPTADFAK.E
K.IHDDC(+71.04)YAR.A
K.SYSC(+71.04)APYWTLYSWK.C
L.NLLQFAFM(+15.99)IR.C

N/A
K.THDEC(+71.04)YAEAGK.L
S.SEIPQPSLDFEQFSN.M
G.PGGSGTPIDDLDR.C
S.LDFEQ(+.98)F.S
S.SEIPQPSLDFEQF.S
K.GGSGTPVDDLDR.C
S.GTPVDDLDR.C
NLLQFGFM(+15.99)IR.C
A.PYWTLYSWK.C
T.PVDDLDR.C
Y.WTLYSWK.C
R.SPYQNSN(+.98)WNINTK.A
N.SNWNINTK.A

32

30
N/A
30

42

201

NLLQFGFM.I
R.SRPVWH.Y
NLLQFGF.M

O. s. canni

90

OPHHA Histone
H4 (V8PGJ1)

17

Basic
phospholipase A2
taipoxin alpha
chain (P00614)

K.TVTAMDVVYALKR.Q
K.TVTAMDVVYALK.R
K.RKTVTAMDVVYALKR.Q
R.KTVTAMDVVYALKR.Q
K.VFLENVIRDAVTYTEHAK.R
R.ISGLIYEETR.G
R.ISGLIYEETRGVLK.V
K.TVTAM(+15.99)DVVYALKR.Q
R.DNIQGITKPAIR.R
R.DAVTYTEHAK.R
R.GVLKVFLENVIR.D
K.RISGLIYEETRGVLK.V
K.VFLENVIR.D
R.DNIQGITKPAIRR.L
R.SRPVWHYMDYGC(+71.04)YC(+71.04)GK.G
R.FGCAPYWTLYSWK.C
R.FGC(+71.04)APYWTLYSWK.C
R.SRPVWHYM(+15.99)DYGC(+71.04)YC(+71.04)GK.G
R.SRPVWHYMDYG.C
R.SRPVWHYMDY.G
R.SRPVWHYM(+15.99)DYG.C
R.SRPVWHYM.D
R.SRPVWHYMDYGC(+71.04)Y.C
R.SPYQNSNWN.I
R.SRPVWHYM(+15.99).D

64

52

202

T. carinatus

50

Venom
prothrombin
activator notecarinD1 (P82807)

R.FGC(+71.04)APYWTLY.S
R.SRPVWHYM(+15.99)DYGC(+71.04)YC(+71.04)G.K
R.RFGC(+71.04)APYWTLY.S
K.FVPPNYYYVHQNFDR.V
R.DTHFITGIISWGEGC(+71.04)AR.K
K.TPIQFSENVVPAC(+71.04)LPTADFANEVLMK.Q
K.FVPPNYYYVHQN(+.98)FDR.V
R.VAYDYDIAIIR.M
K.FVPPN(+.98)YYYVHQNFDR.V
R.VQSETQC(+71.04)SC(+71.04)AESYR.L
N.YYYVHQNFDR.V
K.TPIQFSENVVPAC(+71.04)LPTADFANEVLM(+15.99)K.Q
K.FVPPNYYYVHQ.N
K.TPIQFSENVVPAC(+71.04)LPTADFAN(+.98)EVLMK.Q
P.ACLPTADFANEVLMK.Q
R.M(+15.99)KTPIQFSENVVPAC(+71.04)LPTADFANEVLM(+15.99)K.Q
K.IYVHTK.F
Y.YVHQNFDR.V
R.FKEPTSNTLK.V
P.ACLPTADFANEVLM(+15.99)K.Q
K.FVPPNYYYVH.Q
K.FVPPNYYYVHQN.F
D.FANEVLM(+15.99)K.Q
R.FKEPTSN(+.98)TLK.V
K.YGVYTKVSR.F
Y.VHQNFDR.V
R.M(+15.99)KTPIQFSENVVPAC(+71.04)LPTADFANEVLMK.Q
K.TPIQFSENVVPACLPTADFAN(+.98)EVLMK.Q

64

203

PLA2-7 (B5G6G1)

Venom
prothrombin
activator notecarinD2 (Q58L94)
Basic
phospholipase A2
taipoxin alpha
chain (P00614)

Y.YVHQN(+.98)FDR.V
K.FVPPNYY.Y
K.C(+71.04)YGN(+.98)GPTC(+71.04)NSK.T
L.NLLQFAFM(+15.99)IR.C
R.RPVWHYMN.Y
K.IHDDC(+71.04)YAR.A
R.FVC(+71.04)DC(+71.04)DSK.A
R.RPVWHYMNY.G
R.RPVWHYM(+15.99)NYG.C
R.RPVWHYM(+15.99)N.Y
R.RPVWHYM(+15.99)NY.G
R.RRPVWHYMNY.G
L.NLLQFAF.M
R.RRPVWHYMN.Y
R.RRPVWHYM(+15.99)NY.G
R.RRPVWHYM(+15.99)N.Y
L.NLLQFAFM(+15.99).I
K.KFVPPNSYYQNIDR.F
R.TQSIGYTSNILK.V
K.FVPPNSYYQNIDR.F
R.FAYDYDIAIIR.M
K.TPIQFSENVVPAC(+71.04)LPTADFAK.E

60

44

K.GGSGTPVDDLDR.C
S.PYQNSN(+.98)WNIN(+.98)TK.A

32

S.PYQNSNWN(+.98)IN(+.98)TK.A
L.NLLQFAFM(+15.99)IR.C

204

PLA2-7 (B5G6G1)

17

Venom
prothrombin
activator notecarinD1 (P82807)
PLA2-4
(A6MFM9)
Venom
prothrombin
activator notecarinD2 (Q58L94)

K.IHDDC(+71.04)YAR.A
R.RPVWHYMN.Y
R.RPVWHYM(+15.99)NY.G
K.IYVHTK.F
R.FKEPTSNTLK.V
R.FKEPTSN(+.98)TLK.V
K.FVPPNYYYVHQNFDR.V
R.VAYDYDIAIIR.M
R.DTHFITGIISWGEGC(+71.04)AR.K
K.TPIQFSENVVPAC(+71.04)LPTADFANEVLM(+15.99)K.Q

45

35

Y.ASGPYCNSKTRC(+71.04)Q(+.98)RFVC(+71.04)ACDAAASR.C

32

K.KFVPPNSYYQNIDR.F
R.TQSIGYTSNILK.V
K.FVPPNSYYQNIDR.F
R.FAYDYDIAIIR.M

26
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